US20150025338A1 - Medical Device Inserters and Processes of Inserting and Using Medical Devices - Google Patents

Medical Device Inserters and Processes of Inserting and Using Medical Devices Download PDF

Info

Publication number
US20150025338A1
US20150025338A1 US14/509,985 US201414509985A US2015025338A1 US 20150025338 A1 US20150025338 A1 US 20150025338A1 US 201414509985 A US201414509985 A US 201414509985A US 2015025338 A1 US2015025338 A1 US 2015025338A1
Authority
US
United States
Prior art keywords
sensor
inserter
sharp
housing
analyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/509,985
Inventor
Daniel H. Lee
Michael Love
Louis George Pace
Phillip Yee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44673643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20150025338(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Priority to US14/509,985 priority Critical patent/US20150025338A1/en
Assigned to ABBOTT DIABETES CARE INC. reassignment ABBOTT DIABETES CARE INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LOVE, MICHAEL, LEE, DANIEL H., PACE, LOUIS G., YEE, PHILIP
Publication of US20150025338A1 publication Critical patent/US20150025338A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3468Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/14Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
    • A61B5/1405Devices for taking blood samples
    • A61B5/1411Devices for taking blood samples by percutaneous method, e.g. by lancet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14503Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14542Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150259Improved gripping, e.g. with high friction pattern or projections on the housing surface or an ergonometric shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150274Manufacture or production processes or steps for blood sampling devices
    • A61B5/150282Manufacture or production processes or steps for blood sampling devices for piercing elements, e.g. blade, lancet, canula, needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150389Hollow piercing elements, e.g. canulas, needles, for piercing the skin
    • A61B5/150396Specific tip design, e.g. for improved penetration characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150412Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • A61B5/150419Pointed piercing elements, e.g. needles, lancets for piercing the skin comprising means for capillary action
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150412Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • A61B5/150427Specific tip design, e.g. for improved penetration characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150503Single-ended needles
    • A61B5/150511Details of construction of shaft
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150847Communication to or from blood sampling device
    • A61B5/15087Communication to or from blood sampling device short range, e.g. between console and disposable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15107Piercing being assisted by a triggering mechanism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15107Piercing being assisted by a triggering mechanism
    • A61B5/15113Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15115Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15117Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising biased elements, resilient elements or a spring, e.g. a helical spring, leaf spring, or elastic strap
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15126Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides
    • A61B5/1513Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides comprising linear sliding guides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15186Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15186Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
    • A61B5/15188Constructional features of reusable driving devices
    • A61B5/1519Constructional features of reusable driving devices comprising driving means, e.g. a spring, for propelling the piercing unit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15186Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
    • A61B5/15188Constructional features of reusable driving devices
    • A61B5/15192Constructional features of reusable driving devices comprising driving means, e.g. a spring, for retracting the lancet unit into the driving device housing
    • A61B5/15194Constructional features of reusable driving devices comprising driving means, e.g. a spring, for retracting the lancet unit into the driving device housing fully automatically retracted, i.e. the retraction does not require a deliberate action by the user, e.g. by terminating the contact with the patient's skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/157Devices characterised by integrated means for measuring characteristics of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6848Needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6865Access ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00367Details of actuation of instruments, e.g. relations between pushing buttons, or the like, and activation of the tool, working tip, or the like
    • A61B2017/00371Multiple actuation, e.g. pushing of two buttons, or two working tips becoming operational
    • A61B2017/00384Actuation of one tool by pushing two buttons simultaneously
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/06Accessories for medical measuring apparatus
    • A61B2560/063Devices specially adapted for delivering implantable medical measuring apparatus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150053Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
    • A61B5/150106Means for reducing pain or discomfort applied before puncturing; desensitising the skin at the location where body is to be pierced
    • A61B5/15016Means for reducing pain or discomfort applied before puncturing; desensitising the skin at the location where body is to be pierced by accessories for bringing the piercing element into the body, e.g. through rotation of the piercing element
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150732Needle holders, for instance for holding the needle by the hub, used for example with double-ended needle and pre-evacuated tube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1585Needle inserters

Definitions

  • glucose levels or other analytes such as lactate, oxygen, AlC, or the like
  • the monitoring of glucose is particularly important to individuals with diabetes.
  • Diabetics generally monitor glucose levels to determine if their glucose levels are being maintained within a clinically safe range, and may also use this information to determine if and/or when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.
  • analyte(s) such as glucose
  • bodily fluid such as in the blood stream or in interstitial fluid (“ISF”), or other biological fluid.
  • ISF interstitial fluid
  • Some of these analyte measuring devices are configured so that at least a portion of the devices are positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user, so that the monitoring is accomplished in vivo.
  • An apparatus for inserting a medical device through the skin of a subject which includes a housing defining a longitudinal cavity therein and a interference member extending into the cavity; a biasing member; a driver member coupled to the biasing member for movement from a proximal position to a distal position and further configured for movement between a misaligned configuration in which the driver member is impeded from distal movement by the interference member and an aligned configuration in which the driver member is not impeded from distal movement by the interference member; and an actuator having an alignment surface for moving the driver member from the misaligned configuration to the aligned configuration.
  • the actuator is movable from a proximal position to a distal position. In some embodiments, distal movement of the actuator compresses the first biasing member. In some embodiments, the first position of the driver member is at an oblique angle with respect to the longitudinal cavity. In some embodiments, the second position of the driver member includes a configuration substantially aligned with the longitudinal cavity.
  • An apparatus for inserting a medical device through the skin of a subject which includes a housing defining a cantilever member; a sharp movable within the housing from a retracted position to a partially exposed position; and an electrochemical sensor releasably coupled to the sharp for movement with the sharp, and for subsequent insertion in the skin of a subject; wherein the cantilever member resiliently contacts at least one of the sharp and the sensor.
  • the housing includes a distal opening for release of the electrochemical sensor therefrom.
  • the housing defines a longitudinal notch for reception of a drive member of an inserter.
  • the housing contains a desiccant.
  • the housing defines one or more longitudinal ridges for aligning one of the sharp and the sensor.
  • FIG. 1 illustrates an analyte monitoring system for real time analyte (e.g., glucose) measurement, data acquisition and/or processing in certain embodiments;
  • analyte e.g., glucose
  • FIGS. 2-3 are views of an electrochemical sensor in accordance with a further embodiment of the disclosed subject matter
  • FIGS. 4-5 are schematic views of a needle hub in accordance with one embodiment of the disclosed subject matter
  • FIG. 6 is a distal end view of a sharp in accordance with one embodiment of the disclosed subject matter
  • FIG. 7 is a side view of a sharp in accordance with one embodiment of the disclosed subject matter.
  • FIG. 8 is a side view of a sharp in accordance with one embodiment of the disclosed subject matter.
  • FIG. 9 is a perspective view of a sharp in accordance with one embodiment of the disclosed subject matter.
  • FIG. 10 is a schematic view of an alternate embodiment for forming a sharp to be used in an inserter in accordance with one embodiment of the disclosed subject matter
  • FIG. 11 is a perspective view of an inserter in accordance with one embodiment of the disclosed subject matter.
  • FIG. 12 is a perspective view with parts separated of an inserter in accordance with one embodiment of the disclosed subject matter
  • FIG. 13 is an enlarged sectional view with parts separated of an inserter in accordance with one embodiment of the disclosed subject matter
  • FIG. 14 is a side view of another inserter in accordance with the disclosed subject matter.
  • FIGS. 15-17 are sectional, perspective views of the inserter of FIG. 14 in accordance with another embodiment of the disclosed subject matter
  • FIG. 18 is a perspective view of another inserter in accordance with the disclosed subject matter.
  • FIGS. 19-21 are side views with transparency of the inserter of FIG. 18 in accordance with another embodiment of the disclosed subject matter
  • FIG. 22 is a perspective view of another inserter in accordance with the disclosed subject matter.
  • FIGS. 23-25 are sectional, perspective views of the inserter of FIG. 22 in accordance with another embodiment of the disclosed subject matter
  • FIG. 26 is a sectional view in section of another embodiment of an inserter in accordance with the disclosed subject matter.
  • FIG. 27 is a perspective view of the inserter of FIG. 26 in accordance with the disclosed subject matter.
  • FIGS. 28-31 are perspective views of components of the inserter of FIG. 26 in accordance with the disclosed subject matter
  • FIG. 32 illustrates an exploded view of the inserter of FIG. 26 in accordance with the disclosed subject matter
  • FIG. 33 is a side view of the inserter of FIG. 26 in accordance with the disclosed subject matter.
  • FIGS. 34-36 are side views with transparency of the inserter of FIG. 26 in accordance with the disclosed subject matter
  • FIG. 37 is an inserter in accordance with another embodiment in accordance with the disclosed subject matter.
  • FIG. 38 is a perspective view in section of the inserter of FIG. 37 in accordance with the disclosed subject matter.
  • FIG. 39 is a cross-sectional view of the inserter of FIG. 37 in accordance with the disclosed subject matter.
  • FIG. 40 is a side view of the inserter of FIG. 37 in accordance with the disclosed subject matter.
  • FIGS. 41-44 are perspective views of components of the inserter of FIG. 37 in accordance with the disclosed subject matter
  • FIG. 45 is an exploded view of the inserter of FIG. 37 in accordance with the disclosed subject matter.
  • FIG. 46 is a side view with transparency of the inserter of FIG. 37 in accordance with the disclosed subject matter.
  • FIGS. 47-51 are perspective views of another inserter in accordance with the disclosed subject matter.
  • FIG. 52 is an exploded perspective view of another embodiment of the disclosed subject matter.
  • FIG. 53 is a sectional view of an inserter in accordance with the disclosed subject matter.
  • FIGS. 54-55 are perspective views from below of the inserter of FIG. 53 ;
  • FIG. 56 is a perspective view of another inserter in accordance with the disclosed subject matter.
  • FIGS. 57-60 are perspective views of various components of the inserter of FIG. 56 ;
  • FIG. 61-62 are perspective views of various components of the inserter of FIG. 56 ;
  • FIGS. 63-65 depict different subassemblies of the components of the inserter of FIG. 56 ;
  • FIGS. 66-67 are cross-sectional views of a subassembly of the components of the inserter of FIG. 56 ;
  • FIGS. 68-70 depict the steps used to actuate the inserter of FIG. 56 ;
  • FIG. 71 is a perspective view of an inserter assembly in accordance with the disclosed subject matter.
  • FIG. 72 is a perspective view of a component of an inserter assembly of FIG. 71 in accordance with the disclosed subject matter
  • FIG. 73 is a perspective view of a component of an analyte measurement system in accordance with the disclosed subject matter.
  • FIG. 74 is a perspective view with parts separated of the inserter assembly of FIG. 71 in accordance with the disclosed subject matter;
  • FIG. 75 is a cross-sectional view of the inserter assembly of FIG. 71 in accordance with the disclosed subject matter
  • FIG. 76 is a side view of a portion of an inserter assembly in accordance with the disclosed subject matter.
  • FIG. 77 is a view of an analyte sensor in accordance with the disclosed subject matter.
  • FIGS. 78-79 are perspective views of a portion of an inserter assembly in accordance with the disclosed subject matter.
  • FIGS. 80-90 are views of analyte sensors in accordance with the disclosed subject matter.
  • FIGS. 91-92 are cross-sectional views of an inserter assembly in accordance with the disclosed subject matter.
  • FIGS. 93-94 are cross-sectional views of another inserter assembly in accordance with the disclosed subject matter.
  • FIGS. 95-96 are cross-sectional views of a further inserter assembly in accordance with the disclosed subject matter.
  • FIGS. 97-98 are views of a portion of an inserter assembly in accordance with the disclosed subject matter.
  • FIG. 99 is a cross-sectional view of a portion of an inserter assembly in accordance with the disclosed subject matter.
  • FIGS. 100-101 are perspective views of a portion of an inserter assembly in accordance with the disclosed subject matter.
  • FIGS. 102-105 are side views of various inserter assemblies in accordance with the disclosed subject matter.
  • FIGS. 106-112 are views of a sharp and sharp carrier in accordance with the disclosed subject matter
  • FIG. 113 is a perspective view of a portion of an inserter assembly in accordance with the disclosed subject matter.
  • FIGS. 114-117 are perspective views illustrating the operation of an inserter assembly in accordance with the disclosed subject matter
  • FIG. 118 is a side view of an inserter assembly in accordance with the disclosed subject matter.
  • FIGS. 119-121 are cross-sectional views of an inserter assembly in accordance with the disclosed subject matter.
  • FIG. 122 is a perspective view with parts separated of an embodiment of a sharp/sensor cartridge in accordance with the disclosed subject matter
  • FIG. 123 is a perspective view of the cartridge of FIG. 122 in a first stage of deployment in accordance with the disclosed subject matter;
  • FIG. 124 is a cross-sectional view of the cartridge of FIG. 122 in a neutral state in accordance with the disclosed subject matter;
  • FIG. 125 is a perspective view of the cartridge of FIG. 122 in a neutral state in accordance with the disclosed subject matter;
  • FIG. 126 is a cross-sectional view of the cartridge of FIG. 122 in a first stage of deployment in accordance with the disclosed subject matter;
  • FIG. 127 is a perspective view of the cartridge of FIG. 122 in a second stage of deployment in accordance with the disclosed subject matter;
  • FIG. 128 is a cross-sectional view of the cartridge of FIG. 122 in a second stage of deployment in accordance with the disclosed subject matter;
  • FIG. 129 is a perspective view of the cartridge of FIG. 122 in a third stage of deployment in accordance with the disclosed subject matter;
  • FIG. 130 is a cross-sectional view of the cartridge of FIG. 122 in a third stage of deployment in accordance with the disclosed subject matter;
  • FIG. 131 is a perspective view with parts separated of another embodiment of a component of an inserter in accordance with the disclosed subject matter
  • FIG. 132 is a perspective view of the cartridge of FIG. 131 in a neutral state in accordance with the disclosed subject matter;
  • FIG. 133 is a cross-sectional view of the cartridge of FIG. 131 in a neutral state in accordance with the disclosed subject matter;
  • FIG. 134 is a perspective view of the cartridge of FIG. 131 in a second stage of deployment in accordance with the disclosed subject matter;
  • FIG. 135 is a cross-sectional view of the cartridge of FIG. 131 in a second stage of deployment in accordance with the disclosed subject matter;
  • FIG. 136 is a perspective view of the cartridge of FIG. 131 in a third stage of deployment in accordance with the disclosed subject matter.
  • FIG. 137 is a cross-sectional view of the cartridge of FIG. 131 in a third stage of deployment in accordance with the disclosed subject matter.
  • embodiments of the present disclosure relate to an apparatus for inserting a medical device at least partially into the skin of the patient.
  • Some embodiments relate to in vivo methods and devices for detecting at least one analyte such as glucose in body fluid.
  • embodiments include in vivo analyte sensors configured so that at least a portion of the sensor is positioned in the body of a user (e.g., within the ISF), to obtain information about at least one analyte of the body, e.g., transcutaneously positioned in user's body.
  • an in vivo analyte sensor is coupled to an electronics unit that is maintained on the body of the user to process information obtained from the sensor.
  • analyte information is communicated from a first device such as an on body electronics unit to a second device which may include user interface features, including a display, and/or the like.
  • Information may be communicated from the first device to the second device automatically and/or continuously when the analyte information is available, or may not be communicated automatically and/or continuously, but rather stored or logged in a memory of the first device.
  • analyte information derived by the sensor/on body electronics for example, on body electronics
  • the display of information is selected by the user, while the timing of data communication is not.
  • analyte information is only provided or evident to a user (provided at a user interface device) in some embodiments when desired by the user even though an in vivo analyte sensor automatically and/or continuously monitors the analyte level in vivo, i.e., the sensor automatically monitors analyte such as glucose on a pre-defined time interval over its usage life.
  • an analyte sensor may be positioned in vivo and coupled to on body electronics for a given sensing period, e.g., about 14 days.
  • the sensor-derived analyte information is automatically communicated from the sensor electronics assembly to a remote monitor device or display device for output to a user throughout the 14 day period according to a schedule programmed at the on body electronics (e.g., about every 1 minute or about every 5 minutes or about every 10 minutes, or the like).
  • sensor-derived analyte information is only communicated from the sensor electronics assembly to a remote monitor device or display device at user-determined times, e.g., whenever a user decides to check analyte information. At such times, a communications system is activated and sensor-derived information is then sent from the on body electronics to the remote device or display device.
  • the information may be communicated from the first device to the second device automatically and/or continuously when the analyte information is available, and the second device stores or logs the received information without presenting or outputting the information to the user.
  • the information is received by the second device from the first device when the information becomes available (e.g., when the sensor detects the analyte level according to a time schedule).
  • the received information is initially stored in the second device and only output to a user interface or an output component of the second device (e.g., display) upon detection of a request for the information on the second device.
  • an inserter as described herein is used to place a sensor electronics assembly on the body so that at least a portion of the in vivo sensor is in contact with bodily fluid such as ISF.
  • sensor derived analyte information may be communicated from the on body electronics to a display device on-demand by powering on the display device (or it may be continually powered), and executing a software algorithm stored in and accessed from a memory of the display device, to generate one or more request commands, control signal or data packet to send to the on body electronics.
  • the software algorithm executed under, for example, the control of the microprocessor or application specific integrated circuit (ASIC) of the display device may include routines to detect the position of the on body electronics relative to the display device to initiate the transmission of the generated request command, control signal and/or data packet.
  • ASIC application specific integrated circuit
  • Display devices may also include programming stored in memory for execution by one or more microprocessors and/or ASICs to generate and transmit the one or more request command, control signal or data packet to send to the on body electronics in response to a user activation of an input mechanism on the display device such as depressing a button on the display device, triggering a soft button associated with the data communication function, and so on.
  • the input mechanism may be alternatively or additionally provided on or in the on body electronics which may be configured for user activation.
  • voice commands or audible signals may be used to prompt or instruct the microprocessor or ASIC to execute the software routine(s) stored in the memory to generate and transmit the one or more request command, control signal or data packet to the on body device.
  • on body electronics and/or display device includes a microphone, a speaker, and processing routines stored in the respective memories of the on body electronics and/or the display device to process the voice commands and/or audible signals.
  • positioning the on body electronics and the display device within a predetermined distance (e.g., close proximity) relative to each other initiates one or more software routines stored in the memory of the display device to generate and transmit a request command, control signal or data packet.
  • Different types and/or forms and/or amounts of information may be sent for each on demand reading, including but not limited to one or more of current analyte level information (i.e., real time or the most recently obtained analyte level information temporally corresponding to the time the reading is initiated), rate of change of an analyte over a predetermined time period, rate of the rate of change of an analyte (acceleration in the rate of change), historical analyte information corresponding to analyte information obtained prior to a given reading and stored in memory of the assembly.
  • Some or all of real time, historical, rate of change, rate of rate of change (such as acceleration or deceleration) information may be sent to a display device for a given reading.
  • the type and/or form and/or amount of information sent to a display device may be preprogrammed and/or unchangeable (e.g., preset at manufacturing), or may not be preprogrammed and/or unchangeable so that it may be selectable and/or changeable in the field one or more times (e.g., by activating a switch of the system, etc).
  • a display device will output a current (real time) sensor-derived analyte value (e.g., in numerical format), a current rate of analyte change (e.g., in the form of an analyte rate indicator such as an arrow pointing in a direction to indicate the current rate), and analyte trend history data based on sensor readings acquired by and stored in memory of on body electronics (e.g., in the form of a graphical trace).
  • the on skin or sensor temperature reading or measurement associated with each on demand reading may be communicated from the on body electronics to the display device.
  • the temperature reading or measurement may not be output or displayed on the display device, but rather, used in conjunction with a software routine executed by the display device to correct or compensate the analyte measurement output to the user on the display device.
  • embodiments include inserters for in vivo analyte sensors and on body electronics that together provide body wearable sensor electronics assemblies.
  • in vivo analyte sensors are fully integrated with on body electronics (fixedly connected during manufacture), while in other embodiments they are separate but connectable post manufacture (e.g., before, during or after sensor insertion into a body).
  • On body electronics may include an in vivo glucose sensor, electronics, battery, and antenna encased (except for the sensor portion that is for in vivo positioning) in a waterproof housing that includes or is attachable to an adhesive pad.
  • the housing withstands immersion in about one meter of water for up to at least 30 minutes.
  • the housing withstands continuous underwater contact, e.g., for longer than about 30 minutes, and continues to function properly according to its intended use, e.g., without water damage to the housing electronics where the housing is suitable for water submersion.
  • Embodiments include sensor insertion devices, which also may be referred to herein as sensor delivery units, or the like. Insertion devices may retain on body electronics assemblies completely in an interior compartment, i.e., an insertion device may be “pre-loaded” with on body electronics assemblies during the manufacturing process (e.g., on body electronics may be packaged in a sterile interior compartment of an insertion device). In such embodiments, insertion devices may form sensor assembly packages (including sterile packages) for pre-use or new on body electronics assemblies, and insertion devices configured to apply on body electronics assemblies to recipient bodies.
  • sensor assembly packages including sterile packages
  • Embodiments include portable handheld display devices, as separate devices and spaced apart from an on body electronics assembly, that collect information from the assemblies and provide sensor derived analyte readings to users. Such devices may also be referred to as meters, readers, monitors, receivers, human interface devices, companions, or the like. Certain embodiments may include an integrated in vitro analyte meter.
  • display devices include one or more wired or wireless communications ports such as USB, serial, parallel, or the like, configured to establish communication between a display device and another unit (e.g., on body electronics, power unit to recharge a battery, a PC, etc).
  • a display device communication port may enable charging a display device battery with a respective charging cable and/or data exchange between a display device and its compatible informatics software.
  • Compatible informatics software in certain embodiments include, for example, but not limited to stand alone or network connection enabled data management software program, resident or running on a display device, personal computer, a server terminal, for example, to perform data analysis, charting, data storage, data archiving and data communication as well as data synchronization.
  • Informatics software in certain embodiments may also include software for executing field upgradable functions to upgrade firmware of a display device and/or on body electronics unit to upgrade the resident software on the display device and/or the on body electronics unit, e.g., with versions of firmware that include additional features and/or include software bugs or errors fixed, etc.
  • Embodiments may include a haptic feedback feature such as a vibration motor or the like, configured so that corresponding notifications (e.g., a successful on-demand reading received at a display device), may be delivered in the form of haptic feedback.
  • Embodiments include programming embedded on a computer readable medium, i.e., computer-based application software (may also be referred to herein as informatics software or programming or the like) that processes analyte information obtained from the system and/or user self-reported data.
  • Application software may be installed on a host computer such as a mobile telephone, PC, an Internet-enabled human interface device such as an Internet-enabled phone, personal digital assistant, or the like, by a display device or an on body electronics unit.
  • Informatics programming may transform data acquired and stored on a display device or on body unit for use by a user.
  • Embodiments of the subject disclosure are described primarily with respect to glucose monitoring devices and systems, and methods of glucose monitoring, for convenience only and such description is in no way intended to limit the scope of the disclosure. It is to be understood that the analyte monitoring system may be configured to monitor a variety of analytes at the same time or at different times.
  • embodiments include devices, systems, kits and/or methods to monitor one or more physiological parameters such as, for example, but not limited to, analyte levels, temperature levels, heart rate, user activity level, over a predetermined monitoring time period. Also provided are methods of manufacturing.
  • Predetermined monitoring time periods may be less than about 1 hour, or may include about 1 hour or more, e.g., about a few hours or more, e.g., about a few days of more, e.g., about 3 or more days, e.g., about 5 days or more, e.g., about 7 days or more, e.g., about 10 days or more, e.g., about 14 days or more, e.g., about several weeks, e.g., about 1 month or more.
  • one or more features of the system may be automatically deactivated or disabled at the on body electronics assembly and/or display device.
  • a predetermined monitoring time period may begin with positioning the sensor in vivo and in contact with a body fluid such as ISF, and/or with the initiation (or powering on to full operational mode) of the on body electronics.
  • Initialization of on body electronics may be implemented with a command generated and transmitted by a display device in response to the activation of a switch and/or by placing the display device within a predetermined distance (e.g., close proximity) to the on body electronics, or by user manual activation of a switch on the on body electronics unit, e.g., depressing a button, or such activation may be caused by the insertion device, e.g., as described in U.S.
  • the on body electronics When initialized in response to a received command from a display device, the on body electronics retrieves and executes from its memory software routine to fully power on the components of the on body electronics, effectively placing the on body electronics in full operational mode in response to receiving the activation command from the display device. For example, prior to the receipt of the command from the display device, a portion of the components in the on body electronics may be powered by its internal power supply such as a battery while another portion of the components in the on body electronics may be in powered down or maintained in a low power state including no power state, inactive mode, or all components may be in an inactive, powered down mode. Upon receipt of the command, the remaining portion (or all) of the components of the on body electronics is switched to active, fully operational mode.
  • Embodiments of on body electronics may include one or more printed circuit boards with electronics including control logic implemented in ASIC, microprocessors, memory, and the like, and transcutaneously positionable analyte sensors forming a single assembly.
  • On body electronics may be configured to provide one or more signals or data packets associated with a monitored analyte level upon detection of a display device of the analyte monitoring system within a predetermined proximity for a period of time (for example, about 2 minutes, e.g., 1 minute or less, e.g., about 30 seconds or less, e.g., about 10 seconds or less, e.g., about 5 seconds or less, e.g., about 2 seconds or less) and/or until a confirmation, such as an audible and/or visual and/or tactile (e.g., vibratory) notification, is output on the display device indicating successful acquisition of the analyte related signal from the on body electronics.
  • a distinguishing notification may also be output for unsuccessful acquisition in certain embodiment
  • the monitored analyte level may be correlated and/or converted to glucose levels in blood or other fluids such as ISF. Such conversion may be accomplished with the on body electronics, but in many embodiments will be accomplished with display device electronics.
  • glucose level is derived from the monitored analyte level in the ISF.
  • Analyte sensors may be insertable into a vein, artery, or other portion of the body containing analyte.
  • analyte sensors may be positioned in contact with ISF to detect the level of analyte, where the detected analyte level may be used to infer the user's glucose level in blood or interstitial tissue.
  • Embodiments include transcutaneous sensors and also wholly implantable sensors and wholly implantable assemblies in which a single assembly including the analyte sensor and electronics are provided in a sealed housing (e.g., hermetically sealed biocompatible housing) for implantation in a user's body for monitoring one or more physiological parameters.
  • a sealed housing e.g., hermetically sealed biocompatible housing
  • Embodiments include analyte monitors that are provided in small, lightweight, battery-powered and electronically-controlled systems. Such systems may be configured to detect physical parameters of subjects, such as signals indicative of in vivo analyte levels using an electrochemical sensor, and collect such signals, with or without processing. Any suitable measurement technique may be used to obtain signals from the sensors, e.g., may detect current, may employ potentiometry, etc. Techniques may include, but are not limited to amperometry, coulometry, and voltammetry. In some embodiments, sensing systems may be optical, colorimetric, and the like. In some embodiments, the portion of the system that performs this initial processing may be configured to provide the raw or at least initially processed data to another unit for further collection and/or processing. Such provision of data may be affected, for example, by a wired connection, such as an electrical, or by a wireless connection, such as an IR or RF connection.
  • a wired connection such as an electrical
  • a wireless connection such as an IR
  • the analyte sensor is in communication with on body electronics.
  • the on-body unit may include a housing in which the on body electronics and at least a portion of the sensor are received.
  • the on-body unit may be separately provided as a physically distinct assembly from a monitor unit, e.g., which displays or otherwise indicates analyte levels to a user.
  • the on-body unit may be configured to provide the analyte levels detected by the sensor and/or other information (such as temperature, sensor life, etc.) over a communication link to the monitor unit.
  • the monitor unit in some embodiments, may include, e.g., a mobile telephone device, an in vitro glucose meter, a personal digital assistant, or other consumer electronics such as MP3 device, camera, radio, personal computer, etc., or other communication-enabled data-processing device.
  • the display unit may perform a variety of functions such as but not limited to data storage and/or processing and/or analysis and/or communication, etc., on the received analyte data to generate information pertaining to the monitored analyte levels and/or process the other information.
  • the monitor unit may incorporate a display screen, which can be used, for example, to display measured analyte levels, and/or an audio component such as a speaker to audibly provide information to a user, and/or a vibration device to provide tactile feedback to a user.
  • an analyte-monitoring system it is also useful for a user of an analyte-monitoring system to be able to see trend indications (including the magnitude and direction of any ongoing trend, e.g., the rate of change of an analyte or other parameter, and the amount of time a subject is above and/or below a threshold, such as a hypoglycemic and/or hyperglycemic threshold, etc.); such data may be displayed either numerically, or by a visual indicator such as an arrow that may vary in visual attributes, like size, shape, color, animation, or direction.
  • the monitor unit may further be adapted to receive information from or about an in vitro analyte test strip, which may be manually or automatically entered into the monitor unit.
  • a monitor unit may incorporate an in vitro analyte test strip port and related electronics in order to be able to make discrete (e.g., blood glucose) measurements using an in vitro test strip (see, e.g., U.S. Pat. No. 6,175,752, the disclosure of which is incorporated by reference herein for all purposes).
  • discrete e.g., blood glucose
  • the modularity of these systems may vary where one or more components may be constructed to be single use and one or more may be constructed to be re-useable.
  • the sensor is designed to be attachable and detachable from the on body electronics (and the on-body unit may be reusable), e.g., so that one or more of the components may be reused one or more times, while in other embodiments, the sensor and on body electronics may be provided as an integrated, undetachable package, which may be designed to be disposable after use, i.e., not re-used.
  • FIG. 1 shows an exemplary in vivo-based analyte monitoring system 100 in accordance with embodiments of the present disclosure.
  • analyte monitoring system 100 includes on body electronics 1100 electrically coupled to in vivo analyte sensor 14 (a proximal portion of which is shown in FIG. 1 ), and attached to adhesive layer 218 for attachment on a skin surface on the body of a user.
  • body electronics 1100 includes on body housing 122 that defines an interior compartment.
  • insertion device 200 (or insertion devices 300 , 400 , 2400 , 2500 , 2700 , 3700 described herein) that, when operated, transcutaneously positions a portion of analyte sensor 14 through a skin surface and in fluid contact with ISF, and positions on body electronics 1100 and adhesive layer 218 on a skin surface, as will be described in greater detail herein.
  • analyte sensor 14 and adhesive layer 218 are sealed within the housing of insertion device 200 before use, and in certain embodiments, adhesive layer 218 is also sealed within the housing or the adhesive layer can provide a seal for preserving the sterility of the apparatus.
  • analyte monitoring system 100 includes display device 1200 which includes a display 1220 to output information to the user, an input component 1210 such as a button, actuator, a touch sensitive switch, a capacitive switch, pressure sensitive switch, jog wheel or the like, to input data or command to display device 1200 or otherwise control the operation of display device 1200 .
  • display-less devices or devices without any user interface components. These devices may be functionalized to store data as a data logger and/or provide a conduit to transfer data from on body electronics and/or a display-less device to another device and/or location.
  • Embodiments will be described herein as display devices for exemplary purposes which are in no way intended to limit the embodiments of the present disclosure. It will be apparent that display-less devices may also be used in certain embodiments.
  • on body electronics 1100 may be configured to store some or all of the monitored analyte related data received from analyte sensor 14 in a memory during the monitoring time period, and maintain it in memory until the usage period ends.
  • stored data is retrieved from on body electronics 1100 at the conclusion of the monitoring time period, for example, after removing analyte sensor 14 from the user by detaching on body electronics 1100 from the skin surface where it was positioned during the monitoring time period.
  • real time monitored analyte level is not communicated to display device 1200 during the monitoring period or otherwise transmitted from on body electronics 1100 , but rather, retrieved from on body electronics 1100 after the monitoring time period.
  • input component 1210 of display device 1200 may include a microphone and display device 1200 may include software configured to analyze audio input received from the microphone, such that functions and operation of the display device 1200 may be controlled by voice commands.
  • an output component of display device 1200 includes a speaker for outputting information as audible signals. Similar voice responsive components such as a speaker, microphone and software routines to generate, process and store voice driven signals may be provided to on body electronics 1100 .
  • display 1220 and input component 1210 may be integrated into a single component, for example a display that can detect the presence and location of a physical contact touch upon the display such as a touch screen user interface.
  • the user may control the operation of display device 1200 by utilizing a set of pre-programmed motion commands, including, but not limited to, single or double tapping the display, dragging a finger or instrument across the display, motioning multiple fingers or instruments toward one another, motioning multiple fingers or instruments away from one another, etc.
  • a display includes a touch screen having areas of pixels with single or dual function capacitive elements that serve as LCD elements and touch sensors.
  • Display device 1200 also includes data communication port 1230 for wired data communication with external devices such as remote terminal (personal computer) 1700 , for example.
  • Example embodiments of the data communication port 1230 include USB port, mini USB port, RS-232 port, Ethernet port, Firewire port, or other similar data communication ports configured to connect to the compatible data cables.
  • Display device 1200 may also include an integrated in vitro glucose meter, including in vitro test strip port 1240 to receive an in vitro glucose test strip for performing in vitro blood glucose measurements.
  • display 1220 in certain embodiments is configured to display a variety of information—some or all of which may be displayed at the same or different time on display 1220 .
  • the displayed information is user-selectable so that a user can customize the information shown on a given display screen.
  • Display 1220 may include but is not limited to graphical display 1380 , for example, providing a graphical output of glucose values over a monitored time period (which may show important markers such as meals, exercise, sleep, heart rate, blood pressure, etc, numerical display 1320 , for example, providing monitored glucose values (acquired or received in response to the request for the information), and trend or directional arrow display 1310 that indicates a rate of analyte change and/or a rate of the rate of analyte change, e.g., by moving locations on display 1220 .
  • graphical display 1380 for example, providing a graphical output of glucose values over a monitored time period (which may show important markers such as meals, exercise, sleep, heart rate, blood pressure, etc, numerical display 1320 , for example, providing monitored glucose values (acquired or received in response to the request for the information), and trend or directional arrow display 1310 that indicates a rate of analyte change and/or a rate of the rate of analyte change
  • display 1220 may also include date display 1350 providing for example, date information for the user, time of day information display 1390 providing time of day information to the user, battery level indicator display 1330 which graphically shows the condition of the battery (rechargeable or disposable) of the display device 1200 , sensor calibration status icon display 1340 for example, in monitoring systems that require periodic, routine or a predetermined number of user calibration events, notifying the user that the analyte sensor calibration is necessary, audio/vibratory settings icon display 1360 for displaying the status of the audio/vibratory output or alarm state, and wireless connectivity status icon display 1370 that provides indication of wireless communication connection with other devices such as on body electronics, data processing module 1600 , and/or remote terminal 1700 .
  • display 1220 may further include simulated touch screen button 1250 , 1260 for accessing menus, changing display graph output configurations or otherwise for controlling the operation of display device 1200 .
  • display 1220 of display device 1200 may be additionally, or instead of visual display, configured to output alarms notifications such as alarm and/or alert notifications, glucose values etc, which may be audible, tactile, or any combination thereof.
  • the display device 1200 may include other output components such as a speaker, vibratory output component and the like to provide audible and/or vibratory output indication to the user in addition to the visual output indication provided on display 1220 . Further details and other display embodiments can be found in, e.g., U.S. patent application Ser. No. 12/871,901, U.S. provisional application Nos. 61/238,672, 61/247,541, 61/297,625, the disclosures of each of which are incorporated herein by reference for all purposes.
  • on body electronics 1100 in certain embodiments is configured to wirelessly communicate analyte related data (such as, for example, data corresponding to monitored analyte level and/or monitored temperature data, and/or stored historical analyte related data) when on body electronics 1100 receives a command or request signal from display device 1200 .
  • analyte related data such as, for example, data corresponding to monitored analyte level and/or monitored temperature data, and/or stored historical analyte related data
  • on body electronics 1100 may be configured to at least periodically broadcast real time data associated with monitored analyte level which is received by display device 1200 when display device 1200 is within communication range of the data broadcast from on body electronics 1100 , i.e., it does not need a command or request from a display device to send information.
  • display device 1200 may be configured to transmit one or more commands to on body electronics 1100 to initiate data transfer, and in response, on body electronics 1100 may be configured to wirelessly transmit stored analyte related data collected during the monitoring time period to display device 1200 .
  • Display device 1200 may in turn be connected to a remote terminal 1700 such as a personal computer and functions as a data conduit to transfer the stored analyte level information from the on body electronics 1100 to remote terminal 1700 .
  • the received data from the on body electronics 1100 may be stored (permanently or temporarily) in one or more memory of the display device 1200 .
  • display device 1200 is configured as a data conduit to pass the data received from on body electronics 1100 to remote terminal 1700 that is connected to display device 1200 .
  • Remote terminal 1700 may include a personal computer, a server terminal a laptop computer or other suitable data processing devices including software for data management and analysis and communication with the components in the analyte monitoring system 100 .
  • remote terminal 1700 may be connected to a local area network (LAN), a wide area network (WAN), or other data network for uni-directional or bi-directional data communication between remote terminal 1700 and display device 1200 and/or data processing module 1600 .
  • LAN local area network
  • WAN wide area network
  • Remote terminal 1700 in certain embodiments may include one or more computer terminals located at a physician's office or a hospital.
  • remote terminal 1700 may be located at a location other than the location of display device 1200 .
  • Remote terminal 1700 and display device 1200 could be in different rooms or different buildings.
  • Remote terminal 1700 and display device 1200 could be at least about one mile apart, e.g., at least about 100 miles apart, e.g., at least about 1000 miles apart.
  • remote terminal 1700 could be in the same city as display device 1200 , remote terminal 1700 could be in a different city than display device 1200 , remote terminal 1700 could be in the same state as display device 1200 , remote terminal 1700 could be in a different state than display device 1200 , remote terminal 1700 could be in the same country as display device 1200 , or remote terminal 1700 could be in a different country than display device 1200 , for example.
  • Data processing module 1600 may include components to communicate using one or more wireless communication protocols such as, for example, but not limited to, infrared (IR) protocol, Bluetooth® protocol, Zigbee® protocol, and 802.11 wireless LAN protocol. Additional description of communication protocols including those based on Bluetooth® protocol and/or Zigbee® protocol can be found in U.S. Patent Publication No. 2006/0193375 incorporated herein by reference for all purposes.
  • IR infrared
  • Bluetooth® protocol Bluetooth® protocol
  • Zigbee® protocol Zigbee® protocol
  • 802.11 wireless LAN protocol 802.11 wireless LAN protocol
  • Data processing module 1600 may further include communication ports, drivers or connectors to establish wired communication with one or more of display device 1200 , on body electronics 1100 , or remote terminal 1700 including, for example, but not limited to USB connector and/or USB port, Ethernet connector and/or port, FireWire connector and/or port, or RS-232 port and/or connector.
  • data processing module 1600 is programmed to transmit a polling or query signal to on body electronics 1100 at a predetermined time interval (e.g., once every minute, once every five minutes, or the like), and in response, receive the monitored analyte level information from on body electronics 1100 .
  • Data processing module 1600 stores in its memory the received analyte level information, and/or relays or retransmits the received information to another device such as display device 1200 .
  • data processing module 1600 may be configured as a data relay device to retransmit or pass through the received analyte level data from on body electronics 1100 to display device 1200 or a remote terminal (for example, over a data network such as a cellular or WiFi data network) or both.
  • a data relay device to retransmit or pass through the received analyte level data from on body electronics 1100 to display device 1200 or a remote terminal (for example, over a data network such as a cellular or WiFi data network) or both.
  • on body electronics 1100 and data processing module 1600 may be positioned on the skin surface of the user within a predetermined distance of each other (for example, about 1-12 inches, or about 1-10 inches, or about 1-7 inches, or about 1-5 inches) such that periodic communication between on body electronics 1100 and data processing module 1600 is maintained.
  • data processing module 1600 may be worn on a belt or clothing item of the user, such that the desired distance for communication between the on body electronics 1100 and data processing module 1600 for data communication is maintained.
  • the housing of data processing module 1600 may be configured to couple to or engage with on body electronics 1100 such that the two devices are combined or integrated as a single assembly and positioned on the skin surface.
  • data processing module 1600 is detachably engaged or connected to on body electronics 1100 providing additional modularity such that data processing module 1600 may be optionally removed or reattached as desired.
  • data processing module 1600 is programmed to transmit a command or signal to on body electronics 1100 at a predetermined time interval such as once every minute, or once every 5 minutes or once every 30 minutes or any other suitable or desired programmable time interval to request analyte related data from on body electronics 1100 .
  • a predetermined time interval such as once every minute, or once every 5 minutes or once every 30 minutes or any other suitable or desired programmable time interval to request analyte related data from on body electronics 1100 .
  • data processing module 1600 receives the requested analyte related data, it stores the received data.
  • analyte monitoring system 100 may be configured to receive the continuously monitored analyte related information at the programmed or programmable time interval, which is stored and/or displayed to the user.
  • the stored data in data processing module 1600 may be subsequently provided or transmitted to display device 1200 , remote terminal 1700 or the like for subsequent data analysis such as identifying frequency of periods of glycemic level excursions over the monitored time period, or the frequency of the alarm event occurrence during the monitored time period, for example, to improve therapy related decisions.
  • the doctor, healthcare provider or the user may adjust or recommend modification to the diet, daily habits and routines such as exercise, and the like.
  • data processing module 1600 transmits a command or signal to on body electronics 1100 to receive the analyte related data in response to a user activation of a switch provided on data processing module 1600 or a user initiated command received from display device 1200 .
  • data processing module 1600 is configured to transmit a command or signal to on body electronics 1100 in response to receiving a user initiated command only after a predetermined time interval has elapsed. For example, in certain embodiments, if the user does not initiate communication within a programmed time period, such as, for example about 5 hours from last communication (or 10 hours from the last communication, or 24 hours from the last communication), the data processing module 1600 may be programmed to automatically transmit a request command or signal to on body electronics 1100 .
  • data processing module 1600 may be programmed to activate an alarm to notify the user that a predetermined time period of time has elapsed since the last communication between the data processing module 1600 and on body electronics 1100 .
  • users or healthcare providers may program or configure data processing module 1600 to provide certain compliance with analyte monitoring regimen, so that frequent determination of analyte levels is maintained or performed by the user.
  • the one or more output indications may be generated by the control logic or processor of the on body electronics 1100 and output to the user on a user interface of on body electronics 1100 so that corrective action may be timely taken.
  • the output indications or alarm data may be communicated to display device 1200 whose processor, upon detection of the alarm data reception, controls the display 1220 to output one or more notification.
  • control logic or microprocessors of on body electronics 1100 include software programs to determine future or anticipated analyte levels based on information obtained from analyte sensor 14 , e.g., the current analyte level, the rate of change of the analyte level, the acceleration of the analyte level change, and/or analyte trend information determined based on stored monitored analyte data providing a historical trend or direction of analyte level fluctuation as function time during monitored time period.
  • Predictive alarm parameters may be programmed or programmable in display device 1200 , or the on body electronics 1100 , or both, and output to the user in advance of anticipating the user's analyte level reaching the future level. This provides the user an opportunity to take timely corrective action.
  • Information such as variation or fluctuation of the monitored analyte level as a function of time over the monitored time period providing analyte trend information, for example, may be determined by one or more control logic or microprocessors of display device 1200 , data processing module 1600 , and/or remote terminal 1700 , and/or on body electronics 1100 .
  • Such information may be displayed as, for example, a graph (such as a line graph) to indicate to the user the current and/or historical and/or and predicted future analyte levels as measured and predicted by the analyte monitoring system 100 .
  • Such information may also be displayed as directional arrows (for example, see trend or directional arrow display 1310 ) or other icon(s), e.g., the position of which on the screen relative to a reference point indicated whether the analyte level is increasing or decreasing as well as the acceleration or deceleration of the increase or decrease in analyte level.
  • This information may be utilized by the user to determine any necessary corrective actions to ensure the analyte level remains within an acceptable and/or clinically safe range.
  • Visual indicators including colors, flashing, fading, etc.
  • audio indicators including a change in pitch, volume, or tone of an audio output and/or vibratory or other tactile indicators may also be incorporated into the display of trend data as means of notifying the user of the current level and/or direction and/or rate of change of the monitored analyte level.
  • the system 100 may include an algorithm stored on computer readable medium to determine the time it will take to reach a clinically significant level and will output notification in advance of reaching the clinically significant level, e.g., 30 minutes before a clinically significant level is anticipated, and/or 20 minutes, and/or 10 minutes, and/or 5 minutes, and/or 3 minutes, and/or 1 minute, and so on, with outputs increasing in intensity or the like.
  • programmed clinically significant glucose threshold levels e.g., hyperglycemic and/or hypoglycemic levels
  • current analyte level derived by an in vivo analyte sensor the system 100 may include an algorithm stored on computer readable medium to determine the time it will take to reach a clinically significant level and will output notification in advance of reaching the clinically significant level, e.g., 30 minutes before a clinically significant level is anticipated, and/or 20 minutes, and/or 10 minutes, and/or 5 minutes, and/or 3 minutes, and/or 1 minute, and so on, with outputs
  • software algorithm(s) for execution by data processing module 1600 may be stored in an external memory device such as an SD card, microSD card, compact flash card, XD card, Memory Stick card, Memory Stick Duo card, or USB memory stick/device including executable programs stored in such devices for execution upon connection to the respective one or more of the on body electronics 1100 , remote terminal 1700 or display device 1200 .
  • software algorithms for execution by data processing module 1600 may be provided to a communication device such as a mobile telephone including, for example, WiFi or Internet enabled smart phones or personal digital assistants (PDAs) as a downloadable application for execution by the downloading communication device.
  • a communication device such as a mobile telephone including, for example, WiFi or Internet enabled smart phones or personal digital assistants (PDAs) as a downloadable application for execution by the downloading communication device.
  • PDAs as described above include, for example, portable electronic devices including one or more microprocessors and data communication capability with a user interface (e.g., display/output unit and/or input unit, and configured for performing data processing, data upload/download over the internet, for example.
  • remote terminal 1700 may be configured to provide the executable application software to the one or more of the communication devices described above when communication between the remote terminal 1700 and the devices are established.
  • executable software applications may be provided over-the-air (OTA) as an OTA download such that wired connection to remote terminal 1700 is not necessary.
  • OTA over-the-air
  • executable applications may be automatically downloaded as software download to the communication device, and depending upon the configuration of the communication device, installed on the device for use automatically, or based on user confirmation or acknowledgement on the communication device to execute the installation of the application.
  • the OTA download and installation of software may include software applications and/or routines that are updates or upgrades to the existing functions or features of data processing module 1600 and/or display device 1200 .
  • new software and/or software updates such as software patches or fixes, firmware updates or software driver upgrades, among others, for display device 1200 and/or on body electronics 1100 and/or data processing module 1600 may be provided by remote terminal 1700 when communication between the remote terminal 1700 and display device 1200 and/or data processing module 1600 is established.
  • software upgrades, executable programming changes or modification for on body electronics 1100 may be received from remote terminal 1700 by one or more of display device 1200 or data processing module 1600 , and thereafter, provided to on body electronics 1100 to update its software or programmable functions.
  • software received and installed in on body electronics 1100 may include software bug fixes, modification to the previously stalled software parameters (modification to analyte related data storage time interval, resetting or adjusting time base or information of on body electronics 1100 , modification to the transmitted data type, data transmission sequence, or data storage time period, among others). Additional details describing field upgradability of software of portable electronic devices, and data processing are provided in U.S. application Ser. Nos. 12/698,124, 12/794,721, now U.S. Pat. No. 8,595,607, Ser. No. 12/699,653, and Ser. No. 12/699,844, and U.S. Provisional Application Nos. 61/359,265 and 61/325,155 the disclosures of which are incorporated by reference herein for all purposes.
  • the analyte sensor 14 of the analyte measurement system 100 may be used to monitor levels of a wide variety of analytes.
  • Analytes that may be monitored include, for example, acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid-stimulating hormone, and troponin.
  • CK-MB creatine kinase
  • the concentration of drugs may also be monitored.
  • antibiotics e.g., gentamicin, vancomycin, and the like
  • digitoxin digoxin
  • digoxin drugs of abuse
  • theophylline drugs of abuse
  • warfarin drugs
  • One or more analyte may be monitored by a given sensor.
  • the analytes may be monitored at the same or different times, which may use the same on body electronics (e.g., simultaneously) or with different on body electronics.
  • sensor 14 is physically positioned in or on the body of a user whose analyte level is being monitored.
  • Sensor 14 may be configured to continuously sample the analyte level of the user and convert the sampled analyte level, e.g., glucose concentration into a corresponding data signal, e.g., a current or voltage, for input into on body electronics.
  • sensor 14 may be configured to sample analyte levels on demand.
  • the on body electronics may amplify, filter, average, and/or otherwise process signal provided by the sensor.
  • sensor 14 An embodiment of the sensor 14 is illustrated in FIG. 2 . It is understood that the inserters described herein can be used with other medical devices. The shape(s) described herein are exemplary only. Other sensor shapes are contemplated.
  • sensor 14 includes a substrate which is a dielectric, e.g., a polymer or plastic material, such as polyester or polyamide. In this embodiment, the sensor is constructed so that a portion is positionable beneath skin and a portion is above skin. Accordingly, sensor 14 includes an insertion or internal portion 30 and an external or electrical contact portion 32 .
  • the contact portion 32 includes several conductive contacts 36 , 38 , and 40 (herein shown as three contacts) for connection to other electronics, e.g., at the on body electronics 1100 (See FIG. 1 .).
  • the contacts provided in this embodiment are for a working electrode, a reference electrode, and a counter electrode.
  • two or more working electrodes are provided.
  • the operative portions of these electrodes, that is, working electrode, reference electrode, and counter electrode (not individually shown), are provided at the insertion portion, e.g., at the distal end of insertion portion 30 , e.g., portion 34 .
  • one or more electrodes may be external to the body, e.g., an external counter electrode.
  • the contact and operative portions of the electrodes are connected by circuit traces 42 , 44 , and 46 running on the surface of the substrate.
  • the traces are provided in channels, or may be embedded within the substrate, or may traverse different sides of the substrate.
  • the conductive contacts, conductive traces, and electrodes are fabricated from conductive material, such as platinum, palladium, gold, carbon, or the like. More than one material may be used for a given sensor. Further details of sensors are described, e.g., in U.S. Pat. Nos. 6,175,572 and 6,103,033, which are incorporated by reference herein for all purposes.
  • Sensor 14 may include a proximal retention portion 48 .
  • the insertion portion 30 and the proximal retention portion 48 are sized and configured to be positioned with a sharp for installation into the skin of a subject, as described herein.
  • the sensor 14 may be configured to bend (e.g., along the line B) and therefore be positioned in two substantially perpendicular, intersecting planes. Such bending may occur prior to or during coupling to the on body electronics as described below (See FIG. 17 ).
  • Portions 48 and 52 provide a path for electrical connections, e.g., the conductive traces, between the proximal and distal portions of the sensor.
  • Sensor 14 is further provided with a notch or cut-out 54 .
  • Such configuration facilitates the sensor 14 to bend (e.g., along the line indicated by line B) such that retention portion 48 remains upright and therefore be positioned in two substantially perpendicular, intersecting planes, as illustrated in FIG. 3 .
  • the sensor tab 50 can be encased in the on body housing 122 to aid in securing and positioning the sensor 14 .
  • Proximal retention portion 48 maintains its longitudinal alignment with insertion portion 30 for positioning within an insertion sharp.
  • Embodiments of analyte sensors have been described herein to operate electrochemically, through an arrangement of electrodes having chemical sensing layers applied thereto, by generating an electrical current proportional to the volume of a redox reaction of the analyte (and indicative of analyte concentration), catalyzed by an analyte-specific oxidizing enzyme.
  • Embodiments exist in which the number of electrodes provided to bring about and detect the level of these reactions is two, three, or a greater number.
  • other types of sensors may be employed as described herein.
  • a portion of sensor 14 may be situated above the surface of the skin, with a distal portion 30 penetrating through the skin and into the subcutaneous space in contact with the user's biofluid, such as ISF. Further details regarding the electrochemistry of sensor 14 is provided in U.S. Pat. Nos. 5,264,104; 5,356,786; 5,262,035; 5,320,725; and 6,990,366, each of which is incorporated by reference herein for all purposes.
  • the senor is implantable into a subject's body for a usage period (e.g., a minute or more, at least one day or more, about one to about 30 days or even longer, about three to about fourteen days, about three to about seven days, or in some embodiments, longer periods of up to several weeks) to contact and monitor an analyte present in a biological fluid.
  • a usage period e.g., a minute or more, at least one day or more, about one to about 30 days or even longer, about three to about fourteen days, about three to about seven days, or in some embodiments, longer periods of up to several weeks
  • the sensor can be disposed in a subject at a variety of sites (e.g., abdomen, upper arm, thigh, etc.), including intramuscularly, transcutaneously, intravascularly, or in a body cavity.
  • sensor 14 is employed by insertion and/or implantation into a user's body for some usage period.
  • the substrate may be formed from a relatively flexible material.
  • FIGS. 2-3 have three electrodes, other embodiments can include a fewer or greater number of electrodes.
  • a two-electrode sensor can be utilized.
  • the sensor 14 may be externally-powered and allow a current to pass which is proportional to the amount of analyte present.
  • the sensor 14 itself may act as a current source in some embodiments.
  • the sensor may be self-biasing and there may be no need for a reference electrode.
  • An exemplary self-powered, two-electrode sensor is described in U.S. patent application Ser. No. 12/393,921, filed Feb.
  • the level of current provided by a self-powered sensor may be low, for example, on the order of nanoamperes, in certain embodiments.
  • an insertion assembly includes an inserter and the medical device itself.
  • the inserter can be configured to insert various medical devices into the subject, such as, for example, an analyte sensor, an infusion set, or a cannula.
  • the inserter can be configured to install a combination of such devices, e.g., a combined sensor/infusion set, etc., at the same or different times or locations.
  • a given inserter can be configured to install a first device and a second device at different times. In this regard, the inserter can be reusable.
  • an inserter may be modifiable to be used with more than one medical device, to include more than one type of medical device, e.g., by attaching an adapter and/or detaching a portion of an inserter.
  • the inserter can install the medical device in, under, or through the skin of the subject, or place the medical device on the surface of the skin.
  • the medical device can include features or structures, e.g., barbs, tabs, adhesive, etc., to maintain the device in position with respect to the skin after insertion.
  • the inserter device may also be used as a lancet, e.g., to pierce the skin without inserting or installing a medical device.
  • an insertion assembly includes an inserter, a medical device, such as an analyte sensor, and a mount for supporting the medical device at least partially in or on the skin of the subject.
  • the mount is a support structure, plate and/or member which is attached, adhered, or otherwise secured to the skin of the subject.
  • the mount may be inserted simultaneously with the medical device by the inserter.
  • the mount is installed after or before installation of the medical device.
  • a mount may be applied by the inserter or separately.
  • the mount may include features or structures (e.g., adhesive, guides, barbs, tabs, etc.) to maintain the sensor in position with respect to the skin after insertion and/or maintain the sensor in relative position with respect to the sensor control unit.
  • an adhesive pad or strip is used to secure the medical device, e.g., the sensor and/or the sensor control unit, and no mount is used.
  • an insertion assembly includes an inserter, an analyte sensor, a mount, and a power supply.
  • the mount and power supply may be inserted simultaneously with the analyte sensor by the inserter.
  • the mount and battery are installed after or before installation of the analyte sensor.
  • the mount and/or power supply may be applied by the inserter or separately.
  • the power supply may be used to provide a current or a potential to the sensor and/or to provide power for communication of one or more signals to the monitor unit.
  • an insertion assembly includes an inserter, a medical device such as an analyte sensor, a mount, and a sensor control unit.
  • the mount and sensor control unit may be deployed and/or installed simultaneously with the analyte sensor by the inserter.
  • the mount and sensor control unit are installed after or before installation of the analyte sensor.
  • the mount and the analyte sensor may be installed by the inserter, and the sensor control unit may be subsequently installed.
  • the mount is installed, followed by insertion of the analyte sensor by the inserter, and further followed by installation of the sensor control unit.
  • the mount and sensor control unit are installed first, and the analyte sensor is subsequently installed.
  • electronics of the sensor control unit provide a voltage or current to the analyte sensor.
  • the electronics processes signals are provided by the analyte sensor.
  • the electronics may include communication functionality for providing signal relating to signal provided by the analyte sensor to a further component, such as, e.g., a monitor unit, a computer, or other component.
  • communications circuitry such as RFID antenna or other communications circuitry, is provided. The power supply may be used to power some or all of these functions.
  • power is provided from the monitor unit, e.g., via inductive coupling.
  • An inserter may include a plurality of different components.
  • an inserter may include one or more components for advancing a sharp towards the skin of the subject.
  • the sensor and sensor control unit and/or mounting structure may be supported by a support structure, such as a carriage.
  • a driver may be provided for advancing the sharp and/or the analyte sensor/support structure.
  • the actuator is directly or indirectly coupled to the sharp and/or support structure, such that manual force and speed applied by the subject to the actuator is transferred to the sharp and/or support structure.
  • the applied force drives the sharp and/or support structure between a retracted position and an advanced position.
  • the senor and sensor control unit and/or mounting structure is maintained in a retracted position prior to installation by contacting projections extending inwardly from a sheath.
  • the sensor and sensor control unit and/or mounting structure are temporarily maintained operatively between the support structure and the projections disposed on the interior wall of the sheath.
  • An inserter can also include one or more components for retracting the sharp, while allowing the analyte sensor and optional mount and/or electronics to remain on the subject.
  • the components for retracting the sharp can include a retractor. It is understood that the retractor and the actuator may be the same structure or include some common components.
  • the retractor is directly or indirectly coupled to the sharp such that the manual force applied by the user is transferred from the retractor to the sharp to retract the sharp from the skin.
  • a drive assembly may be provided to retract the sharp.
  • the drive assembly may include a spring, motor, hydraulic piston, etc., to retract the sharp away from the skin of the subject.
  • the drive assembly may also include a linear drive component.
  • the retractor withdraws the sharp upon actuation by the user.
  • the user actuates the retractor when it is desired to withdraw the sharp.
  • the retractor may include a release switch.
  • the drive assembly e.g., the spring or other driver, retracts the sharp from the skin.
  • the retractor and the actuator include common components. After activating the actuator to advance the sharp and the analyte sensor, the user releases the actuator, which allows the drive assembly to withdraw the sharp from the skin.
  • the retractor withdraws the sharp without further user interaction after actuation of insertion.
  • the inserter may include features or components which automatically retract the sharp upon advancement of the sharp and support structure by a predetermined amount. Inserter devices, in which no further action by the user is required to initiate withdrawal of the sharp after insertion, are referred to herein as having “automatic” withdrawal of the sharp.
  • Needle hub 136 supports sharp 124 , having a sharpened distal portion 160 .
  • a longitudinal wall opening or gap 162 is provided in at least a portion of the wall of the sharp 124 .
  • the length N of the gap 162 is selected to be commensurate with the length of the insertion portion 30 through to the proximal retention portion 48 of the sensor, and in certain embodiments may be about 3 mm to about 50 mm, e.g., about 5 mm, or about 10 mm, or about 15 mm, or about 20 mm.
  • the length L of the sharp 124 may be about 3 mm to about 50 mm, e.g., 5 mm or more, or about 10 mm, or about 20 mm, or about 30 mm, or about 50 mm, and is selected based upon the length of the insertion portion 30 of a sensor and the desired depth of the insertion portion 30 of the sensor 14 .
  • the distance or spacing between the two edges of the gap is about 0.2 mm to about 0.5 mm, e.g., about 0.22 mm, about 0.25 mm, etc.
  • sharp 124 has a substantially “C”- or “U”-shaped profile in this embodiment, but may have other configurations, e.g., substantially “V”-shaped.
  • a longitudinal gap 162 is provided in the wall of the sharp 124 .
  • FIG. 7 illustrates distal portion 160 as provided with an angled tip.
  • the angled tip may be provided with a first angled tip portion 164 and a second steep-angled tip portion 166 .
  • the exemplary configuration which includes multiple edges and faces, provides a sharp point to reduce penetration force, trauma, and bleeding for the subject.
  • the distal section of the sensor body has a width sized to fit within the gap 162 of the insertion sharp 124 having a diameter less than about 20 gauge to about 26 gauge, e.g., 21 gauge to about 25 gauge, where in certain embodiments the sharp is 21 gauge or 23 gauge or 25 gauge.
  • Such sharp may be used with a sensor having a width or diameter—at least the portion that is carried by the sharp—of about 0.20 mm to about 0.80 mm, e.g., about 0.25 mm to about 0.60 mm, where, in some embodiments, the width or diameter of at least a portion of a sensor is 0.27 mm or 0.33 mm or 0.58 mm.
  • sharp 124 is fabricated from a sheet of metal and folded into a substantially “V,” “U” or “C” configuration in cross-section.
  • Various technologies can be used to manufacture a folded sheet of metal to form sharp 124 .
  • etched-sheet metal technology can be used to form the sharp 124 .
  • the sharp can be formed having a very sharp edge so that penetration through the skin during insertion is less painful.
  • a progressive die technology may be utilized to form a complex sheet-metal shape that has a sharp edge as depicted in FIG. 9 .
  • the sharp 124 can be molded with a plastic cap so that the sharp can be handled during the inserter assembly process.
  • the die cut sharp may be molded with plastic to reinforce the “V,” “U” or “C” shaped sheet metal configuration.
  • a laser-cut sharp can be formed. In this manner, the laser can be used to form the wall opening or gap 162 and first-angled tip portion 164 and a second, steep-angled tip portion 166 .
  • a sharp 124 may be formed from a standard hypodermic needle utilizing the method depicted in FIG. 10 .
  • the hypodermic needle (having a circular cross-section) is cut to the desired length for sharp 124 .
  • the hypodermic needle is compressed so that its cross-section is permanently deformed from a circular shape to an oval shape.
  • the tip of the hypodermic needle is then ground to a bevel to produce a sharp point to reduce the required penetration force, as previously discussed.
  • the top section of the needle is removed by appropriate techniques (e.g., grinding, electropolishing, etc.).
  • the resulting sharp 124 has a “U”-shaped configuration and provides ample space for the insertion of sensor 14 .
  • the tip-grinding step and the compression step may be carried out in reversed order.
  • a user may initially start with a larger diameter hypodermic needle so that the finished sharp 124 will have similar dimensions to the previously described sharps.
  • FIGS. 11-12 illustrate the position of on body housing 122 with respect to the needle hub 136 and sharp 124 .
  • the on body housing 122 can be configured to hold at least a portion of sensor 14 and sensor control unit.
  • the sharp 124 extends through an aperture 168 in the on body housing 122 .
  • the sharp 124 is uncoupled to on body housing 122 .
  • the distal portion of sensor 14 is positioned within the sharp 124 .
  • electronics of the sensor control unit e.g., a printed circuit board containing electronics components of the on-body unit
  • sensor hub 123 are positioned within on body housing 122 .
  • Sensor 14 may include a positioning structure, or slit 127 , which receives a positioning member, such as tab 129 of sensor hub 123 .
  • a power supply 82 such as a battery, e.g., a single use disposable battery, or rechargeable battery, is provided.
  • the power supply 82 is used to provide potential or current to the sensor in some embodiments.
  • a passive communications protocol such as passive RFID is used
  • no power supply is provided for the communications.
  • Such power is provided by the monitor unit.
  • the sensor control unit is used to transmit one or more signals
  • one or more power supplies may be used to provide power for such communications circuitry.
  • the active operational life of the battery may exceed the active operational life of the sensor 14 .
  • FIG. 13 illustrates in cross-section the orientation of the on body housing 122 with respect to the sharp 124 of an inserter, such as inserter 1500 (see FIG. 52 ).
  • sensor 14 is disposed in a substantially bent configuration in some embodiments, such that a portion of the sensor, e.g., the insertion portion 30 and the proximal retention portion 48 , are substantially vertical (e.g., substantially aligned with the longitudinal axis of an inserter and substantially perpendicular to the skin surface) and the contact portion 32 (shown in profile) is oriented in a substantially horizontal configuration, and in electrical contact with the data-processing unit electronics, such as circuit 80 .
  • the sensor tab 50 can be encased in the plastic of the on body housing 122 (e.g., “overmolded”) and secured in place.
  • the notch 56 provides further stability to the sensor 14 , e.g., by allowing the sensor tab 50 to be encased by the material of the on body housing 122 , and further provides a means for vertically orienting the sensor 14 during mounting, e.g., by allowing vertical positioning of the notch 56 with respect to a vertical landmark of the on body housing 122 .
  • the sensor 14 mounted with the on body housing 122 , can be disposed within a recess of the carriage 130 such as a concave recess in the carriage 130 .
  • the sensor 14 mounted with the on body housing 122
  • the sensor 14 mounted with the on body housing 122
  • the sharp 124 extends through a longitudinal aperture 168 formed in a carriage 130 .
  • the aperture 168 is appropriately sized, such that neither the sharp 124 nor needle hub 136 is in contact with the carriage 130 . Accordingly, the needle hub 136 (and sharp 124 ) on the one hand, and the carriage 130 ( FIG. 13 ) and the on body housing 122 , on the other hand, move simultaneously, but independently from one another. In other embodiments, a friction fit may be provided between the aperture and the sharp.
  • the insertion portion 30 and proximal retention portion 48 of the sensor 14 are disposed within a longitudinal bore 162 within the sharp 124 (See, e.g., FIG. 6 ).
  • the proximal retention portion 48 is disposed within the longitudinal bore of the sharp 124 and provides additional stability to the mounting of the sensor 14 within the sharp 124 .
  • the longitudinal wall gap or opening 162 of sharp 124 is aligned with the sensor 14 , such that the tab 50 and the contact portion 32 extend laterally outward from the sharp 124 .
  • An inserter 900 includes a handle 902 and may include a removable distal cap or seal (not shown) for maintaining a sterile environment for the medical device and sharp housed therein. As illustrated in FIG. 14 , distal cap or seal is removed from handle 902 . Inserter 900 includes a base 942 that defines a distal surface 912 for placement on the skin of a subject. Inserter 900 may be utilized to advance a medical device into the skin of the subject. In some embodiments, handle 902 is advanced relative to base 942 in order to advance the sensor into the skin of the patient.
  • the inserter 900 includes an initial configuration in which the handle 902 is disposed in a proximal position with respect to the base 942 .
  • the sharp 924 is disposed in a configuration spaced apart from the aperture 920 of the adhesive layer 918 .
  • Extending distally from the upper surface of handle 902 are side walls 974 , which terminate in a shoulder portion 975 .
  • Needle carrier 934 is axially slidable within handle 902 and base 942 in the direction of arrow N. Needle carrier 934 supports needle hub 936 , from which sharp 924 extends longitudinally within the inserter 900 . In some embodiments, the sharp is supported at an oblique angle, e.g., between 0° and 90° with respect to the skin surface. Initially, needle carrier 934 is coupled to inner rail 928 through inter-engagement of finger 986 of needle carrier 934 with shoulder 987 of inner rail 928 .
  • Inserter 900 includes an advancement spring 947 .
  • Inner rail 928 includes a spring retention portion 984 for advancement spring 947 .
  • the inner surface of handle 902 serves as an upper engagement surface for advancement spring 947 .
  • spring retention portion 984 is fabricated having several projections that extend through an aperture 982 in the wall of base 942 .
  • Spring retention portion 984 is resiliently movable. As downward force is applied to handle 902 , the ledge 937 of handle 902 contacts spring retention portion 984 , driving such projections inward. Such inward motion releases the inner rail 928 , and allows advancement spring 947 to advance the inner rail 928 distally, thereby advancing the sharp 924 into the skin of the subject, as illustrated in FIG. 16 .
  • Refraction spring 946 is disposed between spring retention portion 948 of base 942 and shoulder portion 949 of needle carrier 934 . Initially, retraction spring 946 is in a compressed state. As carriage 930 reaches a distal position, the distal surface of the on body housing 122 engages the upper surface of adhesive pad 918 , thereby becoming adhered to the skin surface S of the subject. At the same time, flanges 970 of base 942 engage fingers 986 disposed on the needle carrier 934 . Fingers 986 are pivoted outwards by flanges 970 . Such pivoting of fingers causes fingers 986 to become disengaged from shoulder 984 of inner rail 928 . Shuttle 934 is thereby disengaged from inner rail 928 .
  • disengagement of the shuttle 934 from the inner rail 928 permits the spring 946 to expand, thereby advancing the needle carrier 934 to a proximal position, thereby withdrawing the sharp 924 from the skin of the subject, while leaving the sensor 14 in the skin.
  • FIGS. 18-21 A further embodiment of an inserter is illustrated in FIGS. 18-21 and designated inserter 1000 .
  • Inserter 1000 is substantially identical to inserter 900 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • An inserter 1000 includes a housing 1002 , and may include a removable distal cap or seal (not shown) for maintaining a sterile environment for the medical device and sharp housed therein. As illustrated in FIG. 18 , distal cap or seal is removed from housing 1002 . Inserter 1000 includes a base 1042 which defines a distal surface 1012 for placement on the skin of a subject. Inserter 1000 may be utilized to advance a medical device into the skin of the subject. In some embodiments, side buttons 1084 are depressed relative to base 1042 in order to advance the medical device into the skin of the patient.
  • the inserter 1000 includes an initial configuration in which the sharp 1024 is disposed in a configuration spaced apart from distal portion 1012 of the base 1042 . It is understood that inserter 1000 may incorporate an adhesive layer (not shown) positioned across the distal portion 1012 of base 1042 .
  • On-body unit inserter 1028 includes carriage 1030 for supporting on body housing 122 .
  • On-body unit inserter 1028 also includes flange 1029 which normally rests on shoulder portions 1086 (as illustrated in FIGS. 19-21 ). When side buttons 1084 are depressed inwardly, latch portions on flange 1029 are deflected from engagement with shoulder portions 1086 . As illustrated in FIG. 20 , advancement spring 1047 is released from compression, thereby advancing on-body unit inserter 1028 as elsewhere, along with needle carrier 1034 into the skin of the subject.
  • Refraction spring 1046 is disposed between needle carrier 1034 and housing 1002 . Initially, retraction spring 1046 is in a compressed state. As carriage 1028 reaches a distal position, on-body unit inserter 1028 is disengaged from needle carrier 1034 . The distal surface of the on body housing 122 engages the skin or the upper surface of adhesive pad (not shown), thereby becoming adhered to the skin surface S of the subject. Latches on needle carrier 1034 attach it to on-body unit inserter 1028 . Upon firing the inserter by pressing tabs 1084 , the on-body unit inserter 1028 is pushed by spring 1047 towards the skin surface, bringing along needle carrier 1034 and loading extension spring 1046 .
  • disengagement of the needle carrier 1034 from the inner rail 1028 permits the spring 1046 to contract with the bias, thereby advancing the needle carrier 1034 to a proximal position and withdrawing the sharp 1024 from the skin of the subject, while leaving the sensor 14 in the skin.
  • Inserter 1100 is substantially identical to inserters 900 and 1000 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • An inserter 1100 includes a housing 1102 and may include a removable distal cap or seal (not shown) for maintaining a sterile environment for the medical device and/or sharp housed therein. As illustrated in FIG. 22 , distal cap or seal is removed from housing 1102 . Inserter 1100 includes a base 1142 which defines a distal surface 1112 for placement on the skin of a subject. Inserter 1100 may be utilized to advance a medical device into the skin of the subject. In some embodiments, a manual actuator bar 1114 is depressed relative to base 1142 in order to advance the medical device into the skin of the patient. It is understood that inserter 1100 may incorporate an adhesive layer (not shown) which is positioned across the distal portion 1112 of base 1142 .
  • On-body unit inserter 1128 includes carriage 1130 for supporting on body housing 122 .
  • Refraction spring 1146 is disposed between needle carrier 1134 and base 1142 . Initially, retraction spring 1146 is in a compressed state.
  • actuator bar 1114 is moved distally
  • carriage 1128 is moved distally and reaches a distal position, such that flanges 1188 of base 1142 engage fingers 1186 disposed on the shuttle 1134 .
  • Fingers 1186 are pivoted outwards by flanges 1188 . Such pivoting of fingers 1186 causes fingers 1186 to become disengaged from shoulder 1187 of inner rail 1128 .
  • Shuttle 1134 is thereby disengaged from inner rail 1128 .
  • the distal surface of the on body housing 122 engages the skin or the upper surface of adhesive pad (not shown), thereby becoming adhered to the skin surface of the subject ( FIG. 24 ).
  • disengagement of the shuttle 1136 from the inner rail 1028 permits the spring 1146 to expand with the bias, thereby advancing the needle carrier 1136 to a proximal position and withdrawing the sharp 1124 from the skin of the subject, while leaving the sensor 14 in the skin.
  • the sharp 1124 Once the sharp 1124 has been withdrawn from the subject, it is no longer accessible from the distal portion of the inserter 1100 , and unable to make contact by accident with the subject's skin.
  • Inserter 1200 is substantially identical to inserters 900 , 1000 , and 1100 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • Inserter 1200 includes a housing 1202 , an on-body unit inserter 1228 , a needle retractor 1234 , and a rotor 1208 with a torsion spring (not shown), all of which are depicted separately in FIGS. 28-31 .
  • housing 1202 includes slots 1254 ; on-body unit inserter 1228 includes slots 1252 , tabs 1253 , and opening 1262 ; needle retractor 1234 includes tabs 1250 and opening 1260 ; and rotor 1208 includes rotor follower 1264 .
  • FIG. 32 illustrates an exploded view of inserter 1200 .
  • inserter 1200 includes housing 1202 , on-body unit inserter 1228 , needle retractor 1234 , and rotor 1208 .
  • Tabs 1250 can be disposed on needle refractor 1234 and configured to engage slots 1252 disposed on on-body unit inserter 1228 when assembled as shown in FIG. 33 .
  • Tabs 1253 can be disposed on on-body unit inserter 1228 and configured to engage slots 1254 disposed on housing 1202 .
  • Needle retractor 1234 and on-body unit inserter 1228 can each contain openings ( 1260 , 1262 ) to receive rotor follower 1264 disposed on rotor 1208 after rotor 1208 has been inserted into housing 1202 . Additionally, on-body unit inserter 1228 can provide support for on body housing 122 (not shown) for installation to the skin of a subject.
  • manually depressing the on-body unit inserter 1228 can cause the torsion spring to wind as the rotor 1208 rotates, guided by the cam path.
  • FIG. 35 continued distal advancement of the on-body unit inserter 1228 causes the rotor follower 1264 to go “over center” within cam 1264 .
  • the torsion spring (not shown) is allowed to unwind ( FIG. 93 ).
  • FIG. 36 further unwinding of the torsion spring pulls up the needle retractor 1234 from the insertion site, while leaving the on-body unit inserter in place.
  • Inserter 1300 is substantially identical to inserters 900 , 1000 , 1100 , and 1200 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • Inserter 1300 includes a housing 1302 , an on-body unit inserter 1334 , a needle retractor 1328 , and a rotor 1308 with torsion spring 1365 . As illustrated in FIGS. 37 , 38 , 39 , 45 and 46 , the on-body unit inserter 1334 and needle retractor 1328 are disposed within the housing 1302 .
  • Rotor 1308 includes a rotor follower 1364 which engages a slot 1362 provided in the needle retractor 1328 and a slot 1360 in the on-body unit inserter 1334 .
  • the on-body unit inserter 1334 provides a support portion for supporting on body housing 1302 (not shown).
  • torsion spring 1365 is loaded.
  • a release button (not shown) is depressed in order to release torsion spring 1365 .
  • Rotor 1308 drives on-body unit inserter 1334 and needle retractor 1328 downwardly simultaneously.
  • a compression spring 1367 holds down on-body unit inserter 1334 .
  • slot 1360 allows on-body unit inserter 1334 to travel down and then be held down, while slot 1362 allows needle retractor 1328 to travel down and then back up to lift the needle from insertion site.
  • Inserter 1400 is substantially identical to inserters 900 , 1000 , 1100 , 1200 , and 1300 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • Inserter 1400 may be used for installation of a medical device, e.g., on body housing 122 , in connection with a cartridge or carrier 1406 .
  • inserter 1400 includes a body 1402 and an actuator 1404 .
  • the carrier 1406 may include a needle hub 1436 including a sharp (not shown) as well as an on body housing 122 .
  • the body 1402 is placed on a mount 1408 attached to subject by use of an adhesive pad 1418 .
  • carrier 1406 is loaded into inserter 1400 laterally as shown.
  • a first disposable portion of inserter 1400 includes adhesive pad 1418 and mount 1408 .
  • the second disposable portion of inserter 1400 includes carrier 1406 which removably contains needle hub 1436 and sensor hub 1437 (not shown) which is substantially identical to on body housing 122 described herein.
  • Inserter 1400 further includes body 1402 , actuator 1404 , and return spring 1409 (not shown).
  • Mount 1408 is removably attached to body 1402 .
  • Carrier 1406 can be slid on to body 1402 to transfer needle hub 1436 and carrier 1406 to inserter 1400 . As shown in FIG. 48 , carrier 1406 can then be removed from inserter 1400 . Needle hub 1436 and sensor hub 1437 remain in inserter 1400 .
  • Adhesive pad 1418 is then adhesively applied to the skin of a subject. Alternatively, adhesive pad 1418 may be applied to the skin of a subject before attaching body 1402 and mount 1408 .
  • actuator 1404 is pressed down, performing a manual insertion of needle hub 1436 and sensor hub 1437 , with the needle located in needle hub 1436 and a distal sensor portion penetrating the skin of the subject.
  • return spring 1409 retracts the needle from the skin of the subject and out of sensor hub 1437 .
  • body 1402 can be removed from mount 1408 , leaving sensor hub 1437 in mounting base 1408 .
  • carrier 1406 is slid on to housing 1402 , transferring needle 1436 to carrier 1406 .
  • Carrier 1406 with needle 1436 , is then removed from housing 1402 and may be disposed of properly, and inserter 1400 is ready to be used again.
  • Communication electronics (not shown) are then attached to mounting base 1408 , making electrical contact with sensor hub 1437 .
  • Inserter 1500 is substantially identical to inserters 900 , 1000 , 1100 , 1200 , 1300 , and 1400 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • Inserter 1500 includes a housing 1502 , which may be fabricated as a molded plastic tube and may further include a living hinge cap 1504 .
  • a living hinge is a thin flexible plastic junction that connects two mating parts. The hinge keeps the parts attached and may be folded completely without failure to allow the two parts to fully mate.
  • Cap 1504 may be further provided with a cutout portion to provide access to the index finger and restrict the insertion motion along a desired axis. Cap 1504 is closed up and bonded to the housing through chemical or ultrasonic bonding after the bellow-button assembly (described herein) is provided.
  • a button 1514 provides the capability of the user to insert on body housing 122 into the skin of the subject.
  • Button 1514 may be fabricated from plastic and may further include anti-rotation features, e.g., recess 1515 which glides along longitudinal ridge 1517 , restricting motion to the desired longitudinal axis.
  • Needle hub 1536 is glued or directly molded onto button 1514 .
  • Sharp 1524 is securely held on to on body housing 122 , as described herein (See, e.g., FIGS. 11-13 ).
  • An adhesive patch 1518 secures on body housing 122 to the skin of the subject.
  • the adhesive patch 1518 includes a high-tack (i.e., high strength adhesive) region for contact with the skin.
  • a protective liner is provided for removal prior to insertion.
  • low-tack region 1530 is provided on the periphery of the patch to allow easy removal of housing 1502 after insertion is completed.
  • a high-tack region 1532 is provided in the center portion of the patch to secure on body housing 122 in place.
  • inserter kit 1600 is illustrated with inserter 2310 and an adhesive mount 2312 removably attached to the bottom thereof. Inserter 1600 is further described in U.S. Pat. No. 7,381,184, which is incorporated by reference herein for all purposes.
  • the user After preparing an insertion site on the skin, typically in the abdominal region, the user removes a liner (not shown) from adhesive mount 2312 to expose the bottom surface and a portion of the top surface of an adhesive tape 2320 located beneath mount 2312 .
  • Mount 2312 with inserter 2310 attached, is then applied to the subject's skin at the insertion site.
  • Actuator button 2324 is depressed, causing inserter 2310 to fire, thereby inserting sensor 2314 into the subject's skin with a predetermined velocity and force.
  • the patient removes inserter 2310 from mount 2312 by pressing release tabs (not shown) on opposite sides of inserter 2310 and lifting inserter 2310 away from mount 2312 .
  • communications electronics (not shown) can be slid into place.
  • the circuitry of the communications electronics device makes electrical contact with the contact pads on sensor 2314 after the communications electronics is fully seated on mount 2312 .
  • electrochemical measurements from sensor 2314 can be sent wirelessly from the communications electronics to a receiver unit
  • inserter kit 1600 is assembled from the following components: housing 2334 , actuator button 2324 , drive spring 2336 , shuttle 2338 , introducer sharp 2340 , sensor 2314 , retraction spring 2342 , inserter base 2344 , upper liner (not shown), adhesive mount 2312 , adhesive tape 2320 , and lower liner (not shown).
  • Shuttle 2338 is slidably and non-rotatably constrained on base 2344 by arcuate guides 2360 .
  • Shuttle 2338 is generally formed by an outer ring 2362 and an inner cup-shaped post 2364 connected by two bridges 2366 .
  • Bridges 2366 slide between the two slots (not shown) formed between guides 2360 and allow shuttle 2338 to travel along guides 2360 without rotating.
  • Retraction spring 2342 is captivated at its outer circumference by guides 2360 , at its bottom by the floor 2370 of base 2344 , at its top by bridges 2366 , and at its inner circumference by the outer surface of shuttle post 2364 .
  • Drive spring 2336 is captivated at its bottom and outer circumference by the inside surface of shuttle post 2364 , at its top by the ceiling 2372 inside actuator button 2324 , and at its inner circumference by stem 2374 depending from ceiling 2372 .
  • drive spring 2336 is compressed between actuator button 2324 and shuttle 2338 it urges shuttle 2338 towards base 2344 .
  • refraction spring 2342 is compressed between shuttle 2338 and base 2344 , it urges shuttle 2338 towards actuator button 2324 .
  • Retraction spring 2342 will return shuttle 2338 to the neutral position as shown after firing, but without sensor 2314 which remains inserted in subject's skin.
  • Drive spring 2336 is preferably designed to be stiffer than retraction spring 2342 so that shuttle 2338 oscillations are quickly dampened out, and so introducer sharp 2340 does not return to sensor 2314 or the patient to cause injury.
  • inserter 2310 With sensor 2314 inserted in the subject's skin, inserter 2310 can be removed from mount 2312 and then lifting inserter 2310 away from mount 2312 . Introducer sharp 2340 remains protected inside housing 2334 during disposal of inserter 2310 . Communications electronics can now be slid into place on mount 2312 as previously described.
  • a proximal portion of stem 2374 is enlarged to create an interference fit with the coils of spring 2336 .
  • one or more laterally extending ribs 2610 are added to stem 2374 .
  • the interference fit between ribs 2610 and spring 2336 is typically provided at the proximal (top) coils of spring 2336 .
  • the diameter of the coils of spring 2336 increases slightly when compressed and decreases slightly when extended. Ribs 2610 on stem 2374 provide greatest interference when spring 2336 is extended.
  • the interference fit provides increased stability of shuttle 2338 during insertion. In some embodiments, the interference fit prevents or minimizes distal movement of spring 2336 , which may cause impact of spring 2336 against shuttle 2338 and the end of the distal travel of these components.
  • inserter 2600 generally includes: actuator button 2602 ( FIG. 57 ), shuttle 2604 ( FIG. 58 ), inserter sharp 2610 with skin piercing edge 2612 ( FIG. 58 ), retraction spring 2608 ( FIG. 59 ), sensor 2614 ( FIG. 60 ), housing 2616 ( FIG. 61 ), and base 2618 ( FIG. 62 ). It is understood that inserter 2600 may include additional or fewer components than described herein. Inserter 2600 is substantially identical to inserter 1600 described herein, with the substantial differences noted herein and illustrated in the accompanying figures. The assembly of the different components of inserter 2600 is depicted in FIGS. 63-65 . As shown in FIG.
  • actuator button is adapted to be slidably inserted through an opening in shuttle 2604 where it locks into position.
  • retraction spring 2608 is adapted to be inserted into a second opening on the opposite side of shuttle 2604 .
  • sensor 2614 has been attached to inserter sharp 2610 .
  • sensor 2614 incorporates a biasing arm 2615 that positively seats the sensor 2614 into the inserter sharp 2610 . This allows the inserter sharp 2610 and sensor insertion portion 30 to be smaller, reducing the trauma and pain to the subject. Any number of the aforementioned sensor connection methods can be utilized in conjunction with inserter 2600 .
  • inserter sharp 2610 may be provided with rails and dimples, as previously described, in order to retain sensor 2614 , the sharp 2610 having a diameter of about 20 to about 26 gauge, e.g., 21 gauge to about 25 gauge, where, in certain embodiments, the sharp is 21 gauge or 23 gauge or 25 gauge.
  • Such sharp may be used with a sensor having a width or diameter—at least the portion that is carried by the sharp—of about 0.20 mm to about 0.80 mm, e.g., about 0.25 mm to about 0.60 mm, where, in some embodiments, the width or diameter of at least a portion of a sensor is 0.27 mm or 0.33 mm or 0.58 mm.
  • FIG. 67 depicts the actuator button 2602 locked onto the shuttle 2604 using the second of two detent grooves 2607 .
  • the shuttle is ready to be deployed.
  • the actuator button 2602 is moved to the second detent groove 2607 by a user pulling axially on the actuator button 2602 and housing 2616 .
  • Introducer sharp 2610 on which sensor 2614 is mounted, is consequently driven downward and into the skin of the subject (e.g., to a second configuration)
  • Skin piercing edge 2612 pierces the skin of the subject and allows sensor 2614 to be properly inserted, as shown in FIG. 69 .
  • retraction spring 2608 exerts an upward force on shuttle 2604 , thereby causing introducer sharp 2610 to return proximally to its original position inside of housing 2616 (e.g., to the first configuration).
  • Sensor 2614 remains implanted in the patient's skin, as shown in FIG. 70 . In this position, the plunger is bent approximately 90 degrees by the user, which prevents further use of the device, and provides obvious visual and tactile indications that the device is used and ready to be disposed.
  • Inserter assembly 4300 may include an inserter, a medical device, such as an analyte sensor, and a mount for positioning the medical device at least partially in or on the skin of the subject.
  • the mount is a support structure, plate and/or member which is attached, adhered, or otherwise secured to the skin of the subject.
  • the mount may be applied to the skin of the subject simultaneously with the medical device by the inserter.
  • the mount is installed after or before installation of the medical device.
  • a mount may be applied by the inserter or separately.
  • the mount may include features or structures (e.g., adhesive, guides, barbs, tabs, etc.) to maintain the sensor in position with respect to the skin after insertion and/or maintain the sensor in relative position with respect to the sensor control unit.
  • Inserter assembly 4300 is useful for analyte measurement systems, e.g., glucose measurement systems which include an on-body unit that may be assembled on the skin of the subject.
  • the on-body unit may include a sensor and a sensor control unit.
  • the sensor is typically installed in the patient. Subsequently, the sensor control unit is installed and coupled to the sensor. In other embodiments, the sensor control unit is installed at the patient first, followed by installation of the sensor, which is then coupled to the sensor control unit. In yet other embodiments, the sensor and sensor control unit are simultaneously installed and coupled.
  • An optional mount may or may not be used to position the sensor and/or the sensor control unit.
  • the inserter assembly 4300 is useful to install a sensor in the skin of a subject.
  • a sensor (not shown) may be preloaded within inserter 4310 prior to installation.
  • the user After preparing an insertion site on the skin of a subject, the user removes an upper liner 4316 and lower liner 4318 from mount 4312 to expose the bottom surface and a portion of the top surface of an adhesive tape located on the bottom surface of the mount 4312 .
  • Mount 4312 with inserter 4310 attached, is then applied to the subject's skin at the insertion site.
  • the mount 4312 is first attached, and then the inserter is coupled to or positioned within and/or adjacent to the mount 4312 .
  • the inserter includes an actuator button 4324 (see FIG.
  • inserter 4310 to fire, thereby inserting a sensor into the user's skin.
  • the inserter includes a safety member to impede actuation of the inserter as described below.
  • the sensor 4314 remains positioned at the mount 4312 by one or more positioning techniques.
  • sensor 4314 has a surface 4356 that extends orthogonally from main surface 4346 .
  • Surface 4356 may include an adhesive portion that contacts the subject's skin 4328 or the mount 4312 .
  • the raised end stop 4444 of mount 4312 is provided with a raised bead or bump which is received in an aperture in sensor 4314 .
  • the user may remove the inserter 4310 from mount 4312 , e.g., by pressing release tabs 4326 on opposite sides of inserter 4310 and lifting inserter 4310 away from mount 4312 .
  • the inserter 4310 is retained by other techniques, e.g., a friction-fit or a snap-fit with the mount 4312 .
  • a sensor control unit 4330 can be positioned into place with respect to the mount 4312 .
  • the circuitry of sensor control unit 4330 makes electrical contact with the contacts on sensor 4314 after sensor control unit 4330 is seated on mount 4312 .
  • seal has an exterior wall for surrounding electrical contacts on sensor 4314 (not shown in FIG. 72 ), and interior walls for isolating electrical contacts from each other.
  • rails on sensor control unit 4330 are slidable within corresponding rails or grooves 4434 on mount 4312 .
  • initialization and synchronization procedures are completed, and then electrochemical measurements from sensor 4314 can be provided from sensor control unit 4330 to a monitor unit, such as, e.g., portable monitor unit 4332 , shown in FIG. 73 .
  • Sensor control unit 4330 and monitor unit 4332 communicate via connection 20 (in this embodiment, a wireless radio frequency (RF) connection). Communication may occur, e.g., via RF communication, infrared communication, Bluetooth® communication, Zigbee® communication, 802.1x communication, or WiFi communication, etc. In some embodiments, the communication may include a radio frequency of 433 MHz, 13.56 MHz, or the like.
  • RF radio frequency
  • communication between sensor control unit 4330 and monitor unit 4332 may include radio frequency identification (RFID) techniques, and may be active RFID or passive RFID, where, in some embodiments, passive RFID technology and the respective system components include the necessary components therefor.
  • RFID radio frequency identification
  • the monitor unit may include a backscatter RFID reader configured to transmit an RF field such that when the sensor control unit is within the transmitted RF field, an antenna is tuned and in turn provides a reflected or response signal (for example, a backscatter signal) to the monitor unit.
  • the reflected or response signal may include sampled analyte level data from the analyte sensor. Additional exemplary details for various embodiments can be found in, e.g., U.S. patent application Ser. No. 12/698,124 filed Feb. 1, 2010, the disclosure of which is incorporated by reference herein for all purposes.
  • Sensor 4314 , mount 4312 and sensor control unit 4330 can remain in place on the subject for a predetermined maximum period of time that may include hours, days, weeks, or a month or more. These components are then removed so that sensor 4314 and mount 4312 can be properly discarded in some embodiments. The entire procedure above can then be repeated with a new inserter 4310 , sensor 4314 and mount 4312 , reusing sensor control unit 4330 and monitor unit 4332 . In other embodiments, inserter 4310 is reusable.
  • the inserter assembly 4300 can be assembled as shown from the following components: housing 4334 , actuator button 4324 , drive spring 4336 , shuttle 4338 , introducer sharp 4340 , sensor 4314 , retraction spring 4342 , inserter base 4344 , upper liner 4316 , adhesive mount 4312 , adhesive tape 4320 , and lower liner 4318 .
  • sensor main surface 4346 is slidably mounted between U-shaped rails 4348 of introducer sharp 4340 .
  • retention techniques are provided in certain embodiments to retain the sensor 4314 in position on sharp 4340 during storage of the inserter 4300 and/or during insertion of the sensor 4314 into the subject's skin.
  • a sensor dimple (not shown) is provided which engages an introducer dimple (also not shown).
  • Introducer sharp 4340 can be mounted to face 4354 of shuttle 4338 , such as with adhesive, heat stake or ultrasonic weld.
  • shuttle 4338 can be slidably and non-rotatably constrained on base 4344 by arcuate guides 4360 .
  • the shuttle can be generally formed by an outer ring 4362 and an inner cup-shaped post 4364 connected by two bridges 4366 .
  • Bridges 4366 can be configured to slide between the two slots 4368 formed between guides 4360 and allow shuttle 4338 to travel along guides 4360 without rotating.
  • a retraction spring 4342 is provided, which can be captivated at its outer circumference by guides 4360 , at its bottom by the floor 4370 (see FIG. 75 ) of base 4344 , at its top by bridges 4366 , and at its inner circumference by the outer surface of shuttle post 4364 .
  • a drive spring is provided for advancing the sensor 4314 and the sharp 4340 into the skin of the subject.
  • drive spring 4336 is captivated at its bottom and outer circumference by the inside surface of shuttle post 4364 , at its top by the ceiling 4372 (see FIG. 75 ) inside actuator button 4324 , and at its inner circumference by stem 4374 depending from ceiling 4372 .
  • a drive spring is omitted from the inserter assembly. In such case, for example, sensor 4314 and sharp 4340 are distally advanced by manual force applied by a user.
  • retention techniques and/or structures are provided to assist in supporting the sensor 4314 with respect to the sharp 4340 during storage and insertion. As illustrated in FIGS. 76-90 , retention mechanisms are provided which are located on the sensor and/or the sharp.
  • FIGS. 76-77 illustrate a sensor 4514 which is provided with one or two laterally extending tabs 4560 .
  • Tabs 4560 engage the rails 4548 of the sharp 4540 for retention.
  • a radiused edge on the ears allow them to be formed in two punch operations, e.g., a hole punch and a straight cut.
  • a gap between left hard-stop 4549 and the top of sensor 4514 produces, during firing, a moment that biases the sensor tip into the sharp channel. During deployment, the sensor deflects to disengage the sharp.
  • FIG. 81 illustrates another embodiment of a sensor retention technique.
  • Sensor 4814 is provided with a dimple 4860 which is thermally formed.
  • a raised bump 4864 on the sharp 4840 frictionally contacts thermally formed dimple 4860 in order to provide retention force to the sensor 4814 .
  • raised bump is formed using heat.
  • a raised bump is formed on the sensor and the dimple is formed on the sharp.
  • FIGS. 83-84 illustrate an aperture 4960 which is formed in the contact portion of the sensor 4914 .
  • a raised bump or tab 4962 is provided on the sharp 4940 . The interaction of the tab 4962 within the aperture 4960 of the sensor 4914 assists in retaining the sensor 4914 within the inserter.
  • FIGS. 85-86 illustrate a technique for retention of the sensor 5014 which is similar to the techniques illustrated in FIGS. 81-84 .
  • a raised bump 5062 is provided on sharp 5040 which engages the contact portion 5032 of the sensor 5014 .
  • the raised bump 5062 creates a bias force against the contact portion 5032 .
  • Such force acts as a frictional force to assist retention of the sensor 5014 within the sharp 5040 .
  • FIGS. 87 and 88 illustrate sensors having retention members which engage a raised post or button on the sharp.
  • FIG. 87 illustrates that contact portion 5132 of sensor 5114 includes a pair of “pincer fingers” 5160 having a substantially arcuate configuration which surround and engage a post 5162 provided on the sharp.
  • FIG. 88 illustrates sensor 5214 having a pair of proximally extending arms 5260 , which engage a post 5262 on the sharp.
  • FIG. 89 illustrates a sensor 5314 having a laterally extending arm 5360 which defines a channel 5364 between the arm 5360 and the contact portion 5332 of the sensor 5314 .
  • a post 5360 may be positioned within the channel 5364 , and provides frictional resistance to maintain the sensor 5314 within the sharp.
  • FIG. 90 illustrates a sensor 5414 having a proximally extending arm 5460 which defines a channel 5362 between the arm 5460 and the contact portion 5432 of the sensor 5414 .
  • a tab 5364 is provided on the arm 5460 and is received within a gap provided in the rails of the sharp. This interaction of the tab 5364 with the gap provides frictional resistance to maintain the sensor 5414 within the sharp.
  • FIGS. 91-92 refer to sensor retention techniques which include a retention member which provides a frictional force substantially normal (perpendicular) to the surface of the sensor.
  • FIGS. 91 and 92 illustrate a retention member which is provided within the housing 5534 of the inserter 5510 .
  • the retention member 5560 may extend distally from the housing 5534 and includes a laterally extending tab 5562 which contacts the sensor 5563 and provides a frictional force to assist retention of the sensor within the sharp 5540 .
  • FIGS. 93 and 94 illustrate a retention member which is provided with the base 5644 of the inserter 5610 .
  • retention member may include a cantilever 5660 which extends proximally from base 5644 of the inserter 5610 .
  • Cantilever 5660 may include a laterally extending member 5662 which contacts the sensor 5661 and provides a frictional force to assist retention of the sensor within the sharp 5640 .
  • the cantilever 5660 ceases contact and release of the sensor occurs.
  • FIGS. 95 and 96 illustrate a resilient or elastomeric member which is disposed within the housing 5734 of the inserter 5710 .
  • elastomeric member 5760 is manufactured from TPE and presses against the sensor and the resulting friction keeps the sensor in place.
  • the TPE material creates a higher friction with respect to the sensor, and therefore requires less pressure to produce the sensor holding force.
  • the frictional forces are directed upward keeping the sensor inside the sharp.
  • the contact with the friction rib ceases and the sensor releases to the mount.
  • the elastomeric member 5760 , or rib is produced with a second-shot injection molded process or press-fit into housing 5734 .
  • FIGS. 97 and 98 refer to retention members which provide a frictional force in a substantially coplanar direction to the surface of the sensor.
  • FIG. 97 illustrates a retention member or cantilever 5860 which is biased against the side edge of the contact portion 5832 of the sensor 5814 .
  • cantilever 5860 is provided on the carrier or sharp (not shown).
  • FIG. 98 illustrates a sensor retention technique which includes a retention member, or cantilever 5960 which is biased against the sensor, as described in FIG. 97 .
  • Cantilever 5960 includes a laterally extending portion which is at least partially received in an optionally provided notch 5964 in sensor 5914 .
  • a second retention member, or retention spring 5990 is provided which is biased to engage the front surface of the sensor.
  • retention spring 5990 is partially received in cut-out 5994 (or a slot) to capture the sensor.
  • an inserter assembly which includes a reusable inserter apparatus. Repeated uses of the inserter include the use of a removable and exchangeable sensor and sharp which may be coupled to the inserter during deployment of the sensor, and in which the sharp is removed and discarded after deployment.
  • FIGS. 99-101 illustrate a system of sharp/sensor packs 6002 which contain a plurality of sensor/sharp combinations 6006 .
  • a support is provided which includes a plurality of trays 6004 which are useful for containing the sensor/sharp configuration 6006 , and well as a desiccant 6010 which is contained in a chamber 6008 .
  • a well 6012 is provided on one side of the tray 6004 to accommodate the sensor sharp for installation into a patient.
  • a cover, such as a foil lid 6014 is applied to the top of the support to maintain the sterility of the sensor/sharp combination until installation in a subject.
  • FIG. 100 is a perspective view which illustrates an exemplary configuration of pack 6002 .
  • the foil lid 6014 for each of trays 6004 may include a tab 6016 to facilitate removal of the lid from the tray 6004 ( FIGS. 100 , 101 ).
  • FIGS. 102-105 illustrate a plurality of reusable inserters which are useful in combination with the sharp/sensor packs 6002 described herein.
  • FIG. 102 illustrates an inserter 6030 which includes a body portion 6032 , a loading or cocking structure 6036 , and an actuator button 6040 for deploying the sensor into the skin of the subject.
  • the advancement structure of inserter 6030 may include a cocking structure which is pulled to arm, e.g., by withdrawing the cocking structure 6036 from the housing 6032 ; which is pushed to arm, e.g., by depressing the cocking structure 6036 into the housing 6032 ; or which is rotated to arm, e.g., by rotating the cocking structure 6036 in a rotational movement parallel to the longitudinal axis of the inserter 6030 , or perpendicular to the longitudinal axis of the inserter 6030 .
  • the driving mechanism of inserter 6030 is substantially similar to the driving mechanisms as disclosed in U.S. Patent Publication 2008/0082166, now U.S. Pat. No. 8,167,934, U.S. Pat. No. 6,197,040, or U.S. Pat. No. 4,976,724, which are incorporated by reference in their entirety herein for all purposes.
  • the foil lid is removed from sharp/sensor pack 6002 .
  • the distal end portion 6034 of the inserter 6030 is positioned within the walls 6004 of the tray 6002 , as indicated in the direction of arrow E.
  • the distal end portion 6034 comes to rest on the upper surface of desiccant chamber 6008 , such that the insertion sharp remains exposed.
  • FIG. 103 illustrates an inserter 6130 substantially identical to the inserter 6030 described herein.
  • Inserter 6130 is used in connection with sharp/sensor trays 6102 .
  • Trays 6102 include a desiccant chamber 6108 which is located in the center portion of the tray 6102 . Accordingly, a channel 6112 surrounds the periphery of desiccant chamber 6108 .
  • the distal end portion 6134 can be positioned within the channel 6112 . As illustrated in FIG. 103 , this configuration allows the sensor and sharp to be completely housed within the inserter 6130 .
  • FIG. 104 illustrates an inserter 6230 substantially identical to the inserters 6030 and 6130 described herein, with the differences noted herein and illustrated in the figures.
  • Inserter 6230 may be used in connection with sharp/sensor trays 6204 .
  • the tray 6204 and inserter 6230 are sized and configured such that tray 6204 is capable of being positioned entirely within the distal end portion 6234 of inserter 6230 .
  • One or more support struts 6220 are provided adjacent the distal end portion 6234 to stabilize the inserter with respect to any surface on which the inserter 6230 and trays 6204 are placed for the insertion step.
  • Support struts 6220 may also secure inserter 6230 to an adhesive mount (not shown) during insertion.
  • FIG. 105 illustrates an inserter 6330 which is substantially identical to the inserters 6030 , 6130 , and 6230 described herein, with the differences noted herein and illustrated in the figures.
  • Inserter 6330 may be used in connection with sharp/sensor tray 6304 .
  • tray 6304 includes a distally projecting handle portion 6340 which may be grasped by the user to facilitate insertion of the sharp/sensor into the inserter.
  • FIGS. 106-107 illustrate an exemplary sharp/sensor combination for use with inserters 6030 , 6130 , 6230 , and 6330 described herein.
  • Sharp 6440 includes side rails 6448 for sliding reception of a sensor therein.
  • a locking tab 6450 is also provided on the proximal portion of the sharp and includes cut-out portion 6452 for interlocking with the carrier of the inserter 6030 (or 6130 , 6230 , or 6330 ).
  • carrier 6466 includes reception structure for mating reception with the sharp 6440 .
  • carrier 6466 may include a pair of walls 6478 providing a channel 6480 in which said sharp 6440 may be positioned.
  • Walls 6478 are provided with cutout portions 6482 for reception of undercut portion 6452 in locking tab 6450 .
  • a pair of securement members 6484 are movably mounted on the carrier 6466 .
  • members 6484 are biased via a spring 6486 towards a center portion of the carrier 6466 .
  • securement members 6484 may be moved outwardly against the spring bias to allow for the insertion of the locking tab 6450 into the cutout portion 6482 of the carrier.
  • Securement member 6484 is subsequently released and returns to a position to engage the undercut portion 6452 to prevent accidental removal of the sharp and sensor from the inserter ( FIG. 112 ).
  • coupling of the sharp and carrier may be provided by alternative techniques such as frictional fit, snap-fit, bayonet mounts, magnetic coupling, etc.
  • FIGS. 113-117 illustrate a further embodiment of the subject disclosure that is reusable, and useful with the sharp/sensor packs discussed herein.
  • FIG. 113 illustrates a sensor pack 6504 which is similar to the sensor packs described herein.
  • Sharp/sensor pack 6504 also includes one or more reinforcing ribs 6574 to prevent accidental deformation of the pack 6504 when the sensor is being inserted into the inserter.
  • inserter 6530 is provided which is substantially similar to inserters 6030 , 6130 , 6230 , and 6330 described herein, with the differences noted herein or illustrated in the figures.
  • Inserter 6530 includes a carrier (not shown) for coupling with a sharp/sensor combination. As illustrated in the figure, inserter 6530 is lowered onto sharp/sensor pack 6504 in order to couple the sharp 6506 with the carrier. As illustrated in FIG. 115 , inserter 6530 which now contains the sharp/sensor 6506 is positioned over the mount 6512 .
  • Mount 6512 may include an adhesive for securement to the skin of the subject.
  • Inserter 6530 includes a locking structure 6526 which allows for temporary engagement of the inserter 6530 with the mount 6512 .
  • the senor is deployed by depressing actuation button 6532 on the inserter 6530 to advance the sensor into the skin by use of an internal drive mechanism, such as, e.g., a spring. It is understood that the above-described process may alternatively be carried out by using an inserter which allows the user to provide a manual distal force for deployment of the sensor.
  • an internal drive mechanism such as, e.g., a spring.
  • inserter 6530 is decoupled from the mount, e.g., by depressing locking buttons 6526 on inserter 6530 . Once the inserter 6530 is separated from the mount, the user may remove and discard the sharp.
  • inserter 6530 includes a sliding lever 6540 which allows for removal of the sharp. It is understood that disengagement of the sharp from carrier may be executed in one of several ways, e.g., sliding switch allows securement member (discussed herein) to slide outwardly and allow disengagement of the contact portions 6483 of the securement members 6484 from the undercut portions 6452 of locking tab 6450 .
  • FIG. 118 illustrates an inserter 6630 and engagement structure for mounting on mount 6612 .
  • Inserter 6630 includes a body portion 6640 which is configured to advance a sharp/sensor cartridge into the skin S of a subject along longitudinal axis LON.
  • the longitudinal axis LON may be substantially perpendicular to the skin surface. In some embodiments, axis LON forms an acute angle with the skin surface.
  • Mount 6612 and inserter 6630 are each provided with complementary locking structures 6662 on the mount 6612 and 6664 on the inserter. Inserter is advanced laterally (direction LAT) over mount 6612 . Inserter 6630 may be locked in place by pivoting locking structure 6632 about pivot 6626 .
  • cartridge 6650 includes raised tabs 6654 which are slidable within complementary grooves 6652 provided on the inserter 6630 and mount 6612 . Insertion of the cartridge is carried out in a direction perpendicular to the direction in which the inserter is attached to the mount, e.g., a direction perpendicular to the plane of the page.
  • FIGS. 119-121 illustrate another embodiment of an inserter in accordance with the disclosed subject matter.
  • Inserter 6730 is useful for advancing a medical device, such as an analyte sensor, into the skin of a subject.
  • Inserter 6730 includes a hammer member 6760 which accumulates advancement energy to provide a more rapid and powerful advancement stroke.
  • hammer member 6760 is initially positioned somewhat askew with respect to the longitudinal axis of the device.
  • alignment trigger 6734 is advanced distally, alignment sleeves 6736 gradually pivot the hammer member 6760 into a longitudinal configuration.
  • the advancement spring continues to be compressed.
  • the hammer member 6760 is pivoted into alignment with the central bore of the inserter 6730 , e.g., along the longitudinal axis represented by the arrow. Consequently, the tension of advancement spring 6742 is immediately released, which permits rapid distal movement of the hammer member 6760 .
  • Hammer member 6760 contacts carrier 6744 , which in turn contacts sharp/sensor combination 6718 to provide distal movement.
  • a ledge or lateral member 6726 is provided with the internal bore of the inserter. As the hammer member 6760 advances distally, the distal surface of the hammer member contacts the ledge 6726 . Interengagement of the hammer member 6760 and the ledge 6726 inhibits further distal travel of the hammer member 6760 .
  • FIG. 122 illustrates an exemplary embodiment of a simplified unit, or cartridge 6800 , which holds certain components for sterility and subsequent interaction with the subject.
  • the components include the sharp 6840 , the housing 6860 , the sensor 6814 .
  • the cartridge 6800 may be used in connection with any of the inserters 6030 , 6130 , 6230 , 6330 , 6530 and/or 6730 described herein.
  • the cartridge includes a housing and a lid which contain the sharp and sensor therein.
  • a resilient member or other cantilever structure is used to maintain the alignment of the sharp and sensor within the cartridge. Interaction of the cartridge with the inserter advances the sensor and sharp such that the sensor is installed at the subject.
  • the sharp 6840 and sensor 6814 may sit in a recessed portion of the disposable cartridge 6800 .
  • a spring finger or cantilever 6876 on the housing lid maintains a load on the sharp 6840 and sensor 6814 to keep it depressed in the cavity.
  • Attachment for a lid to the base of the cartridge housing 6860 is not shown in the figure above, but methods such as snaps, heat stake, or ultrasonic welding may be used to join the two housings in assembly.
  • the sensor 6814 is contained within the sharp 6840 , laterally by the two rounded ends 6848 of the sharp, and in the orthogonal lateral direction (in relation to the views shown above), by two bent tabs 6849 on the sharp 6840 and the cartridge housing base cavity.
  • the sharp is held in its lateral position by not only the cavity, but also by the raised pyramid feature 6878 shown on the housing base 6870 .
  • the locating pyramid sits in the opening 6882 created from the bent tab in the sharp.
  • the engagement features to locate/attach/engage the cartridge to the inserter portion of the device are not shown in the figures above, but may include such features as illustrated in FIGS. 106-112 above.
  • a stepped feature from the inserter mates with the opening on the sharp (shown as two holes 6864 in the figure above).
  • the stepped portion of the feature provides a force on the back portion of the sharp to keep it raised against the force of the sprung cantilever 6876 on the housing.
  • This feature of the inserter will move in relation to the cartridge and provide the drive and retraction movement for the sharp through insertion and delivery of the sensor.
  • the force is transmitted through driving pins which are part of the movable portion of the inserter device.
  • the driving pins protrude through holes 6864 . In case of minor misalignment of the driving pins (not shown), ribs on the cartridge housing lid will constrain the sharp from tilting up.
  • the sharp and sensor are raised from the cavity portion of the cartridge, they are no longer constrained by the recessed cavity portion of the housing base and the pyramid feature maintaining the sharp position.
  • the sharp is held in its raised position by the stationary and stepped drive feature of the inserter, balanced with the force of the cantilever finger on the lid housing.
  • the sensor is kept in place by being pinched against the cantilever finger on the housing lid.
  • the sharp is constrained in its retracted position by the mated drive feature of the inserter.
  • the mated inserter drive feature drives the sharp downward as it moves through the longer slot shown in the figure above (see FIGS. 127-129 ).
  • the driven sharp slides along the stationary ribs of the inserter, ribbed features built into the cartridge housing, and the housing lid cantilever finger.
  • the friction force of the cantilever keeps the sensor up against the ‘drive block’ and bends in the sharp sheet metal to assure the tail is not exposed from the sharp channel during insertion.
  • the ‘drive block’ features are longitudinal constraints either built into the sharp or the carrier which constrain the sensor from proximal movement with respect to the sharp.
  • the drive block features are protrusions on the carrier or bends on the sharp which push the sensor as the sharp is propelled distally.
  • the sensor is kept from popping over the drive block features by the stationary ribs built into the housing lid.
  • the retention force is relieved from the sensor, and it can be captured onto the mount portion of the device with relatively little force.
  • the pinching of the cantilever on the sharp may provide enough resistance on the return motion of the sharp to keep the sensor in its inserted position even without a capture device on the mount.
  • the inserter drive feature then retracts the sharp, leaving the sensor in place on the mount portion (that is attached to the skin) of the device.
  • the cartridge can be removed from the inserter. As the cartridge is removed, the force from the housing lid cantilever presses the sharp back into the recess on the cartridge base housing. The base housing is removed and can be discarded.
  • FIGS. 131-137 Another embodiment of the cartridge is illustrated in FIGS. 131-137 .
  • the sharp 6940 and sensor 6914 in this embodiment abuts ribs 6972 and 6974 and on insertion plane to which the sharp 6940 will be driven and refracted by the inserter into the skin.
  • the sharp and sensor are held in place by a central cantilever feature 6976 built onto the cartridge lid housing.
  • This cantilever 6976 has geometry such that a vertical portion of the end of the cantilever is butted against the sharp 6940 and sensor 6914 .
  • the cartridge 6900 is loaded onto the inserter, in which a stationary feature on the inserter (not shown) raises the cartridge cantilever so that the ramped portion of the cantilever end feature is now in line with the insertion plane of the sharp. Also, a driving element of the inserter (not shown) fits through the slot opening on the sharp. In the embodiment described herein, a step is not required on the driving element on this design.
  • the cantilever arm 6976 is pushed up, keeping the sensor in position against the sharp 6940 .
  • Stationary ribs on the housing lid assure that the sharp 6940 maintains its insertion plane during insertion, and also assures that the pinching force of the cantilever does not cause the sensor to hop the drive block elements integrated into the sharp.
  • the stationary ribs keep the sensor flat against the sharp through the insertion motion.
  • the sensor 6914 is captured at the bottom of its motion on the mount, as discussed hereinabove.
  • the drive elements on the inserter retract the sharp 6940 back to its starting position.
  • the cantilever arm 6976 returns to its original unbiased configuration.
  • the cartridge 6900 is removed from the inserter and can be discarded.

Abstract

An apparatus for insertion of a medical device in the skin of a subject is provided, as well as methods of inserting medical devices.

Description

    RELATED APPLICATIONS
  • The present application is a continuation of U.S. patent application Ser. No. 13/071,497 filed Mar. 24, 2011, which claims the benefit of U.S. Provisional Application Nos. 61/317,243, filed Mar. 24, 2010; 61/345,562, filed May 17, 2010; 61/361,374, filed Jul. 2, 2010; 61/411,262, filed Nov. 8, 2010, the disclosures of which are incorporated herein by reference for all purposes.
  • INCORPORATION BY REFERENCE
  • Patents, applications and/or publications described herein, including the following patents, applications and/or publications are incorporated herein by reference for all purposes: U.S. Pat. Nos. 4,545,382; 4,711,245; 5,262,035; 5,262,305; 5,264,104; 5,320,715; 5,356,786; 5,509,410; 5,543,326; 5,593,852; 5,601,435; 5,628,890; 5,820,551; 5,822,715; 5,899,855; 5,918,603; 6,071,391; 6,103,033; 6,120,676; 6,121,009; 6,134,461; 6,143,164; 6,144,837; 6,161,095; 6,175,752; 6,270,455; 6,284,478; 6,299,757; 6,338,790; 6,377,894; 6,461,496; 6,503,381; 6,514,460; 6,514,718; 6,540,891; 6,560,471; 6,579,690; 6,591,125; 6,592,745; 6,600,997; 6,605,200; 6,605,201; 6,616,819; 6,618,934; 6,650,471; 6,654,625; 6,676,816; 6,730,200; 6,736,957; 6,746,582; 6,749,740; 6,764,581; 6,773,671; 6,881,551; 6,893,545; 6,932,892; 6,932,894; 6,942,518; 7,041,468; 7,167,818; and 7,299,082; 7,381,184; 7,740,581; 7,811,231 U.S. Published Application Nos. 2005/0182306; 2006/0091006; 2007/0056858, now U.S. Pat. No. 8,298,389; 2007/0068807, now U.S. Pat. No. 7,846,311; 2007/0095661; 2007/0108048, now U.S. Pat. No. 7,918,975; 2007/0149873; 2007/0149875, now U.S. Pat. No. 8,515,518; 2007/0199818, now U.S. Pat. No. 7,811,430; 2007/0227911, now U.S. Pat. No. 7,887,682; 2007/0233013; 2008/0058625, now U.S. Pat. No. 7,920,907; 2008/0064937; 2008/0066305, now U.S. Pat. No. 7,895,740; 2008/0071157; 2008/0071158; 2008/0081977, now U.S. Pat. No. 7,618,369; 2008/0102441, now U.S. Pat. No. 7,822,557; 2008/0148873, now U.S. Pat. No. 7,802,467; 2008/0161666; 2008/0179187; 2008/0267823; 2008/0319295, now U.S. Pat. No. 8,597,188; 2008/0319296, now U.S. Pat. No. 8,617,069; 2009/0018425, now U.S. Pat. No. 8,160,670; 2009/0247857, now U.S. Pat. No. 8,346,335; 2009/0257911, now U.S. Pat. No. 8,252,229; 2009/0281406; 2009/0294277; 2009/0054748, now U.S. Pat. No. 7,885,698; 2009/0054749; 2010/0030052; 2010/0065441, now U.S. Pat. No. 8,636,884; 2010/0081905; 2010/0081909, now U.S. Pat. No. 8,219,173; 2010/0213057; 2010/0325868, now U.S. Pat. No. 7,866,026; 2010/0326842; 2010/0326843, now U.S. Pat. No. 8,437,827; 2010/0331643; 2011/0046466; U.S. patent application Ser. Nos. 12/624,767; 12/625,185, now U.S. Pat. No. 8,354,013; Ser. No. 12/625,208; Ser. No. 12/625,524, now U.S. Pat. No. 8,390,455; Ser. No. 12/625,525, now U.S. Pat. No. 8,358,210; Ser. No. 12/625,528, now U.S. Pat. No. 8,115,635; Ser. No. 12/628,177; Ser. No. 12/628,198; Ser. No. 12/628,201; Ser. No. 12/628,203; Ser. No. 12/628,210; Ser. No. 12/698,124; Ser. No. 12/698,129; Ser. No. 12/699,653; Ser. No. 12/699,844; Ser. No. 12/714,439; Ser. No. 12/730,193; Ser. No. 12/794,721, now U.S. Pat. No. 8,595,607; Ser. No. 12/807,278; Ser. No. 12/842,013; Ser. No. 12/870,818; Ser. No. 12/871,901, now U.S. Pat. No. 8,514,086; Ser. No. 12/873,301; Ser. No. 12/873,302; Ser. No. 13/011,897; and U.S. Provisional Application Nos. 61/238,646; 61/246,825; 61/247,516; 61/249,535; 61/317,243; 61/325,155; 61/345,562; and 61/359,265.
  • BACKGROUND
  • The detection and/or monitoring of glucose levels or other analytes, such as lactate, oxygen, AlC, or the like, in certain individuals is vitally important to their health. For example, the monitoring of glucose is particularly important to individuals with diabetes. Diabetics generally monitor glucose levels to determine if their glucose levels are being maintained within a clinically safe range, and may also use this information to determine if and/or when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.
  • Growing clinical data demonstrates a strong correlation between the frequency of glucose monitoring and glycemic control. Despite such correlation, many individuals diagnosed with a diabetic condition do not monitor their glucose levels as frequently as they should due to a combination of factors including convenience, testing discretion, pain associated with glucose testing, and cost.
  • Devices have been developed for the automatic monitoring of analyte(s), such as glucose, in bodily fluid such as in the blood stream or in interstitial fluid (“ISF”), or other biological fluid. Some of these analyte measuring devices are configured so that at least a portion of the devices are positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user, so that the monitoring is accomplished in vivo.
  • With the continued development of analyte monitoring devices and systems, there is a need for such analyte monitoring devices, systems, and methods, as well as for processes for manufacturing analyte monitoring devices and systems that are cost effective, convenient, and with reduced pain, provide discreet monitoring to encourage frequent analyte monitoring to improve glycemic control.
  • SUMMARY
  • An apparatus for inserting a medical device through the skin of a subject is provided, which includes a housing defining a longitudinal cavity therein and a interference member extending into the cavity; a biasing member; a driver member coupled to the biasing member for movement from a proximal position to a distal position and further configured for movement between a misaligned configuration in which the driver member is impeded from distal movement by the interference member and an aligned configuration in which the driver member is not impeded from distal movement by the interference member; and an actuator having an alignment surface for moving the driver member from the misaligned configuration to the aligned configuration.
  • In some embodiments, the actuator is movable from a proximal position to a distal position. In some embodiments, distal movement of the actuator compresses the first biasing member. In some embodiments, the first position of the driver member is at an oblique angle with respect to the longitudinal cavity. In some embodiments, the second position of the driver member includes a configuration substantially aligned with the longitudinal cavity.
  • An apparatus for inserting a medical device through the skin of a subject is provided, which includes a housing defining a cantilever member; a sharp movable within the housing from a retracted position to a partially exposed position; and an electrochemical sensor releasably coupled to the sharp for movement with the sharp, and for subsequent insertion in the skin of a subject; wherein the cantilever member resiliently contacts at least one of the sharp and the sensor.
  • In some embodiments, the housing includes a distal opening for release of the electrochemical sensor therefrom. In some embodiments, the housing defines a longitudinal notch for reception of a drive member of an inserter. In some embodiments, the housing contains a desiccant. In some embodiments, the housing defines one or more longitudinal ridges for aligning one of the sharp and the sensor.
  • These and other features, objects, and advantages of the disclosed subject matter will become apparent to those persons skilled in the art upon reading the detailed description as more fully described below.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • A detailed description of various aspects, features, and embodiments of the subject matter described herein is provided with reference to the accompanying drawings, which are briefly described below. The drawings are illustrative and are not necessarily drawn to scale, with some components and features being exaggerated for clarity. The drawings illustrate various aspects and features of the present subject matter and may illustrate one or more embodiment(s) or example(s) of the present subject matter in whole or in part.
  • FIG. 1 illustrates an analyte monitoring system for real time analyte (e.g., glucose) measurement, data acquisition and/or processing in certain embodiments;
  • FIGS. 2-3 are views of an electrochemical sensor in accordance with a further embodiment of the disclosed subject matter;
  • FIGS. 4-5 are schematic views of a needle hub in accordance with one embodiment of the disclosed subject matter;
  • FIG. 6 is a distal end view of a sharp in accordance with one embodiment of the disclosed subject matter;
  • FIG. 7 is a side view of a sharp in accordance with one embodiment of the disclosed subject matter;
  • FIG. 8 is a side view of a sharp in accordance with one embodiment of the disclosed subject matter;
  • FIG. 9 is a perspective view of a sharp in accordance with one embodiment of the disclosed subject matter;
  • FIG. 10 is a schematic view of an alternate embodiment for forming a sharp to be used in an inserter in accordance with one embodiment of the disclosed subject matter;
  • FIG. 11 is a perspective view of an inserter in accordance with one embodiment of the disclosed subject matter;
  • FIG. 12 is a perspective view with parts separated of an inserter in accordance with one embodiment of the disclosed subject matter;
  • FIG. 13 is an enlarged sectional view with parts separated of an inserter in accordance with one embodiment of the disclosed subject matter;
  • FIG. 14 is a side view of another inserter in accordance with the disclosed subject matter;
  • FIGS. 15-17 are sectional, perspective views of the inserter of FIG. 14 in accordance with another embodiment of the disclosed subject matter;
  • FIG. 18 is a perspective view of another inserter in accordance with the disclosed subject matter;
  • FIGS. 19-21 are side views with transparency of the inserter of FIG. 18 in accordance with another embodiment of the disclosed subject matter;
  • FIG. 22 is a perspective view of another inserter in accordance with the disclosed subject matter;
  • FIGS. 23-25 are sectional, perspective views of the inserter of FIG. 22 in accordance with another embodiment of the disclosed subject matter;
  • FIG. 26 is a sectional view in section of another embodiment of an inserter in accordance with the disclosed subject matter;
  • FIG. 27 is a perspective view of the inserter of FIG. 26 in accordance with the disclosed subject matter;
  • FIGS. 28-31 are perspective views of components of the inserter of FIG. 26 in accordance with the disclosed subject matter;
  • FIG. 32 illustrates an exploded view of the inserter of FIG. 26 in accordance with the disclosed subject matter;
  • FIG. 33 is a side view of the inserter of FIG. 26 in accordance with the disclosed subject matter;
  • FIGS. 34-36 are side views with transparency of the inserter of FIG. 26 in accordance with the disclosed subject matter;
  • FIG. 37 is an inserter in accordance with another embodiment in accordance with the disclosed subject matter;
  • FIG. 38 is a perspective view in section of the inserter of FIG. 37 in accordance with the disclosed subject matter;
  • FIG. 39 is a cross-sectional view of the inserter of FIG. 37 in accordance with the disclosed subject matter;
  • FIG. 40 is a side view of the inserter of FIG. 37 in accordance with the disclosed subject matter;
  • FIGS. 41-44 are perspective views of components of the inserter of FIG. 37 in accordance with the disclosed subject matter;
  • FIG. 45 is an exploded view of the inserter of FIG. 37 in accordance with the disclosed subject matter;
  • FIG. 46 is a side view with transparency of the inserter of FIG. 37 in accordance with the disclosed subject matter;
  • FIGS. 47-51 are perspective views of another inserter in accordance with the disclosed subject matter;
  • FIG. 52 is an exploded perspective view of another embodiment of the disclosed subject matter;
  • FIG. 53 is a sectional view of an inserter in accordance with the disclosed subject matter;
  • FIGS. 54-55 are perspective views from below of the inserter of FIG. 53;
  • FIG. 56 is a perspective view of another inserter in accordance with the disclosed subject matter;
  • FIGS. 57-60 are perspective views of various components of the inserter of FIG. 56;
  • FIG. 61-62 are perspective views of various components of the inserter of FIG. 56;
  • FIGS. 63-65 depict different subassemblies of the components of the inserter of FIG. 56;
  • FIGS. 66-67 are cross-sectional views of a subassembly of the components of the inserter of FIG. 56;
  • FIGS. 68-70 depict the steps used to actuate the inserter of FIG. 56;
  • FIG. 71 is a perspective view of an inserter assembly in accordance with the disclosed subject matter;
  • FIG. 72 is a perspective view of a component of an inserter assembly of FIG. 71 in accordance with the disclosed subject matter;
  • FIG. 73 is a perspective view of a component of an analyte measurement system in accordance with the disclosed subject matter;
  • FIG. 74 is a perspective view with parts separated of the inserter assembly of FIG. 71 in accordance with the disclosed subject matter;
  • FIG. 75 is a cross-sectional view of the inserter assembly of FIG. 71 in accordance with the disclosed subject matter;
  • FIG. 76 is a side view of a portion of an inserter assembly in accordance with the disclosed subject matter;
  • FIG. 77 is a view of an analyte sensor in accordance with the disclosed subject matter;
  • FIGS. 78-79 are perspective views of a portion of an inserter assembly in accordance with the disclosed subject matter;
  • FIGS. 80-90 are views of analyte sensors in accordance with the disclosed subject matter;
  • FIGS. 91-92 are cross-sectional views of an inserter assembly in accordance with the disclosed subject matter;
  • FIGS. 93-94 are cross-sectional views of another inserter assembly in accordance with the disclosed subject matter;
  • FIGS. 95-96 are cross-sectional views of a further inserter assembly in accordance with the disclosed subject matter;
  • FIGS. 97-98 are views of a portion of an inserter assembly in accordance with the disclosed subject matter;
  • FIG. 99 is a cross-sectional view of a portion of an inserter assembly in accordance with the disclosed subject matter;
  • FIGS. 100-101 are perspective views of a portion of an inserter assembly in accordance with the disclosed subject matter;
  • FIGS. 102-105 are side views of various inserter assemblies in accordance with the disclosed subject matter;
  • FIGS. 106-112 are views of a sharp and sharp carrier in accordance with the disclosed subject matter;
  • FIG. 113 is a perspective view of a portion of an inserter assembly in accordance with the disclosed subject matter;
  • FIGS. 114-117 are perspective views illustrating the operation of an inserter assembly in accordance with the disclosed subject matter;
  • FIG. 118 is a side view of an inserter assembly in accordance with the disclosed subject matter;
  • FIGS. 119-121 are cross-sectional views of an inserter assembly in accordance with the disclosed subject matter;
  • FIG. 122 is a perspective view with parts separated of an embodiment of a sharp/sensor cartridge in accordance with the disclosed subject matter;
  • FIG. 123 is a perspective view of the cartridge of FIG. 122 in a first stage of deployment in accordance with the disclosed subject matter;
  • FIG. 124 is a cross-sectional view of the cartridge of FIG. 122 in a neutral state in accordance with the disclosed subject matter;
  • FIG. 125 is a perspective view of the cartridge of FIG. 122 in a neutral state in accordance with the disclosed subject matter;
  • FIG. 126 is a cross-sectional view of the cartridge of FIG. 122 in a first stage of deployment in accordance with the disclosed subject matter;
  • FIG. 127 is a perspective view of the cartridge of FIG. 122 in a second stage of deployment in accordance with the disclosed subject matter;
  • FIG. 128 is a cross-sectional view of the cartridge of FIG. 122 in a second stage of deployment in accordance with the disclosed subject matter;
  • FIG. 129 is a perspective view of the cartridge of FIG. 122 in a third stage of deployment in accordance with the disclosed subject matter;
  • FIG. 130 is a cross-sectional view of the cartridge of FIG. 122 in a third stage of deployment in accordance with the disclosed subject matter;
  • FIG. 131 is a perspective view with parts separated of another embodiment of a component of an inserter in accordance with the disclosed subject matter;
  • FIG. 132 is a perspective view of the cartridge of FIG. 131 in a neutral state in accordance with the disclosed subject matter;
  • FIG. 133 is a cross-sectional view of the cartridge of FIG. 131 in a neutral state in accordance with the disclosed subject matter;
  • FIG. 134 is a perspective view of the cartridge of FIG. 131 in a second stage of deployment in accordance with the disclosed subject matter;
  • FIG. 135 is a cross-sectional view of the cartridge of FIG. 131 in a second stage of deployment in accordance with the disclosed subject matter;
  • FIG. 136 is a perspective view of the cartridge of FIG. 131 in a third stage of deployment in accordance with the disclosed subject matter; and
  • FIG. 137 is a cross-sectional view of the cartridge of FIG. 131 in a third stage of deployment in accordance with the disclosed subject matter.
  • DETAILED DESCRIPTION
  • A detailed description of the disclosure is provided herein. It should be understood, in connection with the following description, that the subject matter is not limited to particular embodiments described, as the particular embodiments of the subject matter may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the disclosed subject matter will be limited only by the appended claims.
  • Where a range of values is provided, it is understood that each intervening value between the upper and lower limit of that range, and any other stated or intervening value in that stated range, is encompassed within the disclosed subject matter. Every range stated is also intended to specifically disclose each and every “subrange” of the stated range. That is, each and every range smaller than the outside range specified by the outside upper and outside lower limits given for a range, whose upper and lower limits are within the range from said outside lower limit to said outside upper limit (unless the context clearly dictates otherwise), is also to be understood as encompassed within the disclosed subject matter, subject to any specifically excluded range or limit within the stated range. Where a range is stated by specifying one or both of an upper and lower limit, ranges excluding either or both of those stated limits, or including one or both of them, are also encompassed within the disclosed subject matter, regardless of whether or not words such as “from,” “to,” “through,” or “including” are or are not used in describing the range.
  • Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosed subject matter belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosed subject matter, this disclosure may specifically mention certain exemplary methods and materials.
  • All publications mentioned in this disclosure are, unless otherwise specified, incorporated by reference herein for all purposes, including without limitation to disclose and describe the methods and/or materials in connection with which the publications are cited.
  • The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosed subject matter is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates, which may need to be independently confirmed.
  • As used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise.
  • Nothing contained in the Abstract or the Summary should be understood as limiting the scope of the disclosure. The Abstract and the Summary are provided for bibliographic and convenience purposes and due to their formats and purposes should not be considered comprehensive.
  • As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosed subject matter. Any recited method can be carried out in the order of events recited, or in any other order which is logically possible.
  • Reference to a singular item includes the possibility that there are plural of the same item present. When two or more items (for example, elements or processes) are referenced by an alternative “or,” this indicates that either could be present separately or any combination of them could be present together except where the presence of one necessarily excludes the other or others.
  • Generally, embodiments of the present disclosure relate to an apparatus for inserting a medical device at least partially into the skin of the patient. Some embodiments relate to in vivo methods and devices for detecting at least one analyte such as glucose in body fluid. Accordingly, embodiments include in vivo analyte sensors configured so that at least a portion of the sensor is positioned in the body of a user (e.g., within the ISF), to obtain information about at least one analyte of the body, e.g., transcutaneously positioned in user's body. In certain embodiments, an in vivo analyte sensor is coupled to an electronics unit that is maintained on the body of the user to process information obtained from the sensor.
  • In certain embodiments, analyte information is communicated from a first device such as an on body electronics unit to a second device which may include user interface features, including a display, and/or the like. Information may be communicated from the first device to the second device automatically and/or continuously when the analyte information is available, or may not be communicated automatically and/or continuously, but rather stored or logged in a memory of the first device. Accordingly, in many embodiments of the system, analyte information derived by the sensor/on body electronics (for example, on body electronics) is made available in a user-usable or viewable form only when queried by the user such that the timing of data communication is selected by the user. In some embodiments, the display of information is selected by the user, while the timing of data communication is not.
  • In this manner, analyte information is only provided or evident to a user (provided at a user interface device) in some embodiments when desired by the user even though an in vivo analyte sensor automatically and/or continuously monitors the analyte level in vivo, i.e., the sensor automatically monitors analyte such as glucose on a pre-defined time interval over its usage life. For example, an analyte sensor may be positioned in vivo and coupled to on body electronics for a given sensing period, e.g., about 14 days. In certain embodiments, the sensor-derived analyte information is automatically communicated from the sensor electronics assembly to a remote monitor device or display device for output to a user throughout the 14 day period according to a schedule programmed at the on body electronics (e.g., about every 1 minute or about every 5 minutes or about every 10 minutes, or the like). In certain embodiments, sensor-derived analyte information is only communicated from the sensor electronics assembly to a remote monitor device or display device at user-determined times, e.g., whenever a user decides to check analyte information. At such times, a communications system is activated and sensor-derived information is then sent from the on body electronics to the remote device or display device.
  • In still other embodiments, the information may be communicated from the first device to the second device automatically and/or continuously when the analyte information is available, and the second device stores or logs the received information without presenting or outputting the information to the user. In such embodiments, the information is received by the second device from the first device when the information becomes available (e.g., when the sensor detects the analyte level according to a time schedule). However, the received information is initially stored in the second device and only output to a user interface or an output component of the second device (e.g., display) upon detection of a request for the information on the second device.
  • Accordingly, in certain embodiments an inserter as described herein is used to place a sensor electronics assembly on the body so that at least a portion of the in vivo sensor is in contact with bodily fluid such as ISF. Once the sensor is electrically coupled to the electronics unit, sensor derived analyte information may be communicated from the on body electronics to a display device on-demand by powering on the display device (or it may be continually powered), and executing a software algorithm stored in and accessed from a memory of the display device, to generate one or more request commands, control signal or data packet to send to the on body electronics. The software algorithm executed under, for example, the control of the microprocessor or application specific integrated circuit (ASIC) of the display device may include routines to detect the position of the on body electronics relative to the display device to initiate the transmission of the generated request command, control signal and/or data packet.
  • Display devices may also include programming stored in memory for execution by one or more microprocessors and/or ASICs to generate and transmit the one or more request command, control signal or data packet to send to the on body electronics in response to a user activation of an input mechanism on the display device such as depressing a button on the display device, triggering a soft button associated with the data communication function, and so on. The input mechanism may be alternatively or additionally provided on or in the on body electronics which may be configured for user activation. In certain embodiments, voice commands or audible signals may be used to prompt or instruct the microprocessor or ASIC to execute the software routine(s) stored in the memory to generate and transmit the one or more request command, control signal or data packet to the on body device. In the embodiments that are voice activated or responsive to voice commands or audible signals, on body electronics and/or display device includes a microphone, a speaker, and processing routines stored in the respective memories of the on body electronics and/or the display device to process the voice commands and/or audible signals. In certain embodiments, positioning the on body electronics and the display device within a predetermined distance (e.g., close proximity) relative to each other initiates one or more software routines stored in the memory of the display device to generate and transmit a request command, control signal or data packet.
  • Different types and/or forms and/or amounts of information may be sent for each on demand reading, including but not limited to one or more of current analyte level information (i.e., real time or the most recently obtained analyte level information temporally corresponding to the time the reading is initiated), rate of change of an analyte over a predetermined time period, rate of the rate of change of an analyte (acceleration in the rate of change), historical analyte information corresponding to analyte information obtained prior to a given reading and stored in memory of the assembly. Some or all of real time, historical, rate of change, rate of rate of change (such as acceleration or deceleration) information may be sent to a display device for a given reading. In certain embodiments, the type and/or form and/or amount of information sent to a display device may be preprogrammed and/or unchangeable (e.g., preset at manufacturing), or may not be preprogrammed and/or unchangeable so that it may be selectable and/or changeable in the field one or more times (e.g., by activating a switch of the system, etc). Accordingly, in certain embodiments, for each on demand reading, a display device will output a current (real time) sensor-derived analyte value (e.g., in numerical format), a current rate of analyte change (e.g., in the form of an analyte rate indicator such as an arrow pointing in a direction to indicate the current rate), and analyte trend history data based on sensor readings acquired by and stored in memory of on body electronics (e.g., in the form of a graphical trace). Additionally, the on skin or sensor temperature reading or measurement associated with each on demand reading may be communicated from the on body electronics to the display device. The temperature reading or measurement, however, may not be output or displayed on the display device, but rather, used in conjunction with a software routine executed by the display device to correct or compensate the analyte measurement output to the user on the display device.
  • As described, embodiments include inserters for in vivo analyte sensors and on body electronics that together provide body wearable sensor electronics assemblies. In certain embodiments, in vivo analyte sensors are fully integrated with on body electronics (fixedly connected during manufacture), while in other embodiments they are separate but connectable post manufacture (e.g., before, during or after sensor insertion into a body). On body electronics may include an in vivo glucose sensor, electronics, battery, and antenna encased (except for the sensor portion that is for in vivo positioning) in a waterproof housing that includes or is attachable to an adhesive pad. In certain embodiments, the housing withstands immersion in about one meter of water for up to at least 30 minutes. In certain embodiments, the housing withstands continuous underwater contact, e.g., for longer than about 30 minutes, and continues to function properly according to its intended use, e.g., without water damage to the housing electronics where the housing is suitable for water submersion.
  • Embodiments include sensor insertion devices, which also may be referred to herein as sensor delivery units, or the like. Insertion devices may retain on body electronics assemblies completely in an interior compartment, i.e., an insertion device may be “pre-loaded” with on body electronics assemblies during the manufacturing process (e.g., on body electronics may be packaged in a sterile interior compartment of an insertion device). In such embodiments, insertion devices may form sensor assembly packages (including sterile packages) for pre-use or new on body electronics assemblies, and insertion devices configured to apply on body electronics assemblies to recipient bodies.
  • Embodiments include portable handheld display devices, as separate devices and spaced apart from an on body electronics assembly, that collect information from the assemblies and provide sensor derived analyte readings to users. Such devices may also be referred to as meters, readers, monitors, receivers, human interface devices, companions, or the like. Certain embodiments may include an integrated in vitro analyte meter. In certain embodiments, display devices include one or more wired or wireless communications ports such as USB, serial, parallel, or the like, configured to establish communication between a display device and another unit (e.g., on body electronics, power unit to recharge a battery, a PC, etc). For example, a display device communication port may enable charging a display device battery with a respective charging cable and/or data exchange between a display device and its compatible informatics software.
  • Compatible informatics software in certain embodiments include, for example, but not limited to stand alone or network connection enabled data management software program, resident or running on a display device, personal computer, a server terminal, for example, to perform data analysis, charting, data storage, data archiving and data communication as well as data synchronization. Informatics software in certain embodiments may also include software for executing field upgradable functions to upgrade firmware of a display device and/or on body electronics unit to upgrade the resident software on the display device and/or the on body electronics unit, e.g., with versions of firmware that include additional features and/or include software bugs or errors fixed, etc. Embodiments may include a haptic feedback feature such as a vibration motor or the like, configured so that corresponding notifications (e.g., a successful on-demand reading received at a display device), may be delivered in the form of haptic feedback.
  • Embodiments include programming embedded on a computer readable medium, i.e., computer-based application software (may also be referred to herein as informatics software or programming or the like) that processes analyte information obtained from the system and/or user self-reported data. Application software may be installed on a host computer such as a mobile telephone, PC, an Internet-enabled human interface device such as an Internet-enabled phone, personal digital assistant, or the like, by a display device or an on body electronics unit. Informatics programming may transform data acquired and stored on a display device or on body unit for use by a user.
  • Embodiments of the subject disclosure are described primarily with respect to glucose monitoring devices and systems, and methods of glucose monitoring, for convenience only and such description is in no way intended to limit the scope of the disclosure. It is to be understood that the analyte monitoring system may be configured to monitor a variety of analytes at the same time or at different times.
  • As described in detail below, embodiments include devices, systems, kits and/or methods to monitor one or more physiological parameters such as, for example, but not limited to, analyte levels, temperature levels, heart rate, user activity level, over a predetermined monitoring time period. Also provided are methods of manufacturing. Predetermined monitoring time periods may be less than about 1 hour, or may include about 1 hour or more, e.g., about a few hours or more, e.g., about a few days of more, e.g., about 3 or more days, e.g., about 5 days or more, e.g., about 7 days or more, e.g., about 10 days or more, e.g., about 14 days or more, e.g., about several weeks, e.g., about 1 month or more. In certain embodiments, after the expiration of the predetermined monitoring time period, one or more features of the system may be automatically deactivated or disabled at the on body electronics assembly and/or display device.
  • For example, a predetermined monitoring time period may begin with positioning the sensor in vivo and in contact with a body fluid such as ISF, and/or with the initiation (or powering on to full operational mode) of the on body electronics. Initialization of on body electronics may be implemented with a command generated and transmitted by a display device in response to the activation of a switch and/or by placing the display device within a predetermined distance (e.g., close proximity) to the on body electronics, or by user manual activation of a switch on the on body electronics unit, e.g., depressing a button, or such activation may be caused by the insertion device, e.g., as described in U.S. patent application Ser. No. 12/698,129 filed on Feb. 1, 2010 and U.S. Provisional Application Nos. 61/238,646, 61/246,825, 61/247,516, 61/249,535, 61/317,243, 61/345,562, and 61/361,374, the disclosures of each of which are incorporated herein by reference for all purposes.
  • When initialized in response to a received command from a display device, the on body electronics retrieves and executes from its memory software routine to fully power on the components of the on body electronics, effectively placing the on body electronics in full operational mode in response to receiving the activation command from the display device. For example, prior to the receipt of the command from the display device, a portion of the components in the on body electronics may be powered by its internal power supply such as a battery while another portion of the components in the on body electronics may be in powered down or maintained in a low power state including no power state, inactive mode, or all components may be in an inactive, powered down mode. Upon receipt of the command, the remaining portion (or all) of the components of the on body electronics is switched to active, fully operational mode.
  • Embodiments of on body electronics may include one or more printed circuit boards with electronics including control logic implemented in ASIC, microprocessors, memory, and the like, and transcutaneously positionable analyte sensors forming a single assembly. On body electronics may be configured to provide one or more signals or data packets associated with a monitored analyte level upon detection of a display device of the analyte monitoring system within a predetermined proximity for a period of time (for example, about 2 minutes, e.g., 1 minute or less, e.g., about 30 seconds or less, e.g., about 10 seconds or less, e.g., about 5 seconds or less, e.g., about 2 seconds or less) and/or until a confirmation, such as an audible and/or visual and/or tactile (e.g., vibratory) notification, is output on the display device indicating successful acquisition of the analyte related signal from the on body electronics. A distinguishing notification may also be output for unsuccessful acquisition in certain embodiments.
  • In certain embodiments, the monitored analyte level may be correlated and/or converted to glucose levels in blood or other fluids such as ISF. Such conversion may be accomplished with the on body electronics, but in many embodiments will be accomplished with display device electronics. In certain embodiments, glucose level is derived from the monitored analyte level in the ISF.
  • Analyte sensors may be insertable into a vein, artery, or other portion of the body containing analyte. In certain embodiments, analyte sensors may be positioned in contact with ISF to detect the level of analyte, where the detected analyte level may be used to infer the user's glucose level in blood or interstitial tissue.
  • Embodiments include transcutaneous sensors and also wholly implantable sensors and wholly implantable assemblies in which a single assembly including the analyte sensor and electronics are provided in a sealed housing (e.g., hermetically sealed biocompatible housing) for implantation in a user's body for monitoring one or more physiological parameters.
  • Embodiments include analyte monitors that are provided in small, lightweight, battery-powered and electronically-controlled systems. Such systems may be configured to detect physical parameters of subjects, such as signals indicative of in vivo analyte levels using an electrochemical sensor, and collect such signals, with or without processing. Any suitable measurement technique may be used to obtain signals from the sensors, e.g., may detect current, may employ potentiometry, etc. Techniques may include, but are not limited to amperometry, coulometry, and voltammetry. In some embodiments, sensing systems may be optical, colorimetric, and the like. In some embodiments, the portion of the system that performs this initial processing may be configured to provide the raw or at least initially processed data to another unit for further collection and/or processing. Such provision of data may be affected, for example, by a wired connection, such as an electrical, or by a wireless connection, such as an IR or RF connection.
  • In certain systems, the analyte sensor is in communication with on body electronics. The on-body unit may include a housing in which the on body electronics and at least a portion of the sensor are received.
  • Certain embodiments are modular. The on-body unit may be separately provided as a physically distinct assembly from a monitor unit, e.g., which displays or otherwise indicates analyte levels to a user. The on-body unit may be configured to provide the analyte levels detected by the sensor and/or other information (such as temperature, sensor life, etc.) over a communication link to the monitor unit. The monitor unit, in some embodiments, may include, e.g., a mobile telephone device, an in vitro glucose meter, a personal digital assistant, or other consumer electronics such as MP3 device, camera, radio, personal computer, etc., or other communication-enabled data-processing device.
  • The display unit may perform a variety of functions such as but not limited to data storage and/or processing and/or analysis and/or communication, etc., on the received analyte data to generate information pertaining to the monitored analyte levels and/or process the other information. The monitor unit may incorporate a display screen, which can be used, for example, to display measured analyte levels, and/or an audio component such as a speaker to audibly provide information to a user, and/or a vibration device to provide tactile feedback to a user. It is also useful for a user of an analyte-monitoring system to be able to see trend indications (including the magnitude and direction of any ongoing trend, e.g., the rate of change of an analyte or other parameter, and the amount of time a subject is above and/or below a threshold, such as a hypoglycemic and/or hyperglycemic threshold, etc.); such data may be displayed either numerically, or by a visual indicator such as an arrow that may vary in visual attributes, like size, shape, color, animation, or direction. The monitor unit may further be adapted to receive information from or about an in vitro analyte test strip, which may be manually or automatically entered into the monitor unit. In some embodiments, a monitor unit may incorporate an in vitro analyte test strip port and related electronics in order to be able to make discrete (e.g., blood glucose) measurements using an in vitro test strip (see, e.g., U.S. Pat. No. 6,175,752, the disclosure of which is incorporated by reference herein for all purposes).
  • The modularity of these systems may vary where one or more components may be constructed to be single use and one or more may be constructed to be re-useable. In some embodiments, the sensor is designed to be attachable and detachable from the on body electronics (and the on-body unit may be reusable), e.g., so that one or more of the components may be reused one or more times, while in other embodiments, the sensor and on body electronics may be provided as an integrated, undetachable package, which may be designed to be disposable after use, i.e., not re-used.
  • Embodiments of In Vivo Monitoring Systems
  • For purpose of illustration, and not limitation, the inserters described herein may be used in connection with an exemplary analyte monitoring system as depicted in FIG. 1. It is understood that the inserters described herein may be used with any medical device on its own or in connection with a system. FIG. 1 shows an exemplary in vivo-based analyte monitoring system 100 in accordance with embodiments of the present disclosure. As shown, in certain embodiments, analyte monitoring system 100 includes on body electronics 1100 electrically coupled to in vivo analyte sensor 14 (a proximal portion of which is shown in FIG. 1), and attached to adhesive layer 218 for attachment on a skin surface on the body of a user. On body electronics 1100 includes on body housing 122 that defines an interior compartment.
  • Also shown in FIG. 1 is insertion device 200 (or insertion devices 300, 400, 2400, 2500, 2700, 3700 described herein) that, when operated, transcutaneously positions a portion of analyte sensor 14 through a skin surface and in fluid contact with ISF, and positions on body electronics 1100 and adhesive layer 218 on a skin surface, as will be described in greater detail herein. In certain embodiments, on body electronics 1100, analyte sensor 14 and adhesive layer 218 are sealed within the housing of insertion device 200 before use, and in certain embodiments, adhesive layer 218 is also sealed within the housing or the adhesive layer can provide a seal for preserving the sterility of the apparatus. Additional details regarding insertion devices are discussed, e.g., in U.S. patent application Ser. No. 12/698,129 and U.S. Provisional Application Nos. 61/238,646, 61/246,825, 61/247,516, 61/249,535, and 61/345,562, the disclosures of each of which are incorporated herein by reference for all purposes.
  • Referring back to the FIG. 1, analyte monitoring system 100 includes display device 1200 which includes a display 1220 to output information to the user, an input component 1210 such as a button, actuator, a touch sensitive switch, a capacitive switch, pressure sensitive switch, jog wheel or the like, to input data or command to display device 1200 or otherwise control the operation of display device 1200. It is noted that some embodiments may include display-less devices or devices without any user interface components. These devices may be functionalized to store data as a data logger and/or provide a conduit to transfer data from on body electronics and/or a display-less device to another device and/or location. Embodiments will be described herein as display devices for exemplary purposes which are in no way intended to limit the embodiments of the present disclosure. It will be apparent that display-less devices may also be used in certain embodiments.
  • In certain embodiments, on body electronics 1100 may be configured to store some or all of the monitored analyte related data received from analyte sensor 14 in a memory during the monitoring time period, and maintain it in memory until the usage period ends. In such embodiments, stored data is retrieved from on body electronics 1100 at the conclusion of the monitoring time period, for example, after removing analyte sensor 14 from the user by detaching on body electronics 1100 from the skin surface where it was positioned during the monitoring time period. In such data logging configurations, real time monitored analyte level is not communicated to display device 1200 during the monitoring period or otherwise transmitted from on body electronics 1100, but rather, retrieved from on body electronics 1100 after the monitoring time period.
  • In certain embodiments, input component 1210 of display device 1200 may include a microphone and display device 1200 may include software configured to analyze audio input received from the microphone, such that functions and operation of the display device 1200 may be controlled by voice commands. In certain embodiments, an output component of display device 1200 includes a speaker for outputting information as audible signals. Similar voice responsive components such as a speaker, microphone and software routines to generate, process and store voice driven signals may be provided to on body electronics 1100.
  • In certain embodiments, display 1220 and input component 1210 may be integrated into a single component, for example a display that can detect the presence and location of a physical contact touch upon the display such as a touch screen user interface. In such embodiments, the user may control the operation of display device 1200 by utilizing a set of pre-programmed motion commands, including, but not limited to, single or double tapping the display, dragging a finger or instrument across the display, motioning multiple fingers or instruments toward one another, motioning multiple fingers or instruments away from one another, etc. In certain embodiments, a display includes a touch screen having areas of pixels with single or dual function capacitive elements that serve as LCD elements and touch sensors.
  • Display device 1200 also includes data communication port 1230 for wired data communication with external devices such as remote terminal (personal computer) 1700, for example. Example embodiments of the data communication port 1230 include USB port, mini USB port, RS-232 port, Ethernet port, Firewire port, or other similar data communication ports configured to connect to the compatible data cables. Display device 1200 may also include an integrated in vitro glucose meter, including in vitro test strip port 1240 to receive an in vitro glucose test strip for performing in vitro blood glucose measurements.
  • Referring still to FIG. 1, display 1220 in certain embodiments is configured to display a variety of information—some or all of which may be displayed at the same or different time on display 1220. In certain embodiments the displayed information is user-selectable so that a user can customize the information shown on a given display screen. Display 1220 may include but is not limited to graphical display 1380, for example, providing a graphical output of glucose values over a monitored time period (which may show important markers such as meals, exercise, sleep, heart rate, blood pressure, etc, numerical display 1320, for example, providing monitored glucose values (acquired or received in response to the request for the information), and trend or directional arrow display 1310 that indicates a rate of analyte change and/or a rate of the rate of analyte change, e.g., by moving locations on display 1220.
  • As further shown in FIG. 1, display 1220 may also include date display 1350 providing for example, date information for the user, time of day information display 1390 providing time of day information to the user, battery level indicator display 1330 which graphically shows the condition of the battery (rechargeable or disposable) of the display device 1200, sensor calibration status icon display 1340 for example, in monitoring systems that require periodic, routine or a predetermined number of user calibration events, notifying the user that the analyte sensor calibration is necessary, audio/vibratory settings icon display 1360 for displaying the status of the audio/vibratory output or alarm state, and wireless connectivity status icon display 1370 that provides indication of wireless communication connection with other devices such as on body electronics, data processing module 1600, and/or remote terminal 1700. As additionally shown in FIG. 1, display 1220 may further include simulated touch screen button 1250, 1260 for accessing menus, changing display graph output configurations or otherwise for controlling the operation of display device 1200.
  • Referring back to FIG. 1, in certain embodiments, display 1220 of display device 1200 may be additionally, or instead of visual display, configured to output alarms notifications such as alarm and/or alert notifications, glucose values etc, which may be audible, tactile, or any combination thereof. In one aspect, the display device 1200 may include other output components such as a speaker, vibratory output component and the like to provide audible and/or vibratory output indication to the user in addition to the visual output indication provided on display 1220. Further details and other display embodiments can be found in, e.g., U.S. patent application Ser. No. 12/871,901, U.S. provisional application Nos. 61/238,672, 61/247,541, 61/297,625, the disclosures of each of which are incorporated herein by reference for all purposes.
  • After the positioning of on body electronics 1100 on the skin surface and analyte sensor 14 in vivo to establish fluid contact with ISF (or other appropriate body fluid), on body electronics 1100 in certain embodiments is configured to wirelessly communicate analyte related data (such as, for example, data corresponding to monitored analyte level and/or monitored temperature data, and/or stored historical analyte related data) when on body electronics 1100 receives a command or request signal from display device 1200. In certain embodiments, on body electronics 1100 may be configured to at least periodically broadcast real time data associated with monitored analyte level which is received by display device 1200 when display device 1200 is within communication range of the data broadcast from on body electronics 1100, i.e., it does not need a command or request from a display device to send information.
  • For example, display device 1200 may be configured to transmit one or more commands to on body electronics 1100 to initiate data transfer, and in response, on body electronics 1100 may be configured to wirelessly transmit stored analyte related data collected during the monitoring time period to display device 1200. Display device 1200 may in turn be connected to a remote terminal 1700 such as a personal computer and functions as a data conduit to transfer the stored analyte level information from the on body electronics 1100 to remote terminal 1700. In certain embodiments, the received data from the on body electronics 1100 may be stored (permanently or temporarily) in one or more memory of the display device 1200. In certain other embodiments, display device 1200 is configured as a data conduit to pass the data received from on body electronics 1100 to remote terminal 1700 that is connected to display device 1200.
  • Referring still to FIG. 1, also shown in analyte monitoring system 100 are data processing module 1600 and remote terminal 1700. Remote terminal 1700 may include a personal computer, a server terminal a laptop computer or other suitable data processing devices including software for data management and analysis and communication with the components in the analyte monitoring system 100. For example, remote terminal 1700 may be connected to a local area network (LAN), a wide area network (WAN), or other data network for uni-directional or bi-directional data communication between remote terminal 1700 and display device 1200 and/or data processing module 1600.
  • Remote terminal 1700 in certain embodiments may include one or more computer terminals located at a physician's office or a hospital. For example, remote terminal 1700 may be located at a location other than the location of display device 1200. Remote terminal 1700 and display device 1200 could be in different rooms or different buildings. Remote terminal 1700 and display device 1200 could be at least about one mile apart, e.g., at least about 100 miles apart, e.g., at least about 1000 miles apart. For example, remote terminal 1700 could be in the same city as display device 1200, remote terminal 1700 could be in a different city than display device 1200, remote terminal 1700 could be in the same state as display device 1200, remote terminal 1700 could be in a different state than display device 1200, remote terminal 1700 could be in the same country as display device 1200, or remote terminal 1700 could be in a different country than display device 1200, for example.
  • In certain embodiments, a separate, optional data communication/processing device such as data processing module 1600 may be provided in analyte monitoring system 100. Data processing module 1600 may include components to communicate using one or more wireless communication protocols such as, for example, but not limited to, infrared (IR) protocol, Bluetooth® protocol, Zigbee® protocol, and 802.11 wireless LAN protocol. Additional description of communication protocols including those based on Bluetooth® protocol and/or Zigbee® protocol can be found in U.S. Patent Publication No. 2006/0193375 incorporated herein by reference for all purposes. Data processing module 1600 may further include communication ports, drivers or connectors to establish wired communication with one or more of display device 1200, on body electronics 1100, or remote terminal 1700 including, for example, but not limited to USB connector and/or USB port, Ethernet connector and/or port, FireWire connector and/or port, or RS-232 port and/or connector.
  • In certain embodiments, data processing module 1600 is programmed to transmit a polling or query signal to on body electronics 1100 at a predetermined time interval (e.g., once every minute, once every five minutes, or the like), and in response, receive the monitored analyte level information from on body electronics 1100. Data processing module 1600 stores in its memory the received analyte level information, and/or relays or retransmits the received information to another device such as display device 1200. More specifically in certain embodiments, data processing module 1600 may be configured as a data relay device to retransmit or pass through the received analyte level data from on body electronics 1100 to display device 1200 or a remote terminal (for example, over a data network such as a cellular or WiFi data network) or both.
  • In certain embodiments, on body electronics 1100 and data processing module 1600 may be positioned on the skin surface of the user within a predetermined distance of each other (for example, about 1-12 inches, or about 1-10 inches, or about 1-7 inches, or about 1-5 inches) such that periodic communication between on body electronics 1100 and data processing module 1600 is maintained. Alternatively, data processing module 1600 may be worn on a belt or clothing item of the user, such that the desired distance for communication between the on body electronics 1100 and data processing module 1600 for data communication is maintained. In a further aspect, the housing of data processing module 1600 may be configured to couple to or engage with on body electronics 1100 such that the two devices are combined or integrated as a single assembly and positioned on the skin surface. In further embodiments, data processing module 1600 is detachably engaged or connected to on body electronics 1100 providing additional modularity such that data processing module 1600 may be optionally removed or reattached as desired.
  • Referring again to FIG. 1, in certain embodiments, data processing module 1600 is programmed to transmit a command or signal to on body electronics 1100 at a predetermined time interval such as once every minute, or once every 5 minutes or once every 30 minutes or any other suitable or desired programmable time interval to request analyte related data from on body electronics 1100. When data processing module 1600 receives the requested analyte related data, it stores the received data. In this manner, analyte monitoring system 100 may be configured to receive the continuously monitored analyte related information at the programmed or programmable time interval, which is stored and/or displayed to the user. The stored data in data processing module 1600 may be subsequently provided or transmitted to display device 1200, remote terminal 1700 or the like for subsequent data analysis such as identifying frequency of periods of glycemic level excursions over the monitored time period, or the frequency of the alarm event occurrence during the monitored time period, for example, to improve therapy related decisions. Using this information, the doctor, healthcare provider or the user may adjust or recommend modification to the diet, daily habits and routines such as exercise, and the like.
  • In another embodiment, data processing module 1600 transmits a command or signal to on body electronics 1100 to receive the analyte related data in response to a user activation of a switch provided on data processing module 1600 or a user initiated command received from display device 1200. In further embodiments, data processing module 1600 is configured to transmit a command or signal to on body electronics 1100 in response to receiving a user initiated command only after a predetermined time interval has elapsed. For example, in certain embodiments, if the user does not initiate communication within a programmed time period, such as, for example about 5 hours from last communication (or 10 hours from the last communication, or 24 hours from the last communication), the data processing module 1600 may be programmed to automatically transmit a request command or signal to on body electronics 1100. Alternatively, data processing module 1600 may be programmed to activate an alarm to notify the user that a predetermined time period of time has elapsed since the last communication between the data processing module 1600 and on body electronics 1100. In this manner, users or healthcare providers may program or configure data processing module 1600 to provide certain compliance with analyte monitoring regimen, so that frequent determination of analyte levels is maintained or performed by the user.
  • In certain embodiments, when a programmed or programmable alarm condition is detected (for example, a detected glucose level monitored by analyte sensor 14 that is outside a predetermined acceptable range indicating a physiological condition) which requires attention or intervention for medical treatment or analysis (for example, a hypoglycemic condition, a hyperglycemic condition, an impending hyperglycemic condition or an impending hypoglycemic condition), the one or more output indications may be generated by the control logic or processor of the on body electronics 1100 and output to the user on a user interface of on body electronics 1100 so that corrective action may be timely taken. In addition to or alternatively, if display device 1200 is within communication range, the output indications or alarm data may be communicated to display device 1200 whose processor, upon detection of the alarm data reception, controls the display 1220 to output one or more notification.
  • In certain embodiments, control logic or microprocessors of on body electronics 1100 include software programs to determine future or anticipated analyte levels based on information obtained from analyte sensor 14, e.g., the current analyte level, the rate of change of the analyte level, the acceleration of the analyte level change, and/or analyte trend information determined based on stored monitored analyte data providing a historical trend or direction of analyte level fluctuation as function time during monitored time period. Predictive alarm parameters may be programmed or programmable in display device 1200, or the on body electronics 1100, or both, and output to the user in advance of anticipating the user's analyte level reaching the future level. This provides the user an opportunity to take timely corrective action.
  • Information, such as variation or fluctuation of the monitored analyte level as a function of time over the monitored time period providing analyte trend information, for example, may be determined by one or more control logic or microprocessors of display device 1200, data processing module 1600, and/or remote terminal 1700, and/or on body electronics 1100. Such information may be displayed as, for example, a graph (such as a line graph) to indicate to the user the current and/or historical and/or and predicted future analyte levels as measured and predicted by the analyte monitoring system 100. Such information may also be displayed as directional arrows (for example, see trend or directional arrow display 1310) or other icon(s), e.g., the position of which on the screen relative to a reference point indicated whether the analyte level is increasing or decreasing as well as the acceleration or deceleration of the increase or decrease in analyte level. This information may be utilized by the user to determine any necessary corrective actions to ensure the analyte level remains within an acceptable and/or clinically safe range. Other visual indicators, including colors, flashing, fading, etc., as well as audio indicators including a change in pitch, volume, or tone of an audio output and/or vibratory or other tactile indicators may also be incorporated into the display of trend data as means of notifying the user of the current level and/or direction and/or rate of change of the monitored analyte level. For example, based on a determined rate of glucose change, programmed clinically significant glucose threshold levels (e.g., hyperglycemic and/or hypoglycemic levels), and current analyte level derived by an in vivo analyte sensor, the system 100 may include an algorithm stored on computer readable medium to determine the time it will take to reach a clinically significant level and will output notification in advance of reaching the clinically significant level, e.g., 30 minutes before a clinically significant level is anticipated, and/or 20 minutes, and/or 10 minutes, and/or 5 minutes, and/or 3 minutes, and/or 1 minute, and so on, with outputs increasing in intensity or the like.
  • Referring again back to FIG. 1, in certain embodiments, software algorithm(s) for execution by data processing module 1600 may be stored in an external memory device such as an SD card, microSD card, compact flash card, XD card, Memory Stick card, Memory Stick Duo card, or USB memory stick/device including executable programs stored in such devices for execution upon connection to the respective one or more of the on body electronics 1100, remote terminal 1700 or display device 1200. In a further aspect, software algorithms for execution by data processing module 1600 may be provided to a communication device such as a mobile telephone including, for example, WiFi or Internet enabled smart phones or personal digital assistants (PDAs) as a downloadable application for execution by the downloading communication device.
  • Examples of smart phones include Windows®, Android™, iPhone® operating system, Palm® WebOS™, Blackberry® operating system, or Symbian® operating system based mobile telephones with data network connectivity functionality for data communication over an internet connection and/or a local area network (LAN). PDAs as described above include, for example, portable electronic devices including one or more microprocessors and data communication capability with a user interface (e.g., display/output unit and/or input unit, and configured for performing data processing, data upload/download over the internet, for example. In such embodiments, remote terminal 1700 may be configured to provide the executable application software to the one or more of the communication devices described above when communication between the remote terminal 1700 and the devices are established.
  • In still further embodiments, executable software applications may be provided over-the-air (OTA) as an OTA download such that wired connection to remote terminal 1700 is not necessary. For example, executable applications may be automatically downloaded as software download to the communication device, and depending upon the configuration of the communication device, installed on the device for use automatically, or based on user confirmation or acknowledgement on the communication device to execute the installation of the application. The OTA download and installation of software may include software applications and/or routines that are updates or upgrades to the existing functions or features of data processing module 1600 and/or display device 1200.
  • Referring back to remote terminal 1700 of FIG. 1, in certain embodiments, new software and/or software updates such as software patches or fixes, firmware updates or software driver upgrades, among others, for display device 1200 and/or on body electronics 1100 and/or data processing module 1600 may be provided by remote terminal 1700 when communication between the remote terminal 1700 and display device 1200 and/or data processing module 1600 is established. For example, software upgrades, executable programming changes or modification for on body electronics 1100 may be received from remote terminal 1700 by one or more of display device 1200 or data processing module 1600, and thereafter, provided to on body electronics 1100 to update its software or programmable functions. For example, in certain embodiments, software received and installed in on body electronics 1100 may include software bug fixes, modification to the previously stalled software parameters (modification to analyte related data storage time interval, resetting or adjusting time base or information of on body electronics 1100, modification to the transmitted data type, data transmission sequence, or data storage time period, among others). Additional details describing field upgradability of software of portable electronic devices, and data processing are provided in U.S. application Ser. Nos. 12/698,124, 12/794,721, now U.S. Pat. No. 8,595,607, Ser. No. 12/699,653, and Ser. No. 12/699,844, and U.S. Provisional Application Nos. 61/359,265 and 61/325,155 the disclosures of which are incorporated by reference herein for all purposes.
  • The Sensor
  • The analyte sensor 14 of the analyte measurement system 100 may be used to monitor levels of a wide variety of analytes. Analytes that may be monitored include, for example, acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid-stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. One or more analyte may be monitored by a given sensor. In those embodiments that monitor more than one analyte, the analytes may be monitored at the same or different times, which may use the same on body electronics (e.g., simultaneously) or with different on body electronics.
  • In one embodiment of the present disclosure, sensor 14 is physically positioned in or on the body of a user whose analyte level is being monitored. Sensor 14 may be configured to continuously sample the analyte level of the user and convert the sampled analyte level, e.g., glucose concentration into a corresponding data signal, e.g., a current or voltage, for input into on body electronics. Alternatively, sensor 14 may be configured to sample analyte levels on demand. The on body electronics may amplify, filter, average, and/or otherwise process signal provided by the sensor.
  • An embodiment of the sensor 14 is illustrated in FIG. 2. It is understood that the inserters described herein can be used with other medical devices. The shape(s) described herein are exemplary only. Other sensor shapes are contemplated. In some embodiments, sensor 14 includes a substrate which is a dielectric, e.g., a polymer or plastic material, such as polyester or polyamide. In this embodiment, the sensor is constructed so that a portion is positionable beneath skin and a portion is above skin. Accordingly, sensor 14 includes an insertion or internal portion 30 and an external or electrical contact portion 32. In some embodiments, the contact portion 32 includes several conductive contacts 36, 38, and 40 (herein shown as three contacts) for connection to other electronics, e.g., at the on body electronics 1100 (See FIG. 1.). The contacts provided in this embodiment are for a working electrode, a reference electrode, and a counter electrode. In some embodiments, two or more working electrodes are provided. The operative portions of these electrodes, that is, working electrode, reference electrode, and counter electrode (not individually shown), are provided at the insertion portion, e.g., at the distal end of insertion portion 30, e.g., portion 34. In some embodiments, one or more electrodes may be external to the body, e.g., an external counter electrode. The contact and operative portions of the electrodes are connected by circuit traces 42, 44, and 46 running on the surface of the substrate. In some embodiments, the traces are provided in channels, or may be embedded within the substrate, or may traverse different sides of the substrate. The conductive contacts, conductive traces, and electrodes are fabricated from conductive material, such as platinum, palladium, gold, carbon, or the like. More than one material may be used for a given sensor. Further details of sensors are described, e.g., in U.S. Pat. Nos. 6,175,572 and 6,103,033, which are incorporated by reference herein for all purposes.
  • Sensor 14 may include a proximal retention portion 48. The insertion portion 30 and the proximal retention portion 48 are sized and configured to be positioned with a sharp for installation into the skin of a subject, as described herein. In use, the sensor 14 may be configured to bend (e.g., along the line B) and therefore be positioned in two substantially perpendicular, intersecting planes. Such bending may occur prior to or during coupling to the on body electronics as described below (See FIG. 17).
  • Portions 48 and 52 provide a path for electrical connections, e.g., the conductive traces, between the proximal and distal portions of the sensor. Sensor 14 is further provided with a notch or cut-out 54. Such configuration facilitates the sensor 14 to bend (e.g., along the line indicated by line B) such that retention portion 48 remains upright and therefore be positioned in two substantially perpendicular, intersecting planes, as illustrated in FIG. 3. As will be described below, the sensor tab 50 can be encased in the on body housing 122 to aid in securing and positioning the sensor 14. Proximal retention portion 48 maintains its longitudinal alignment with insertion portion 30 for positioning within an insertion sharp.
  • Embodiments of analyte sensors have been described herein to operate electrochemically, through an arrangement of electrodes having chemical sensing layers applied thereto, by generating an electrical current proportional to the volume of a redox reaction of the analyte (and indicative of analyte concentration), catalyzed by an analyte-specific oxidizing enzyme. Embodiments exist in which the number of electrodes provided to bring about and detect the level of these reactions is two, three, or a greater number. However, other types of sensors may be employed as described herein.
  • A portion of sensor 14 may be situated above the surface of the skin, with a distal portion 30 penetrating through the skin and into the subcutaneous space in contact with the user's biofluid, such as ISF. Further details regarding the electrochemistry of sensor 14 is provided in U.S. Pat. Nos. 5,264,104; 5,356,786; 5,262,035; 5,320,725; and 6,990,366, each of which is incorporated by reference herein for all purposes.
  • In some embodiments, the sensor is implantable into a subject's body for a usage period (e.g., a minute or more, at least one day or more, about one to about 30 days or even longer, about three to about fourteen days, about three to about seven days, or in some embodiments, longer periods of up to several weeks) to contact and monitor an analyte present in a biological fluid. In this regard, the sensor can be disposed in a subject at a variety of sites (e.g., abdomen, upper arm, thigh, etc.), including intramuscularly, transcutaneously, intravascularly, or in a body cavity.
  • In some embodiments, sensor 14 is employed by insertion and/or implantation into a user's body for some usage period. In such embodiments, the substrate may be formed from a relatively flexible material.
  • While the embodiments illustrated in FIGS. 2-3 have three electrodes, other embodiments can include a fewer or greater number of electrodes. For example, a two-electrode sensor can be utilized. The sensor 14 may be externally-powered and allow a current to pass which is proportional to the amount of analyte present. Alternatively, the sensor 14 itself may act as a current source in some embodiments. In some two-electrode embodiments, the sensor may be self-biasing and there may be no need for a reference electrode. An exemplary self-powered, two-electrode sensor is described in U.S. patent application Ser. No. 12/393,921, filed Feb. 26, 2009, and entitled “Self-Powered Analyte Sensor,” which is hereby incorporated by reference herein for all purposes. The level of current provided by a self-powered sensor may be low, for example, on the order of nanoamperes, in certain embodiments.
  • Insertion Assembly
  • Insertion assemblies are provided which are used to install a medical device to the subject. In some embodiments, an insertion assembly includes an inserter and the medical device itself. The inserter can be configured to insert various medical devices into the subject, such as, for example, an analyte sensor, an infusion set, or a cannula. In some embodiments, the inserter can be configured to install a combination of such devices, e.g., a combined sensor/infusion set, etc., at the same or different times or locations. For example, in certain embodiments, a given inserter can be configured to install a first device and a second device at different times. In this regard, the inserter can be reusable. For example, an inserter may be modifiable to be used with more than one medical device, to include more than one type of medical device, e.g., by attaching an adapter and/or detaching a portion of an inserter. The inserter can install the medical device in, under, or through the skin of the subject, or place the medical device on the surface of the skin. The medical device can include features or structures, e.g., barbs, tabs, adhesive, etc., to maintain the device in position with respect to the skin after insertion. The inserter device may also be used as a lancet, e.g., to pierce the skin without inserting or installing a medical device.
  • In some embodiments, an insertion assembly includes an inserter, a medical device, such as an analyte sensor, and a mount for supporting the medical device at least partially in or on the skin of the subject. In some embodiments, the mount is a support structure, plate and/or member which is attached, adhered, or otherwise secured to the skin of the subject. The mount may be inserted simultaneously with the medical device by the inserter. In other embodiments, the mount is installed after or before installation of the medical device. A mount may be applied by the inserter or separately. The mount may include features or structures (e.g., adhesive, guides, barbs, tabs, etc.) to maintain the sensor in position with respect to the skin after insertion and/or maintain the sensor in relative position with respect to the sensor control unit. In some embodiments, an adhesive pad or strip is used to secure the medical device, e.g., the sensor and/or the sensor control unit, and no mount is used.
  • In some embodiments, an insertion assembly includes an inserter, an analyte sensor, a mount, and a power supply. The mount and power supply may be inserted simultaneously with the analyte sensor by the inserter. In other embodiments, the mount and battery are installed after or before installation of the analyte sensor. In such case, the mount and/or power supply may be applied by the inserter or separately. The power supply may be used to provide a current or a potential to the sensor and/or to provide power for communication of one or more signals to the monitor unit.
  • In some embodiments, an insertion assembly includes an inserter, a medical device such as an analyte sensor, a mount, and a sensor control unit. The mount and sensor control unit may be deployed and/or installed simultaneously with the analyte sensor by the inserter. In other embodiments, the mount and sensor control unit are installed after or before installation of the analyte sensor. For example, the mount and the analyte sensor may be installed by the inserter, and the sensor control unit may be subsequently installed. In other embodiments, the mount is installed, followed by insertion of the analyte sensor by the inserter, and further followed by installation of the sensor control unit. In other embodiments, the mount and sensor control unit are installed first, and the analyte sensor is subsequently installed.
  • In some embodiments, electronics of the sensor control unit provide a voltage or current to the analyte sensor. In some embodiments, the electronics processes signals are provided by the analyte sensor. In further embodiments, the electronics may include communication functionality for providing signal relating to signal provided by the analyte sensor to a further component, such as, e.g., a monitor unit, a computer, or other component. In some embodiments, communications circuitry, such as RFID antenna or other communications circuitry, is provided. The power supply may be used to power some or all of these functions. In some embodiments, power is provided from the monitor unit, e.g., via inductive coupling.
  • An inserter may include a plurality of different components. For example, an inserter may include one or more components for advancing a sharp towards the skin of the subject. The sensor and sensor control unit and/or mounting structure may be supported by a support structure, such as a carriage. A driver may be provided for advancing the sharp and/or the analyte sensor/support structure. In some embodiments, the actuator is directly or indirectly coupled to the sharp and/or support structure, such that manual force and speed applied by the subject to the actuator is transferred to the sharp and/or support structure. In some embodiments, the applied force drives the sharp and/or support structure between a retracted position and an advanced position. In some embodiments, the sensor and sensor control unit and/or mounting structure is maintained in a retracted position prior to installation by contacting projections extending inwardly from a sheath. In accordance with this embodiment, the sensor and sensor control unit and/or mounting structure are temporarily maintained operatively between the support structure and the projections disposed on the interior wall of the sheath.
  • An inserter can also include one or more components for retracting the sharp, while allowing the analyte sensor and optional mount and/or electronics to remain on the subject. The components for retracting the sharp can include a retractor. It is understood that the retractor and the actuator may be the same structure or include some common components. In some embodiments, the retractor is directly or indirectly coupled to the sharp such that the manual force applied by the user is transferred from the retractor to the sharp to retract the sharp from the skin. In other embodiments, a drive assembly may be provided to retract the sharp. For example, the drive assembly may include a spring, motor, hydraulic piston, etc., to retract the sharp away from the skin of the subject. The drive assembly may also include a linear drive component.
  • In some embodiments, the retractor withdraws the sharp upon actuation by the user. In such cases, the user actuates the retractor when it is desired to withdraw the sharp. For example, the retractor may include a release switch. Upon activation of the release switch, the drive assembly, e.g., the spring or other driver, retracts the sharp from the skin. In other embodiments, the retractor and the actuator include common components. After activating the actuator to advance the sharp and the analyte sensor, the user releases the actuator, which allows the drive assembly to withdraw the sharp from the skin.
  • In some embodiments, the retractor withdraws the sharp without further user interaction after actuation of insertion. For example, the inserter may include features or components which automatically retract the sharp upon advancement of the sharp and support structure by a predetermined amount. Inserter devices, in which no further action by the user is required to initiate withdrawal of the sharp after insertion, are referred to herein as having “automatic” withdrawal of the sharp.
  • Inserter Devices
  • One embodiment of a needle hub for an inserter is illustrated in FIGS. 4-5. Needle hub 136 supports sharp 124, having a sharpened distal portion 160. In some embodiments, as discussed herein, a longitudinal wall opening or gap 162 is provided in at least a portion of the wall of the sharp 124. The length N of the gap 162 is selected to be commensurate with the length of the insertion portion 30 through to the proximal retention portion 48 of the sensor, and in certain embodiments may be about 3 mm to about 50 mm, e.g., about 5 mm, or about 10 mm, or about 15 mm, or about 20 mm. The length L of the sharp 124 may be about 3 mm to about 50 mm, e.g., 5 mm or more, or about 10 mm, or about 20 mm, or about 30 mm, or about 50 mm, and is selected based upon the length of the insertion portion 30 of a sensor and the desired depth of the insertion portion 30 of the sensor 14. In some embodiments, the distance or spacing between the two edges of the gap is about 0.2 mm to about 0.5 mm, e.g., about 0.22 mm, about 0.25 mm, etc.
  • The distal portion 160 of sharp 124 is illustrated in greater detail in FIGS. 6-8. As illustrated in FIG. 6, sharp 124 has a substantially “C”- or “U”-shaped profile in this embodiment, but may have other configurations, e.g., substantially “V”-shaped. A longitudinal gap 162 is provided in the wall of the sharp 124. FIG. 7 illustrates distal portion 160 as provided with an angled tip. In some embodiments, the angled tip may be provided with a first angled tip portion 164 and a second steep-angled tip portion 166. The exemplary configuration, which includes multiple edges and faces, provides a sharp point to reduce penetration force, trauma, and bleeding for the subject. The distal section of the sensor body has a width sized to fit within the gap 162 of the insertion sharp 124 having a diameter less than about 20 gauge to about 26 gauge, e.g., 21 gauge to about 25 gauge, where in certain embodiments the sharp is 21 gauge or 23 gauge or 25 gauge. Such sharp may be used with a sensor having a width or diameter—at least the portion that is carried by the sharp—of about 0.20 mm to about 0.80 mm, e.g., about 0.25 mm to about 0.60 mm, where, in some embodiments, the width or diameter of at least a portion of a sensor is 0.27 mm or 0.33 mm or 0.58 mm. In some embodiments, sharp 124 is fabricated from a sheet of metal and folded into a substantially “V,” “U” or “C” configuration in cross-section. Various technologies can be used to manufacture a folded sheet of metal to form sharp 124. For example, etched-sheet metal technology can be used to form the sharp 124. In this manner, the sharp can be formed having a very sharp edge so that penetration through the skin during insertion is less painful. In other embodiments, a progressive die technology may be utilized to form a complex sheet-metal shape that has a sharp edge as depicted in FIG. 9. In some embodiments, the sharp 124 can be molded with a plastic cap so that the sharp can be handled during the inserter assembly process. Further, the die cut sharp may be molded with plastic to reinforce the “V,” “U” or “C” shaped sheet metal configuration. In other embodiments, a laser-cut sharp can be formed. In this manner, the laser can be used to form the wall opening or gap 162 and first-angled tip portion 164 and a second, steep-angled tip portion 166.
  • In another embodiment, a sharp 124 may be formed from a standard hypodermic needle utilizing the method depicted in FIG. 10. First, the hypodermic needle (having a circular cross-section) is cut to the desired length for sharp 124. Next, the hypodermic needle is compressed so that its cross-section is permanently deformed from a circular shape to an oval shape. The tip of the hypodermic needle is then ground to a bevel to produce a sharp point to reduce the required penetration force, as previously discussed. Finally, the top section of the needle is removed by appropriate techniques (e.g., grinding, electropolishing, etc.). The resulting sharp 124 has a “U”-shaped configuration and provides ample space for the insertion of sensor 14. In some embodiments, the tip-grinding step and the compression step may be carried out in reversed order.
  • Due to the compression step, a user may initially start with a larger diameter hypodermic needle so that the finished sharp 124 will have similar dimensions to the previously described sharps.
  • FIGS. 11-12 illustrate the position of on body housing 122 with respect to the needle hub 136 and sharp 124. The on body housing 122 can be configured to hold at least a portion of sensor 14 and sensor control unit. As illustrated in FIG. 11, the sharp 124 extends through an aperture 168 in the on body housing 122. Thus, in some embodiments, the sharp 124 is uncoupled to on body housing 122. The distal portion of sensor 14 is positioned within the sharp 124. As further illustrated in FIG. 12, electronics of the sensor control unit (e.g., a printed circuit board containing electronics components of the on-body unit) and sensor hub 123 are positioned within on body housing 122. Sensor 14 may include a positioning structure, or slit 127, which receives a positioning member, such as tab 129 of sensor hub 123. A power supply 82, such as a battery, e.g., a single use disposable battery, or rechargeable battery, is provided. The power supply 82 is used to provide potential or current to the sensor in some embodiments. In embodiments where a passive communications protocol such as passive RFID is used, no power supply is provided for the communications. Such power is provided by the monitor unit. In some embodiments, where the sensor control unit is used to transmit one or more signals, one or more power supplies may be used to provide power for such communications circuitry. In some embodiments, the active operational life of the battery may exceed the active operational life of the sensor 14.
  • FIG. 13 illustrates in cross-section the orientation of the on body housing 122 with respect to the sharp 124 of an inserter, such as inserter 1500 (see FIG. 52). As discussed herein, sensor 14 is disposed in a substantially bent configuration in some embodiments, such that a portion of the sensor, e.g., the insertion portion 30 and the proximal retention portion 48, are substantially vertical (e.g., substantially aligned with the longitudinal axis of an inserter and substantially perpendicular to the skin surface) and the contact portion 32 (shown in profile) is oriented in a substantially horizontal configuration, and in electrical contact with the data-processing unit electronics, such as circuit 80. The sensor tab 50 can be encased in the plastic of the on body housing 122 (e.g., “overmolded”) and secured in place. The notch 56 provides further stability to the sensor 14, e.g., by allowing the sensor tab 50 to be encased by the material of the on body housing 122, and further provides a means for vertically orienting the sensor 14 during mounting, e.g., by allowing vertical positioning of the notch 56 with respect to a vertical landmark of the on body housing 122.
  • The sensor 14, mounted with the on body housing 122, can be disposed within a recess of the carriage 130 such as a concave recess in the carriage 130. Alternatively, the sensor 14, mounted with the on body housing 122, can be disposed between the support structure and one or more projections extending from the wall of the sheath. In yet another alternative, the sensor 14, mounted with the on body housing 122, can be held in position by a releasable friction fit coupling to the sharp 124. In this manner, the carriage need not have a recess within which the sensor mounted with the on body housing is disposed. In the initial configuration of the inserter, the sharp 124 extends through a longitudinal aperture 168 formed in a carriage 130. In some embodiments, the aperture 168 is appropriately sized, such that neither the sharp 124 nor needle hub 136 is in contact with the carriage 130. Accordingly, the needle hub 136 (and sharp 124) on the one hand, and the carriage 130 (FIG. 13) and the on body housing 122, on the other hand, move simultaneously, but independently from one another. In other embodiments, a friction fit may be provided between the aperture and the sharp.
  • The insertion portion 30 and proximal retention portion 48 of the sensor 14 are disposed within a longitudinal bore 162 within the sharp 124 (See, e.g., FIG. 6). The proximal retention portion 48 is disposed within the longitudinal bore of the sharp 124 and provides additional stability to the mounting of the sensor 14 within the sharp 124. The longitudinal wall gap or opening 162 of sharp 124 is aligned with the sensor 14, such that the tab 50 and the contact portion 32 extend laterally outward from the sharp 124.
  • An embodiment of an inserter is illustrated in FIGS. 14-17. An inserter 900 includes a handle 902 and may include a removable distal cap or seal (not shown) for maintaining a sterile environment for the medical device and sharp housed therein. As illustrated in FIG. 14, distal cap or seal is removed from handle 902. Inserter 900 includes a base 942 that defines a distal surface 912 for placement on the skin of a subject. Inserter 900 may be utilized to advance a medical device into the skin of the subject. In some embodiments, handle 902 is advanced relative to base 942 in order to advance the sensor into the skin of the patient.
  • As illustrated in FIG. 15, the inserter 900 includes an initial configuration in which the handle 902 is disposed in a proximal position with respect to the base 942. In such configuration, the sharp 924 is disposed in a configuration spaced apart from the aperture 920 of the adhesive layer 918. Extending distally from the upper surface of handle 902 are side walls 974, which terminate in a shoulder portion 975.
  • Needle carrier 934 is axially slidable within handle 902 and base 942 in the direction of arrow N. Needle carrier 934 supports needle hub 936, from which sharp 924 extends longitudinally within the inserter 900. In some embodiments, the sharp is supported at an oblique angle, e.g., between 0° and 90° with respect to the skin surface. Initially, needle carrier 934 is coupled to inner rail 928 through inter-engagement of finger 986 of needle carrier 934 with shoulder 987 of inner rail 928.
  • Inserter 900 includes an advancement spring 947. Inner rail 928 includes a spring retention portion 984 for advancement spring 947. The inner surface of handle 902 serves as an upper engagement surface for advancement spring 947. In some embodiments, spring retention portion 984 is fabricated having several projections that extend through an aperture 982 in the wall of base 942. Spring retention portion 984 is resiliently movable. As downward force is applied to handle 902, the ledge 937 of handle 902 contacts spring retention portion 984, driving such projections inward. Such inward motion releases the inner rail 928, and allows advancement spring 947 to advance the inner rail 928 distally, thereby advancing the sharp 924 into the skin of the subject, as illustrated in FIG. 16.
  • Refraction spring 946 is disposed between spring retention portion 948 of base 942 and shoulder portion 949 of needle carrier 934. Initially, retraction spring 946 is in a compressed state. As carriage 930 reaches a distal position, the distal surface of the on body housing 122 engages the upper surface of adhesive pad 918, thereby becoming adhered to the skin surface S of the subject. At the same time, flanges 970 of base 942 engage fingers 986 disposed on the needle carrier 934. Fingers 986 are pivoted outwards by flanges 970. Such pivoting of fingers causes fingers 986 to become disengaged from shoulder 984 of inner rail 928. Shuttle 934 is thereby disengaged from inner rail 928.
  • As illustrated in FIG. 17, disengagement of the shuttle 934 from the inner rail 928 permits the spring 946 to expand, thereby advancing the needle carrier 934 to a proximal position, thereby withdrawing the sharp 924 from the skin of the subject, while leaving the sensor 14 in the skin.
  • A further embodiment of an inserter is illustrated in FIGS. 18-21 and designated inserter 1000. Inserter 1000 is substantially identical to inserter 900 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • An inserter 1000 includes a housing 1002, and may include a removable distal cap or seal (not shown) for maintaining a sterile environment for the medical device and sharp housed therein. As illustrated in FIG. 18, distal cap or seal is removed from housing 1002. Inserter 1000 includes a base 1042 which defines a distal surface 1012 for placement on the skin of a subject. Inserter 1000 may be utilized to advance a medical device into the skin of the subject. In some embodiments, side buttons 1084 are depressed relative to base 1042 in order to advance the medical device into the skin of the patient.
  • As illustrated in FIG. 19, the inserter 1000 includes an initial configuration in which the sharp 1024 is disposed in a configuration spaced apart from distal portion 1012 of the base 1042. It is understood that inserter 1000 may incorporate an adhesive layer (not shown) positioned across the distal portion 1012 of base 1042.
  • On-body unit inserter 1028 includes carriage 1030 for supporting on body housing 122. On-body unit inserter 1028 also includes flange 1029 which normally rests on shoulder portions 1086 (as illustrated in FIGS. 19-21). When side buttons 1084 are depressed inwardly, latch portions on flange 1029 are deflected from engagement with shoulder portions 1086. As illustrated in FIG. 20, advancement spring 1047 is released from compression, thereby advancing on-body unit inserter 1028 as elsewhere, along with needle carrier 1034 into the skin of the subject.
  • Refraction spring 1046 is disposed between needle carrier 1034 and housing 1002. Initially, retraction spring 1046 is in a compressed state. As carriage 1028 reaches a distal position, on-body unit inserter 1028 is disengaged from needle carrier 1034. The distal surface of the on body housing 122 engages the skin or the upper surface of adhesive pad (not shown), thereby becoming adhered to the skin surface S of the subject. Latches on needle carrier 1034 attach it to on-body unit inserter 1028. Upon firing the inserter by pressing tabs 1084, the on-body unit inserter 1028 is pushed by spring 1047 towards the skin surface, bringing along needle carrier 1034 and loading extension spring 1046. As on-body unit inserter 1028 reaches the distal position (towards the skin of the subject), protrusions on housing 1002 disengage latches on needle carrier 1034, connecting it to on-body unit inserter 1028. Extension spring 1046 now pulls needle carrier 1034 back into the proximal position.
  • As illustrated in FIG. 21, disengagement of the needle carrier 1034 from the inner rail 1028 permits the spring 1046 to contract with the bias, thereby advancing the needle carrier 1034 to a proximal position and withdrawing the sharp 1024 from the skin of the subject, while leaving the sensor 14 in the skin.
  • A further embodiment of an inserter is illustrated in FIGS. 22-25. Inserter 1100 is substantially identical to inserters 900 and 1000 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • An inserter 1100 includes a housing 1102 and may include a removable distal cap or seal (not shown) for maintaining a sterile environment for the medical device and/or sharp housed therein. As illustrated in FIG. 22, distal cap or seal is removed from housing 1102. Inserter 1100 includes a base 1142 which defines a distal surface 1112 for placement on the skin of a subject. Inserter 1100 may be utilized to advance a medical device into the skin of the subject. In some embodiments, a manual actuator bar 1114 is depressed relative to base 1142 in order to advance the medical device into the skin of the patient. It is understood that inserter 1100 may incorporate an adhesive layer (not shown) which is positioned across the distal portion 1112 of base 1142.
  • As illustrated in FIG. 23, the inserter 1100 includes an initial configuration in which the sharp 1124 is disposed in a configuration spaced apart from distal portion 1112 of the base 1142. Manual advancement of the actuator may be performed by distal advancement of actuator bar 1114.
  • On-body unit inserter 1128 includes carriage 1130 for supporting on body housing 122. Refraction spring 1146 is disposed between needle carrier 1134 and base 1142. Initially, retraction spring 1146 is in a compressed state. As actuator bar 1114 is moved distally, carriage 1128 is moved distally and reaches a distal position, such that flanges 1188 of base 1142 engage fingers 1186 disposed on the shuttle 1134. Fingers 1186 are pivoted outwards by flanges 1188. Such pivoting of fingers 1186 causes fingers 1186 to become disengaged from shoulder 1187 of inner rail 1128. Shuttle 1134 is thereby disengaged from inner rail 1128. The distal surface of the on body housing 122 engages the skin or the upper surface of adhesive pad (not shown), thereby becoming adhered to the skin surface of the subject (FIG. 24).
  • As illustrated in FIG. 25, disengagement of the shuttle 1136 from the inner rail 1028 permits the spring 1146 to expand with the bias, thereby advancing the needle carrier 1136 to a proximal position and withdrawing the sharp 1124 from the skin of the subject, while leaving the sensor 14 in the skin. Once the sharp 1124 has been withdrawn from the subject, it is no longer accessible from the distal portion of the inserter 1100, and unable to make contact by accident with the subject's skin.
  • A further embodiment of an inserter is illustrated in FIGS. 26-36. Inserter 1200 is substantially identical to inserters 900, 1000, and 1100 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • Inserter 1200 includes a housing 1202, an on-body unit inserter 1228, a needle retractor 1234, and a rotor 1208 with a torsion spring (not shown), all of which are depicted separately in FIGS. 28-31. As illustrated in FIGS. 28-31, housing 1202 includes slots 1254; on-body unit inserter 1228 includes slots 1252, tabs 1253, and opening 1262; needle retractor 1234 includes tabs 1250 and opening 1260; and rotor 1208 includes rotor follower 1264.
  • FIG. 32 illustrates an exploded view of inserter 1200. As illustrated, in some embodiments, inserter 1200 includes housing 1202, on-body unit inserter 1228, needle retractor 1234, and rotor 1208. Tabs 1250 can be disposed on needle refractor 1234 and configured to engage slots 1252 disposed on on-body unit inserter 1228 when assembled as shown in FIG. 33. Tabs 1253 can be disposed on on-body unit inserter 1228 and configured to engage slots 1254 disposed on housing 1202. Needle retractor 1234 and on-body unit inserter 1228 can each contain openings (1260, 1262) to receive rotor follower 1264 disposed on rotor 1208 after rotor 1208 has been inserted into housing 1202. Additionally, on-body unit inserter 1228 can provide support for on body housing 122 (not shown) for installation to the skin of a subject.
  • As illustrated in FIG. 34, in some embodiments, manually depressing the on-body unit inserter 1228 can cause the torsion spring to wind as the rotor 1208 rotates, guided by the cam path. As illustrated in FIG. 35, continued distal advancement of the on-body unit inserter 1228 causes the rotor follower 1264 to go “over center” within cam 1264. At such point, the torsion spring (not shown) is allowed to unwind (FIG. 93). With reference to FIG. 36, further unwinding of the torsion spring pulls up the needle retractor 1234 from the insertion site, while leaving the on-body unit inserter in place.
  • A further embodiment of an inserter is illustrated in FIGS. 37-46. Inserter 1300 is substantially identical to inserters 900, 1000, 1100, and 1200 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • Inserter 1300 includes a housing 1302, an on-body unit inserter 1334, a needle retractor 1328, and a rotor 1308 with torsion spring 1365. As illustrated in FIGS. 37, 38, 39, 45 and 46, the on-body unit inserter 1334 and needle retractor 1328 are disposed within the housing 1302. Rotor 1308 includes a rotor follower 1364 which engages a slot 1362 provided in the needle retractor 1328 and a slot 1360 in the on-body unit inserter 1334. The on-body unit inserter 1334 provides a support portion for supporting on body housing 1302 (not shown).
  • In operation, torsion spring 1365 is loaded. A release button (not shown) is depressed in order to release torsion spring 1365. Rotor 1308 drives on-body unit inserter 1334 and needle retractor 1328 downwardly simultaneously. A compression spring 1367 holds down on-body unit inserter 1334. As rotor 1308 continues to rotate, slot 1360 allows on-body unit inserter 1334 to travel down and then be held down, while slot 1362 allows needle retractor 1328 to travel down and then back up to lift the needle from insertion site.
  • A further embodiment of an inserter is illustrated in FIGS. 47-51. Inserter 1400 is substantially identical to inserters 900, 1000, 1100, 1200, and 1300 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • Inserter 1400 may be used for installation of a medical device, e.g., on body housing 122, in connection with a cartridge or carrier 1406. In some embodiments, inserter 1400 includes a body 1402 and an actuator 1404. The carrier 1406 may include a needle hub 1436 including a sharp (not shown) as well as an on body housing 122. In use, the body 1402 is placed on a mount 1408 attached to subject by use of an adhesive pad 1418. As shown in FIG. 47, carrier 1406 is loaded into inserter 1400 laterally as shown.
  • With reference to FIG. 48, a first disposable portion of inserter 1400 includes adhesive pad 1418 and mount 1408. The second disposable portion of inserter 1400 includes carrier 1406 which removably contains needle hub 1436 and sensor hub 1437 (not shown) which is substantially identical to on body housing 122 described herein. Inserter 1400 further includes body 1402, actuator 1404, and return spring 1409 (not shown). Mount 1408 is removably attached to body 1402. Carrier 1406 can be slid on to body 1402 to transfer needle hub 1436 and carrier 1406 to inserter 1400. As shown in FIG. 48, carrier 1406 can then be removed from inserter 1400. Needle hub 1436 and sensor hub 1437 remain in inserter 1400. Adhesive pad 1418 is then adhesively applied to the skin of a subject. Alternatively, adhesive pad 1418 may be applied to the skin of a subject before attaching body 1402 and mount 1408.
  • In FIG. 49, actuator 1404 is pressed down, performing a manual insertion of needle hub 1436 and sensor hub 1437, with the needle located in needle hub 1436 and a distal sensor portion penetrating the skin of the subject. When pressure is released from actuator 1404, return spring 1409 (not shown) retracts the needle from the skin of the subject and out of sensor hub 1437. As shown in FIG. 50, body 1402 can be removed from mount 1408, leaving sensor hub 1437 in mounting base 1408. In FIG. 51, in some exemplary embodiments, carrier 1406 is slid on to housing 1402, transferring needle 1436 to carrier 1406. Carrier 1406, with needle 1436, is then removed from housing 1402 and may be disposed of properly, and inserter 1400 is ready to be used again. Communication electronics (not shown) are then attached to mounting base 1408, making electrical contact with sensor hub 1437.
  • A further embodiment of an inserter is illustrated in FIG. 52. Inserter 1500 is substantially identical to inserters 900, 1000, 1100, 1200, 1300, and 1400 described herein, with the substantial differences noted herein and illustrated in the accompanying figures.
  • Inserter 1500 includes a housing 1502, which may be fabricated as a molded plastic tube and may further include a living hinge cap 1504. In some embodiments, a living hinge is a thin flexible plastic junction that connects two mating parts. The hinge keeps the parts attached and may be folded completely without failure to allow the two parts to fully mate.
  • Cap 1504 may be further provided with a cutout portion to provide access to the index finger and restrict the insertion motion along a desired axis. Cap 1504 is closed up and bonded to the housing through chemical or ultrasonic bonding after the bellow-button assembly (described herein) is provided.
  • Inserter further includes bellows 1506, which, in some embodiments, is constructed from molded thin wall plastic with an integrated compression spring which collapses during the insertion action, and which provides the force to retract sharp 1524 after insertion. Bellows 1506 also hides sharp 1524 from exposure. The top portion 1520 of the bellows 1506 is secured to button 1514, and bottom portion 1521 is secured to housing 1502.
  • A button 1514 provides the capability of the user to insert on body housing 122 into the skin of the subject. Button 1514 may be fabricated from plastic and may further include anti-rotation features, e.g., recess 1515 which glides along longitudinal ridge 1517, restricting motion to the desired longitudinal axis. Needle hub 1536 is glued or directly molded onto button 1514. Sharp 1524 is securely held on to on body housing 122, as described herein (See, e.g., FIGS. 11-13).
  • An adhesive patch 1518 secures on body housing 122 to the skin of the subject. In some embodiments, the adhesive patch 1518 includes a high-tack (i.e., high strength adhesive) region for contact with the skin. A protective liner is provided for removal prior to insertion. On the side of the adhesive patch facing inserter 1500, low-tack region 1530 is provided on the periphery of the patch to allow easy removal of housing 1502 after insertion is completed. A high-tack region 1532 is provided in the center portion of the patch to secure on body housing 122 in place.
  • Referring to FIGS. 53-55, inserter kit 1600 is illustrated with inserter 2310 and an adhesive mount 2312 removably attached to the bottom thereof. Inserter 1600 is further described in U.S. Pat. No. 7,381,184, which is incorporated by reference herein for all purposes.
  • After preparing an insertion site on the skin, typically in the abdominal region, the user removes a liner (not shown) from adhesive mount 2312 to expose the bottom surface and a portion of the top surface of an adhesive tape 2320 located beneath mount 2312. Mount 2312, with inserter 2310 attached, is then applied to the subject's skin at the insertion site. Actuator button 2324 is depressed, causing inserter 2310 to fire, thereby inserting sensor 2314 into the subject's skin with a predetermined velocity and force. Once sensor 2314 has been inserted into the skin, the patient removes inserter 2310 from mount 2312 by pressing release tabs (not shown) on opposite sides of inserter 2310 and lifting inserter 2310 away from mount 2312.
  • Once inserter 2310 is removed from mount 2312, communications electronics (not shown) can be slid into place. The circuitry of the communications electronics device makes electrical contact with the contact pads on sensor 2314 after the communications electronics is fully seated on mount 2312. Once initialization and synchronization procedures are completed, electrochemical measurements from sensor 2314 can be sent wirelessly from the communications electronics to a receiver unit
  • In some embodiments, inserter kit 1600 is assembled from the following components: housing 2334, actuator button 2324, drive spring 2336, shuttle 2338, introducer sharp 2340, sensor 2314, retraction spring 2342, inserter base 2344, upper liner (not shown), adhesive mount 2312, adhesive tape 2320, and lower liner (not shown).
  • Shuttle 2338 is slidably and non-rotatably constrained on base 2344 by arcuate guides 2360. Shuttle 2338 is generally formed by an outer ring 2362 and an inner cup-shaped post 2364 connected by two bridges 2366. Bridges 2366 slide between the two slots (not shown) formed between guides 2360 and allow shuttle 2338 to travel along guides 2360 without rotating. Retraction spring 2342 is captivated at its outer circumference by guides 2360, at its bottom by the floor 2370 of base 2344, at its top by bridges 2366, and at its inner circumference by the outer surface of shuttle post 2364. Drive spring 2336 is captivated at its bottom and outer circumference by the inside surface of shuttle post 2364, at its top by the ceiling 2372 inside actuator button 2324, and at its inner circumference by stem 2374 depending from ceiling 2372. When drive spring 2336 is compressed between actuator button 2324 and shuttle 2338 it urges shuttle 2338 towards base 2344. When refraction spring 2342 is compressed between shuttle 2338 and base 2344, it urges shuttle 2338 towards actuator button 2324.
  • Retraction spring 2342 will return shuttle 2338 to the neutral position as shown after firing, but without sensor 2314 which remains inserted in subject's skin. Drive spring 2336 is preferably designed to be stiffer than retraction spring 2342 so that shuttle 2338 oscillations are quickly dampened out, and so introducer sharp 2340 does not return to sensor 2314 or the patient to cause injury. With sensor 2314 inserted in the subject's skin, inserter 2310 can be removed from mount 2312 and then lifting inserter 2310 away from mount 2312. Introducer sharp 2340 remains protected inside housing 2334 during disposal of inserter 2310. Communications electronics can now be slid into place on mount 2312 as previously described.
  • In some embodiments, a proximal portion of stem 2374 is enlarged to create an interference fit with the coils of spring 2336. For example, one or more laterally extending ribs 2610 are added to stem 2374. The interference fit between ribs 2610 and spring 2336 is typically provided at the proximal (top) coils of spring 2336.
  • The diameter of the coils of spring 2336 increases slightly when compressed and decreases slightly when extended. Ribs 2610 on stem 2374 provide greatest interference when spring 2336 is extended. The interference fit provides increased stability of shuttle 2338 during insertion. In some embodiments, the interference fit prevents or minimizes distal movement of spring 2336, which may cause impact of spring 2336 against shuttle 2338 and the end of the distal travel of these components.
  • Referring to FIGS. 56-70, in another exemplary embodiment, inserter 2600 generally includes: actuator button 2602 (FIG. 57), shuttle 2604 (FIG. 58), inserter sharp 2610 with skin piercing edge 2612 (FIG. 58), retraction spring 2608 (FIG. 59), sensor 2614 (FIG. 60), housing 2616 (FIG. 61), and base 2618 (FIG. 62). It is understood that inserter 2600 may include additional or fewer components than described herein. Inserter 2600 is substantially identical to inserter 1600 described herein, with the substantial differences noted herein and illustrated in the accompanying figures. The assembly of the different components of inserter 2600 is depicted in FIGS. 63-65. As shown in FIG. 63, actuator button is adapted to be slidably inserted through an opening in shuttle 2604 where it locks into position. Further, as shown in FIG. 64, retraction spring 2608 is adapted to be inserted into a second opening on the opposite side of shuttle 2604. Additionally, in this view, sensor 2614 has been attached to inserter sharp 2610. As shown in FIG. 60, sensor 2614 incorporates a biasing arm 2615 that positively seats the sensor 2614 into the inserter sharp 2610. This allows the inserter sharp 2610 and sensor insertion portion 30 to be smaller, reducing the trauma and pain to the subject. Any number of the aforementioned sensor connection methods can be utilized in conjunction with inserter 2600. For example, inserter sharp 2610 may be provided with rails and dimples, as previously described, in order to retain sensor 2614, the sharp 2610 having a diameter of about 20 to about 26 gauge, e.g., 21 gauge to about 25 gauge, where, in certain embodiments, the sharp is 21 gauge or 23 gauge or 25 gauge. Such sharp may be used with a sensor having a width or diameter—at least the portion that is carried by the sharp—of about 0.20 mm to about 0.80 mm, e.g., about 0.25 mm to about 0.60 mm, where, in some embodiments, the width or diameter of at least a portion of a sensor is 0.27 mm or 0.33 mm or 0.58 mm.
  • FIG. 66 depicts a cross-sectional view of the assemblage of FIG. 65 after inserter 2600 has been fully assembled (joining housing 2616 to base 2618). As depicted, retraction spring 2608 is surrounded by guides 2622 on its sides and by shuttle 2604 and base 2618 when inserter 2600 is assembled. Additionally, shuttle 2604 is adapted to slidably move on rails (not shown) within base 2618, thereby allowing it to move in a linear direction when actuator button 2602 is depressed. FIG. 66 depicts the actuator button 2602 locked onto the shuttle 2604 using the first of two detent grooves 2607. In this configuration, the shuttle 2604 and actuator button 2602 are in a locked state relative to the housing 2616 and base 2618, preventing accidental deployment of the shuttle during shipping and handling. This configuration also allows for significantly smaller packaging, resulting in lower shipping costs and improved bulk process efficiencies such as sterilization. FIG. 67 depicts the actuator button 2602 locked onto the shuttle 2604 using the second of two detent grooves 2607. In this configuration, the shuttle is ready to be deployed. The actuator button 2602 is moved to the second detent groove 2607 by a user pulling axially on the actuator button 2602 and housing 2616.
  • FIGS. 68-70 illustrate the steps utilized to deploy sensor 2614 using inserter 2600. FIG. 68 depicts inserter 2600 in a first configuration. The upward force exerted by retraction spring 2608 on shuttle 2604 (and consequently actuator button 2602) keeps inserter 2600 in its cocked position in the first configuration. As actuator button 2602 is pressed by a user against the bias of retraction spring 2608, it exerts a downward force on shuttle 2604 and retraction spring 2608. Introducer sharp 2610, on which sensor 2614 is mounted, is consequently driven downward and into the skin of the subject (e.g., to a second configuration) Skin piercing edge 2612 pierces the skin of the subject and allows sensor 2614 to be properly inserted, as shown in FIG. 69.
  • As the force is removed from actuator button 2602, retraction spring 2608 exerts an upward force on shuttle 2604, thereby causing introducer sharp 2610 to return proximally to its original position inside of housing 2616 (e.g., to the first configuration). Sensor 2614 remains implanted in the patient's skin, as shown in FIG. 70. In this position, the plunger is bent approximately 90 degrees by the user, which prevents further use of the device, and provides obvious visual and tactile indications that the device is used and ready to be disposed.
  • In another aspect of the disclosed subject matter, an inserter assembly, as illustrated in FIG. 71, is provided which is useful for installing a medical device, such as an analyte sensor, in the skin of a subject. Inserter assembly 4300 may include an inserter, a medical device, such as an analyte sensor, and a mount for positioning the medical device at least partially in or on the skin of the subject. In some embodiments, the mount is a support structure, plate and/or member which is attached, adhered, or otherwise secured to the skin of the subject. The mount may be applied to the skin of the subject simultaneously with the medical device by the inserter. In other embodiments, the mount is installed after or before installation of the medical device. A mount may be applied by the inserter or separately. The mount may include features or structures (e.g., adhesive, guides, barbs, tabs, etc.) to maintain the sensor in position with respect to the skin after insertion and/or maintain the sensor in relative position with respect to the sensor control unit.
  • Inserter assembly 4300 is useful for analyte measurement systems, e.g., glucose measurement systems which include an on-body unit that may be assembled on the skin of the subject. For example, the on-body unit may include a sensor and a sensor control unit. The sensor is typically installed in the patient. Subsequently, the sensor control unit is installed and coupled to the sensor. In other embodiments, the sensor control unit is installed at the patient first, followed by installation of the sensor, which is then coupled to the sensor control unit. In yet other embodiments, the sensor and sensor control unit are simultaneously installed and coupled. An optional mount may or may not be used to position the sensor and/or the sensor control unit.
  • Generally, the inserter assembly 4300 is useful to install a sensor in the skin of a subject. A sensor (not shown) may be preloaded within inserter 4310 prior to installation. After preparing an insertion site on the skin of a subject, the user removes an upper liner 4316 and lower liner 4318 from mount 4312 to expose the bottom surface and a portion of the top surface of an adhesive tape located on the bottom surface of the mount 4312. Mount 4312, with inserter 4310 attached, is then applied to the subject's skin at the insertion site. In some embodiments, the mount 4312 is first attached, and then the inserter is coupled to or positioned within and/or adjacent to the mount 4312. The inserter includes an actuator button 4324 (see FIG. 74) to be depressed causing inserter 4310 to fire, thereby inserting a sensor into the user's skin. As will be described herein, certain embodiments install the sensor with a predetermined velocity and force upon actuation. In some embodiments of the disclosed subject matter, the inserter includes a safety member to impede actuation of the inserter as described below.
  • In some embodiments, the sensor 4314 remains positioned at the mount 4312 by one or more positioning techniques. For example, as illustrated in FIG. 72, sensor 4314 has a surface 4356 that extends orthogonally from main surface 4346. Surface 4356 may include an adhesive portion that contacts the subject's skin 4328 or the mount 4312. In some embodiments, the raised end stop 4444 of mount 4312 is provided with a raised bead or bump which is received in an aperture in sensor 4314. Following insertion of the sensor 4314 into the skin, the user may remove the inserter 4310 from mount 4312, e.g., by pressing release tabs 4326 on opposite sides of inserter 4310 and lifting inserter 4310 away from mount 4312. In some embodiments, the inserter 4310 is retained by other techniques, e.g., a friction-fit or a snap-fit with the mount 4312.
  • Once inserter 4310 is removed from mount 4312, a sensor control unit 4330 can be positioned into place with respect to the mount 4312. The circuitry of sensor control unit 4330 makes electrical contact with the contacts on sensor 4314 after sensor control unit 4330 is seated on mount 4312. For example, as shown in FIG. 72, seal has an exterior wall for surrounding electrical contacts on sensor 4314 (not shown in FIG. 72), and interior walls for isolating electrical contacts from each other. In some embodiments, rails on sensor control unit 4330 are slidable within corresponding rails or grooves 4434 on mount 4312.
  • In some embodiments, initialization and synchronization procedures are completed, and then electrochemical measurements from sensor 4314 can be provided from sensor control unit 4330 to a monitor unit, such as, e.g., portable monitor unit 4332, shown in FIG. 73. Sensor control unit 4330 and monitor unit 4332 communicate via connection 20 (in this embodiment, a wireless radio frequency (RF) connection). Communication may occur, e.g., via RF communication, infrared communication, Bluetooth® communication, Zigbee® communication, 802.1x communication, or WiFi communication, etc. In some embodiments, the communication may include a radio frequency of 433 MHz, 13.56 MHz, or the like. In some embodiments, communication between sensor control unit 4330 and monitor unit 4332 may include radio frequency identification (RFID) techniques, and may be active RFID or passive RFID, where, in some embodiments, passive RFID technology and the respective system components include the necessary components therefor. For example, in one embodiment, the monitor unit may include a backscatter RFID reader configured to transmit an RF field such that when the sensor control unit is within the transmitted RF field, an antenna is tuned and in turn provides a reflected or response signal (for example, a backscatter signal) to the monitor unit. The reflected or response signal may include sampled analyte level data from the analyte sensor. Additional exemplary details for various embodiments can be found in, e.g., U.S. patent application Ser. No. 12/698,124 filed Feb. 1, 2010, the disclosure of which is incorporated by reference herein for all purposes.
  • Sensor 4314, mount 4312 and sensor control unit 4330 can remain in place on the subject for a predetermined maximum period of time that may include hours, days, weeks, or a month or more. These components are then removed so that sensor 4314 and mount 4312 can be properly discarded in some embodiments. The entire procedure above can then be repeated with a new inserter 4310, sensor 4314 and mount 4312, reusing sensor control unit 4330 and monitor unit 4332. In other embodiments, inserter 4310 is reusable.
  • Referring to FIG. 74, the inserter assembly 4300 according to one embodiment can be assembled as shown from the following components: housing 4334, actuator button 4324, drive spring 4336, shuttle 4338, introducer sharp 4340, sensor 4314, retraction spring 4342, inserter base 4344, upper liner 4316, adhesive mount 4312, adhesive tape 4320, and lower liner 4318.
  • In some embodiments, sensor main surface 4346 is slidably mounted between U-shaped rails 4348 of introducer sharp 4340. In addition to the holding members disposed on the introducer, as described above, retention techniques are provided in certain embodiments to retain the sensor 4314 in position on sharp 4340 during storage of the inserter 4300 and/or during insertion of the sensor 4314 into the subject's skin. For example, a sensor dimple (not shown) is provided which engages an introducer dimple (also not shown). Introducer sharp 4340 can be mounted to face 4354 of shuttle 4338, such as with adhesive, heat stake or ultrasonic weld.
  • In some embodiments, shuttle 4338 can be slidably and non-rotatably constrained on base 4344 by arcuate guides 4360. The shuttle can be generally formed by an outer ring 4362 and an inner cup-shaped post 4364 connected by two bridges 4366. Bridges 4366 can be configured to slide between the two slots 4368 formed between guides 4360 and allow shuttle 4338 to travel along guides 4360 without rotating. In some embodiments, a retraction spring 4342 is provided, which can be captivated at its outer circumference by guides 4360, at its bottom by the floor 4370 (see FIG. 75) of base 4344, at its top by bridges 4366, and at its inner circumference by the outer surface of shuttle post 4364. In some embodiments, a drive spring is provided for advancing the sensor 4314 and the sharp 4340 into the skin of the subject. For example, drive spring 4336 is captivated at its bottom and outer circumference by the inside surface of shuttle post 4364, at its top by the ceiling 4372 (see FIG. 75) inside actuator button 4324, and at its inner circumference by stem 4374 depending from ceiling 4372. In some embodiments, a drive spring is omitted from the inserter assembly. In such case, for example, sensor 4314 and sharp 4340 are distally advanced by manual force applied by a user.
  • When drive spring 4336 is compressed between actuator button 4324 and shuttle 4338 it can urge shuttle 4338 towards base 4344. When retraction spring 4342 is compressed between shuttle 4338 and base 4344, it urges shuttle 4338 towards actuator button 4324.
  • When sensor 4314, introducer sharp 4340, shuttle 4338, retraction spring 4342, drive spring 4336 and actuator button 4324 are assembled between base 4344 and housing 4334 as shown in FIGS. 74-75 and described above, housing 4334 is snapped into place on base 4344. Base 4344 is held onto housing 4334 by upper base barbs 4390 that engage upper openings 4392 in housing 4334, and lower base barbs that engage lower openings in housing 4334. Further details regarding the construction and operation of inserter 4300 is provided in U.S. Pat. No. 7,381,184 which is incorporated by reference herein in its entirety for all purposes.
  • In some embodiments, retention techniques and/or structures are provided to assist in supporting the sensor 4314 with respect to the sharp 4340 during storage and insertion. As illustrated in FIGS. 76-90, retention mechanisms are provided which are located on the sensor and/or the sharp.
  • FIGS. 76-77 illustrate a sensor 4514 which is provided with one or two laterally extending tabs 4560. Tabs 4560 engage the rails 4548 of the sharp 4540 for retention. In some embodiments, a radiused edge on the ears allow them to be formed in two punch operations, e.g., a hole punch and a straight cut. A gap between left hard-stop 4549 and the top of sensor 4514 produces, during firing, a moment that biases the sensor tip into the sharp channel. During deployment, the sensor deflects to disengage the sharp.
  • FIGS. 78-79 illustrate an inserter having a sensor retention mechanism in accordance with a further embodiment of the subject disclosure. Sharp 4640 is provided with a clip 4660 that engages a retention window 4662 at the top of sensor 4614 to provide retention of sensor 4614 in sharp 4640, and vertical registration. Two drive blocks 4659 and 4661 on carrier 4654 traverse sharp 4640 to engage the top edge of sensor 4614. There is a gap between the left drive block 4659 and the top edge of sensor 4614. Right drive block 4661 is in contact with the top edge of sensor 4614. During insertion, the upward drive force of the skin on sensor 4614 produces a clock-wise rotational moment on sensor 4614 that biases sharp 4614 into the sharp channel.
  • The clip feature 4660 and the window 4662 can be moved to the left to bias the tip of the sensor 4614 into the channel during shipping. During deployment, the sensor 4614 and the clip 4662 deflect to transfer the sensor 4614 to the mount 4312.
  • FIG. 80 illustrates a further embodiment of a sensor retention technique. In particular, sensor 4714 is provided with a retention member 4760, which extends from the contact portion 4732 of the sensor 4714. Retention member 4760 is resiliently biased in the position as shown. When the sensor 4714 is inserted within the sharp (not shown), the retention member engages the inner portion of rails (not shown) of the sharp, and provides a retention force to the sensor 4714.
  • FIG. 81 illustrates another embodiment of a sensor retention technique. Sensor 4814 is provided with a dimple 4860 which is thermally formed. As shown in FIG. 82, a raised bump 4864 on the sharp 4840 frictionally contacts thermally formed dimple 4860 in order to provide retention force to the sensor 4814. In some embodiments, raised bump is formed using heat. In another embodiment, a raised bump is formed on the sensor and the dimple is formed on the sharp.
  • FIGS. 83-84 illustrate an aperture 4960 which is formed in the contact portion of the sensor 4914. A raised bump or tab 4962 is provided on the sharp 4940. The interaction of the tab 4962 within the aperture 4960 of the sensor 4914 assists in retaining the sensor 4914 within the inserter.
  • FIGS. 85-86 illustrate a technique for retention of the sensor 5014 which is similar to the techniques illustrated in FIGS. 81-84. For example, a raised bump 5062 is provided on sharp 5040 which engages the contact portion 5032 of the sensor 5014. In such configuration, the raised bump 5062 creates a bias force against the contact portion 5032. Such force acts as a frictional force to assist retention of the sensor 5014 within the sharp 5040.
  • FIGS. 87 and 88 illustrate sensors having retention members which engage a raised post or button on the sharp. FIG. 87 illustrates that contact portion 5132 of sensor 5114 includes a pair of “pincer fingers” 5160 having a substantially arcuate configuration which surround and engage a post 5162 provided on the sharp. Similarly, FIG. 88 illustrates sensor 5214 having a pair of proximally extending arms 5260, which engage a post 5262 on the sharp.
  • FIG. 89 illustrates a sensor 5314 having a laterally extending arm 5360 which defines a channel 5364 between the arm 5360 and the contact portion 5332 of the sensor 5314. As illustrated in the figure, a post 5360 may be positioned within the channel 5364, and provides frictional resistance to maintain the sensor 5314 within the sharp.
  • FIG. 90 illustrates a sensor 5414 having a proximally extending arm 5460 which defines a channel 5362 between the arm 5460 and the contact portion 5432 of the sensor 5414. As illustrated in the figure, a tab 5364 is provided on the arm 5460 and is received within a gap provided in the rails of the sharp. This interaction of the tab 5364 with the gap provides frictional resistance to maintain the sensor 5414 within the sharp.
  • FIGS. 91-92 refer to sensor retention techniques which include a retention member which provides a frictional force substantially normal (perpendicular) to the surface of the sensor. FIGS. 91 and 92 illustrate a retention member which is provided within the housing 5534 of the inserter 5510. For example, the retention member 5560 may extend distally from the housing 5534 and includes a laterally extending tab 5562 which contacts the sensor 5563 and provides a frictional force to assist retention of the sensor within the sharp 5540.
  • FIGS. 93 and 94 illustrate a retention member which is provided with the base 5644 of the inserter 5610. For example, retention member may include a cantilever 5660 which extends proximally from base 5644 of the inserter 5610. Cantilever 5660 may include a laterally extending member 5662 which contacts the sensor 5661 and provides a frictional force to assist retention of the sensor within the sharp 5640. When the carrier 5666 bottoms down, the cantilever 5660 ceases contact and release of the sensor occurs.
  • FIGS. 95 and 96 illustrate a resilient or elastomeric member which is disposed within the housing 5734 of the inserter 5710. For example, elastomeric member 5760 is manufactured from TPE and presses against the sensor and the resulting friction keeps the sensor in place. The TPE material creates a higher friction with respect to the sensor, and therefore requires less pressure to produce the sensor holding force. When the inserter 5710 is actuated, the frictional forces are directed upward keeping the sensor inside the sharp. When the carrier bottoms down, the contact with the friction rib ceases and the sensor releases to the mount. In some embodiments, the elastomeric member 5760, or rib, is produced with a second-shot injection molded process or press-fit into housing 5734.
  • FIGS. 97 and 98 refer to retention members which provide a frictional force in a substantially coplanar direction to the surface of the sensor. FIG. 97 illustrates a retention member or cantilever 5860 which is biased against the side edge of the contact portion 5832 of the sensor 5814. In some embodiments, cantilever 5860 is provided on the carrier or sharp (not shown). FIG. 98 illustrates a sensor retention technique which includes a retention member, or cantilever 5960 which is biased against the sensor, as described in FIG. 97. Cantilever 5960 includes a laterally extending portion which is at least partially received in an optionally provided notch 5964 in sensor 5914. In addition, a second retention member, or retention spring 5990, is provided which is biased to engage the front surface of the sensor. In some embodiments, retention spring 5990 is partially received in cut-out 5994 (or a slot) to capture the sensor.
  • In some embodiments, an inserter assembly is provided which includes a reusable inserter apparatus. Repeated uses of the inserter include the use of a removable and exchangeable sensor and sharp which may be coupled to the inserter during deployment of the sensor, and in which the sharp is removed and discarded after deployment.
  • FIGS. 99-101 illustrate a system of sharp/sensor packs 6002 which contain a plurality of sensor/sharp combinations 6006. As illustrated in FIGS. 99 and 101, a support is provided which includes a plurality of trays 6004 which are useful for containing the sensor/sharp configuration 6006, and well as a desiccant 6010 which is contained in a chamber 6008. A well 6012 is provided on one side of the tray 6004 to accommodate the sensor sharp for installation into a patient. A cover, such as a foil lid 6014 is applied to the top of the support to maintain the sterility of the sensor/sharp combination until installation in a subject. FIG. 100 is a perspective view which illustrates an exemplary configuration of pack 6002. The foil lid 6014 for each of trays 6004 may include a tab 6016 to facilitate removal of the lid from the tray 6004 (FIGS. 100, 101).
  • FIGS. 102-105 illustrate a plurality of reusable inserters which are useful in combination with the sharp/sensor packs 6002 described herein. FIG. 102 illustrates an inserter 6030 which includes a body portion 6032, a loading or cocking structure 6036, and an actuator button 6040 for deploying the sensor into the skin of the subject. The advancement structure of inserter 6030 may include a cocking structure which is pulled to arm, e.g., by withdrawing the cocking structure 6036 from the housing 6032; which is pushed to arm, e.g., by depressing the cocking structure 6036 into the housing 6032; or which is rotated to arm, e.g., by rotating the cocking structure 6036 in a rotational movement parallel to the longitudinal axis of the inserter 6030, or perpendicular to the longitudinal axis of the inserter 6030. The driving mechanism of inserter 6030 is substantially similar to the driving mechanisms as disclosed in U.S. Patent Publication 2008/0082166, now U.S. Pat. No. 8,167,934, U.S. Pat. No. 6,197,040, or U.S. Pat. No. 4,976,724, which are incorporated by reference in their entirety herein for all purposes.
  • To insert the sharp/sensor combination into the inserter 6030, the foil lid is removed from sharp/sensor pack 6002. The distal end portion 6034 of the inserter 6030 is positioned within the walls 6004 of the tray 6002, as indicated in the direction of arrow E. The distal end portion 6034 comes to rest on the upper surface of desiccant chamber 6008, such that the insertion sharp remains exposed.
  • FIG. 103 illustrates an inserter 6130 substantially identical to the inserter 6030 described herein. Inserter 6130 is used in connection with sharp/sensor trays 6102. Trays 6102 include a desiccant chamber 6108 which is located in the center portion of the tray 6102. Accordingly, a channel 6112 surrounds the periphery of desiccant chamber 6108. When the inserter 6130 is applied to the sharp/sensor tray 6102, the distal end portion 6134 can be positioned within the channel 6112. As illustrated in FIG. 103, this configuration allows the sensor and sharp to be completely housed within the inserter 6130.
  • FIG. 104 illustrates an inserter 6230 substantially identical to the inserters 6030 and 6130 described herein, with the differences noted herein and illustrated in the figures. Inserter 6230 may be used in connection with sharp/sensor trays 6204. The tray 6204 and inserter 6230 are sized and configured such that tray 6204 is capable of being positioned entirely within the distal end portion 6234 of inserter 6230. One or more support struts 6220 are provided adjacent the distal end portion 6234 to stabilize the inserter with respect to any surface on which the inserter 6230 and trays 6204 are placed for the insertion step. Support struts 6220 may also secure inserter 6230 to an adhesive mount (not shown) during insertion.
  • FIG. 105 illustrates an inserter 6330 which is substantially identical to the inserters 6030, 6130, and 6230 described herein, with the differences noted herein and illustrated in the figures. Inserter 6330 may be used in connection with sharp/sensor tray 6304. In some embodiment, tray 6304 includes a distally projecting handle portion 6340 which may be grasped by the user to facilitate insertion of the sharp/sensor into the inserter.
  • FIGS. 106-107 illustrate an exemplary sharp/sensor combination for use with inserters 6030, 6130, 6230, and 6330 described herein. Sharp 6440 includes side rails 6448 for sliding reception of a sensor therein. A locking tab 6450 is also provided on the proximal portion of the sharp and includes cut-out portion 6452 for interlocking with the carrier of the inserter 6030 (or 6130, 6230, or 6330). As illustrated in FIGS. 108-112 carrier 6466 includes reception structure for mating reception with the sharp 6440. For example, carrier 6466 may include a pair of walls 6478 providing a channel 6480 in which said sharp 6440 may be positioned. Walls 6478 are provided with cutout portions 6482 for reception of undercut portion 6452 in locking tab 6450. A pair of securement members 6484 are movably mounted on the carrier 6466. For example, members 6484 are biased via a spring 6486 towards a center portion of the carrier 6466. As illustrated in FIG. 111, securement members 6484 may be moved outwardly against the spring bias to allow for the insertion of the locking tab 6450 into the cutout portion 6482 of the carrier. Securement member 6484 is subsequently released and returns to a position to engage the undercut portion 6452 to prevent accidental removal of the sharp and sensor from the inserter (FIG. 112). It is understood that coupling of the sharp and carrier may be provided by alternative techniques such as frictional fit, snap-fit, bayonet mounts, magnetic coupling, etc.
  • FIGS. 113-117 illustrate a further embodiment of the subject disclosure that is reusable, and useful with the sharp/sensor packs discussed herein. FIG. 113 illustrates a sensor pack 6504 which is similar to the sensor packs described herein. Sharp/sensor pack 6504 also includes one or more reinforcing ribs 6574 to prevent accidental deformation of the pack 6504 when the sensor is being inserted into the inserter.
  • As illustrated in FIG. 114, inserter 6530 is provided which is substantially similar to inserters 6030, 6130, 6230, and 6330 described herein, with the differences noted herein or illustrated in the figures. Inserter 6530 includes a carrier (not shown) for coupling with a sharp/sensor combination. As illustrated in the figure, inserter 6530 is lowered onto sharp/sensor pack 6504 in order to couple the sharp 6506 with the carrier. As illustrated in FIG. 115, inserter 6530 which now contains the sharp/sensor 6506 is positioned over the mount 6512. Mount 6512 may include an adhesive for securement to the skin of the subject. Inserter 6530 includes a locking structure 6526 which allows for temporary engagement of the inserter 6530 with the mount 6512.
  • As illustrated in FIG. 116, the sensor is deployed by depressing actuation button 6532 on the inserter 6530 to advance the sensor into the skin by use of an internal drive mechanism, such as, e.g., a spring. It is understood that the above-described process may alternatively be carried out by using an inserter which allows the user to provide a manual distal force for deployment of the sensor.
  • Following installation of the sensor, inserter 6530 is decoupled from the mount, e.g., by depressing locking buttons 6526 on inserter 6530. Once the inserter 6530 is separated from the mount, the user may remove and discard the sharp. In some embodiments, inserter 6530 includes a sliding lever 6540 which allows for removal of the sharp. It is understood that disengagement of the sharp from carrier may be executed in one of several ways, e.g., sliding switch allows securement member (discussed herein) to slide outwardly and allow disengagement of the contact portions 6483 of the securement members 6484 from the undercut portions 6452 of locking tab 6450.
  • FIG. 118 illustrates an inserter 6630 and engagement structure for mounting on mount 6612. Inserter 6630 includes a body portion 6640 which is configured to advance a sharp/sensor cartridge into the skin S of a subject along longitudinal axis LON. The longitudinal axis LON may be substantially perpendicular to the skin surface. In some embodiments, axis LON forms an acute angle with the skin surface. Mount 6612 and inserter 6630 are each provided with complementary locking structures 6662 on the mount 6612 and 6664 on the inserter. Inserter is advanced laterally (direction LAT) over mount 6612. Inserter 6630 may be locked in place by pivoting locking structure 6632 about pivot 6626. Following such pivoting action, the engagement portion 6666 of locking structure 6632 is received in recess 6668 in mount 6612. Securement of the inserter to the mount is further provided by insertion of the sharp/sensor cartridge 6650 between the inserter 6630 and the mount 6612. For example, cartridge 6650 includes raised tabs 6654 which are slidable within complementary grooves 6652 provided on the inserter 6630 and mount 6612. Insertion of the cartridge is carried out in a direction perpendicular to the direction in which the inserter is attached to the mount, e.g., a direction perpendicular to the plane of the page.
  • FIGS. 119-121 illustrate another embodiment of an inserter in accordance with the disclosed subject matter. Inserter 6730 is useful for advancing a medical device, such as an analyte sensor, into the skin of a subject. Inserter 6730 includes a hammer member 6760 which accumulates advancement energy to provide a more rapid and powerful advancement stroke. As illustrated in FIG. 119, hammer member 6760 is initially positioned somewhat askew with respect to the longitudinal axis of the device. As the alignment trigger 6734 is advanced distally, alignment sleeves 6736 gradually pivot the hammer member 6760 into a longitudinal configuration. As the hammer member 6760 is being pivoted into position, the advancement spring continues to be compressed. With reference to FIG. 120, the hammer member 6760 is pivoted into alignment with the central bore of the inserter 6730, e.g., along the longitudinal axis represented by the arrow. Consequently, the tension of advancement spring 6742 is immediately released, which permits rapid distal movement of the hammer member 6760. Hammer member 6760 contacts carrier 6744, which in turn contacts sharp/sensor combination 6718 to provide distal movement.
  • As illustrated in FIG. 121, a ledge or lateral member 6726 is provided with the internal bore of the inserter. As the hammer member 6760 advances distally, the distal surface of the hammer member contacts the ledge 6726. Interengagement of the hammer member 6760 and the ledge 6726 inhibits further distal travel of the hammer member 6760.
  • FIG. 122 illustrates an exemplary embodiment of a simplified unit, or cartridge 6800, which holds certain components for sterility and subsequent interaction with the subject. In some embodiments, the components include the sharp 6840, the housing 6860, the sensor 6814. The cartridge 6800 may be used in connection with any of the inserters 6030, 6130, 6230, 6330, 6530 and/or 6730 described herein. In some embodiments, the cartridge includes a housing and a lid which contain the sharp and sensor therein. In some embodiments, a resilient member or other cantilever structure is used to maintain the alignment of the sharp and sensor within the cartridge. Interaction of the cartridge with the inserter advances the sensor and sharp such that the sensor is installed at the subject.
  • As illustrated in FIGS. 123-124, the sharp 6840 and sensor 6814 may sit in a recessed portion of the disposable cartridge 6800. A spring finger or cantilever 6876 on the housing lid maintains a load on the sharp 6840 and sensor 6814 to keep it depressed in the cavity. Attachment for a lid to the base of the cartridge housing 6860 is not shown in the figure above, but methods such as snaps, heat stake, or ultrasonic welding may be used to join the two housings in assembly. The sensor 6814 is contained within the sharp 6840, laterally by the two rounded ends 6848 of the sharp, and in the orthogonal lateral direction (in relation to the views shown above), by two bent tabs 6849 on the sharp 6840 and the cartridge housing base cavity. The sharp is held in its lateral position by not only the cavity, but also by the raised pyramid feature 6878 shown on the housing base 6870. In the figure above, the locating pyramid sits in the opening 6882 created from the bent tab in the sharp. The engagement features to locate/attach/engage the cartridge to the inserter portion of the device are not shown in the figures above, but may include such features as illustrated in FIGS. 106-112 above.
  • As illustrated in FIGS. 125 and 126, when the cartridge 6800 is loaded onto the reusable inserter part of the device, the sharp is raised out of its cavity by stationary elements built onto the inserter (not shown). Features from the reusable portion of the inserter enter through the two shorter slots shown FIG. 122. These features will remain stationary throughout the sensor delivery action of the inserter device.
  • In the longer middle slot 6866, a stepped feature from the inserter, mates with the opening on the sharp (shown as two holes 6864 in the figure above). The stepped portion of the feature provides a force on the back portion of the sharp to keep it raised against the force of the sprung cantilever 6876 on the housing. This feature of the inserter will move in relation to the cartridge and provide the drive and retraction movement for the sharp through insertion and delivery of the sensor. In some embodiments, the force is transmitted through driving pins which are part of the movable portion of the inserter device. The driving pins protrude through holes 6864. In case of minor misalignment of the driving pins (not shown), ribs on the cartridge housing lid will constrain the sharp from tilting up.
  • Once the sharp and sensor are raised from the cavity portion of the cartridge, they are no longer constrained by the recessed cavity portion of the housing base and the pyramid feature maintaining the sharp position. The sharp is held in its raised position by the stationary and stepped drive feature of the inserter, balanced with the force of the cantilever finger on the lid housing. The sensor is kept in place by being pinched against the cantilever finger on the housing lid. The sharp is constrained in its retracted position by the mated drive feature of the inserter.
  • As the inserter is actuated, the mated inserter drive feature drives the sharp downward as it moves through the longer slot shown in the figure above (see FIGS. 127-129). The driven sharp slides along the stationary ribs of the inserter, ribbed features built into the cartridge housing, and the housing lid cantilever finger. The friction force of the cantilever keeps the sensor up against the ‘drive block’ and bends in the sharp sheet metal to assure the tail is not exposed from the sharp channel during insertion. In some embodiments, the ‘drive block’ features are longitudinal constraints either built into the sharp or the carrier which constrain the sensor from proximal movement with respect to the sharp. In another embodiment, the drive block features are protrusions on the carrier or bends on the sharp which push the sensor as the sharp is propelled distally.
  • The sensor is kept from popping over the drive block features by the stationary ribs built into the housing lid. As the cantilever slides over the top edge of the sensor, the retention force is relieved from the sensor, and it can be captured onto the mount portion of the device with relatively little force. Alternately, if geometry permits, and the finger is positioned appropriately, the pinching of the cantilever on the sharp may provide enough resistance on the return motion of the sharp to keep the sensor in its inserted position even without a capture device on the mount. The inserter drive feature then retracts the sharp, leaving the sensor in place on the mount portion (that is attached to the skin) of the device.
  • The cartridge can be removed from the inserter. As the cartridge is removed, the force from the housing lid cantilever presses the sharp back into the recess on the cartridge base housing. The base housing is removed and can be discarded.
  • Another embodiment of the cartridge is illustrated in FIGS. 131-137. As illustrated in FIG. 131, the sharp 6940 and sensor 6914 in this embodiment abuts ribs 6972 and 6974 and on insertion plane to which the sharp 6940 will be driven and refracted by the inserter into the skin. The sharp and sensor are held in place by a central cantilever feature 6976 built onto the cartridge lid housing. This cantilever 6976 has geometry such that a vertical portion of the end of the cantilever is butted against the sharp 6940 and sensor 6914.
  • As illustrated in FIGS. 132 and 133, the cartridge 6900 is loaded onto the inserter, in which a stationary feature on the inserter (not shown) raises the cartridge cantilever so that the ramped portion of the cantilever end feature is now in line with the insertion plane of the sharp. Also, a driving element of the inserter (not shown) fits through the slot opening on the sharp. In the embodiment described herein, a step is not required on the driving element on this design.
  • As the sharp is driven downward (see, FIGS. 134-135), the cantilever arm 6976 is pushed up, keeping the sensor in position against the sharp 6940. Stationary ribs on the housing lid assure that the sharp 6940 maintains its insertion plane during insertion, and also assures that the pinching force of the cantilever does not cause the sensor to hop the drive block elements integrated into the sharp. The stationary ribs keep the sensor flat against the sharp through the insertion motion.
  • As illustrated in FIGS. 136-137, the sensor 6914 is captured at the bottom of its motion on the mount, as discussed hereinabove. The drive elements on the inserter retract the sharp 6940 back to its starting position. The cantilever arm 6976 returns to its original unbiased configuration. The cartridge 6900 is removed from the inserter and can be discarded.
  • It is understood that the subject matter described herein is not limited to particular embodiments described, as such may, of course, vary. It is also understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present subject matter is limited only by the appended claims.

Claims (18)

1-10. (canceled)
11. A device for applying an on-skin sensor assembly to skin of a host, the device comprising:
a base configured to secure a housing, wherein the housing is configured to receive an electronics unit, wherein the electronics unit is configured to generate analyte information based on a signal from a sensor;
a sensor insertion mechanism configured to insert the sensor into the host; and
a trigger configured, in response to being activated, to cause the sensor insertion mechanism to insert the sensor into the host, to secure the electronics unit to the housing such that the sensor electrically contacts the electronics unit, and to cause the housing to detach from the base.
12. The device of claim 11, wherein the electronics unit is configured, in response to the trigger being activated and/or the electrical connection of the sensor to the electronics unit, to generate analyte information.
13. The device of claim 11, wherein the housing is configured such that the electronics unit cannot be removed from the housing while the housing is adhered to the skin of the host.
14. The device of claim 11, wherein, in use, a time between sensor insertion into the host and the electronics unit securing to the housing is less than about 1 second.
15. The device of claim 11, wherein the device is configured to disengage from the housing and from the electronics unit in response to the electronics unit being released from a lock.
16. The device of claim 11, further comprising a trigger lock configured to prevent activation of the trigger.
17. The device of claim 11, wherein the sensor insertion mechanism is configured to insert the sensor into the host at a maximum velocity influenced by a centrifugal brake.
18. The device of claim 17, wherein the sensor insertion mechanism comprises a tab protruding in an axial direction from a wheel and configured to rotate about a fixed point, wherein rotational movement of the tab translates into a linear movement of a needle carrier to insert the sensor into the host.
19. The device of claim 11, further comprising a protective cover configured to cover the electronics unit and the housing after sensor insertion and to secure the electronics unit to the housing.
20. A device for applying an on-skin sensor assembly to skin of a host, the device comprising:
a base configured to secure a housing, wherein the housing is configured to receive a transmitter, and the transmitter is configured to generate analyte information based on a signal from a sensor; and
a mechanism configured to, in response to a single action by a user, cause the sensor to be inserted into the host, to secure the electronics unit to the housing such that the sensor electrically contacts the electronics unit, and to cause the housing to detach from the base.
21. The device of claim 20, wherein the mechanism includes a trigger, and the single action comprises activating the trigger to release stored energy and set components within the device in motion.
22. The device of claim 21, wherein the stored energy is stored in a torsion spring that, when released, is configured to cause a wheel to rotate.
23. The device of claim 22, wherein rotation of the wheel is configured to induce linear motion in a needle carrier.
24. A device for applying an on-skin sensor assembly to skin of a host, the device comprising:
a base configured to secure a housing, wherein the housing is configured to receive an electronics unit, wherein the electronics unit is configured to generate analyte information based on a signal from a sensor;
a sensor insertion mechanism configured to insert the sensor into the host, and including a needle carrying the sensor, a rotatable wheel, and a linearly translatable needle carrier; and
a trigger configured, in response to being activated, to cause the rotatable wheel to rotate, which in turn causes the linearly translatable needle carrier to translate toward the host to implant the sensor, and subsequently to translate away from the host to withdraw the needle from the host.
25. The device of claim 24, further comprising a torsion spring that stores energy, wherein the device is configured such that when the trigger is activated, the energy stored in the torsion spring is released, causing the wheel to rotate.
26. The device of claim 25, wherein the wheel includes a flange, and the trigger bears against the flange to retain the energy stored within the torsion spring.
27. The device of claim 24, further comprising a pushrod and a needle, and when the trigger is activated the pushrod ejects the sensor from a lumen of the needle and subsequently retracts into the needle lumen.
US14/509,985 2010-03-24 2014-10-08 Medical Device Inserters and Processes of Inserting and Using Medical Devices Abandoned US20150025338A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/509,985 US20150025338A1 (en) 2010-03-24 2014-10-08 Medical Device Inserters and Processes of Inserting and Using Medical Devices

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US31724310P 2010-03-24 2010-03-24
US34556210P 2010-05-17 2010-05-17
US36137410P 2010-07-02 2010-07-02
US41126210P 2010-11-08 2010-11-08
US13/071,497 US9186098B2 (en) 2010-03-24 2011-03-24 Medical device inserters and processes of inserting and using medical devices
US14/509,985 US20150025338A1 (en) 2010-03-24 2014-10-08 Medical Device Inserters and Processes of Inserting and Using Medical Devices

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/071,497 Continuation US9186098B2 (en) 2010-03-24 2011-03-24 Medical device inserters and processes of inserting and using medical devices

Publications (1)

Publication Number Publication Date
US20150025338A1 true US20150025338A1 (en) 2015-01-22

Family

ID=44673643

Family Applications (36)

Application Number Title Priority Date Filing Date
US13/071,487 Active US9265453B2 (en) 2010-03-24 2011-03-24 Medical device inserters and processes of inserting and using medical devices
US13/071,461 Active 2033-03-28 US9215992B2 (en) 2010-03-24 2011-03-24 Medical device inserters and processes of inserting and using medical devices
US13/071,497 Active 2031-07-24 US9186098B2 (en) 2010-03-24 2011-03-24 Medical device inserters and processes of inserting and using medical devices
US13/436,777 Active 2032-03-06 US9687183B2 (en) 2010-03-24 2012-03-30 Medical device inserters and processes of inserting and using medical devices
US13/436,789 Abandoned US20120190942A1 (en) 2010-03-24 2012-03-30 Medical Device Inserters and Processes of Inserting and Using Medical Devices
US13/436,807 Abandoned US20120197098A1 (en) 2010-03-24 2012-03-30 Medical Device Inserters and Processes of Inserting and Using Medical Devices
US13/436,768 Active 2033-03-04 US10010280B2 (en) 2010-03-24 2012-03-30 Medical device inserters and processes of inserting and using medical devices
US13/436,793 Abandoned US20120190943A1 (en) 2010-03-24 2012-03-30 Medical Device Inserters and Processes of Inserting and Using Medical Devices
US13/436,816 Active 2031-04-15 US8764657B2 (en) 2010-03-24 2012-03-30 Medical device inserters and processes of inserting and using medical devices
US14/509,985 Abandoned US20150025338A1 (en) 2010-03-24 2014-10-08 Medical Device Inserters and Processes of Inserting and Using Medical Devices
US14/884,622 Active 2032-04-26 US10292632B2 (en) 2010-03-24 2015-10-15 Medical device inserters and processes of inserting and using medical devices
US14/996,751 Active 2032-06-15 US10881340B2 (en) 2010-03-24 2016-01-15 Medical device inserters and processes of inserting and using medical devices
US16/002,847 Pending US20190076073A1 (en) 2010-03-24 2018-06-07 Medical device inserters and processes of inserting and using medical devices
US29/685,591 Active USD948722S1 (en) 2010-03-24 2019-03-29 Analyte sensor inserter
US16/387,023 Abandoned US20190298240A1 (en) 2010-03-24 2019-04-17 Medical device inserters and processes of inserting and using medical devices
US16/906,811 Active US10772547B1 (en) 2010-03-24 2020-06-19 Medical device inserters and processes of inserting and using medical devices
US17/008,630 Active US10945649B2 (en) 2010-03-24 2020-08-31 Medical device inserters and processes of inserting and using medical devices
US17/017,590 Active US11013440B2 (en) 2010-03-24 2020-09-10 Medical device inserters and processes of inserting and using medical devices
US17/019,110 Active US11266335B2 (en) 2010-03-24 2020-09-11 Medical device inserters and processes of inserting and using medical devices
US17/030,120 Active US10952657B2 (en) 2010-03-24 2020-09-23 Medical device inserters and processes of inserting and using medical devices
US17/030,030 Active US11000216B2 (en) 2010-03-24 2020-09-23 Medical device inserters and processes of inserting and using medical devices
US17/030,053 Active US10881341B1 (en) 2010-03-24 2020-09-23 Medical device inserters and processes of inserting and using medical devices
US17/077,445 Active US10959654B2 (en) 2010-03-24 2020-10-22 Medical device inserters and processes of inserting and using medical devices
US17/138,123 Abandoned US20210204849A1 (en) 2010-03-24 2020-12-30 Medical device inserters and processes of inserting and using medical devices
US17/138,095 Abandoned US20210113126A1 (en) 2010-03-24 2020-12-30 Medical device inserters and processes of inserting and using medical devices
US17/174,958 Active US11246519B2 (en) 2010-03-24 2021-02-12 Medical device inserters and processes of inserting and using medical devices
US17/206,013 Active US11058334B1 (en) 2010-03-24 2021-03-18 Medical device inserters and processes of inserting and using medical devices
US17/211,153 Active US11064922B1 (en) 2010-03-24 2021-03-24 Medical device inserters and processes of inserting and using medical devices
US29/777,141 Active USD987830S1 (en) 2010-03-24 2021-04-02 Analyte sensor inserter
US17/362,529 Pending US20220125358A1 (en) 2010-03-24 2021-06-29 Medical device inserters and processes of inserting and using medical devices
US17/544,536 Pending US20220087580A1 (en) 2010-03-24 2021-12-07 Medical device inserters and processes of inserting and using medical devices
US17/581,691 Pending US20220142533A1 (en) 2010-03-24 2022-01-21 Medical device inserters and processes of inserting and using medical devices
US17/707,515 Abandoned US20220218247A1 (en) 2010-03-24 2022-03-29 Medical device inserters and processes of inserting and using medical devices
US29/843,137 Active USD997362S1 (en) 2010-03-24 2022-06-17 Analyte sensor inserter
US18/087,659 Pending US20230125528A1 (en) 2010-03-24 2022-12-22 Medical device inserters and processes of inserting and using medical devices
US18/372,319 Pending US20240008779A1 (en) 2010-03-24 2023-09-25 Medical device inserters and processes of inserting and using medical devices

Family Applications Before (9)

Application Number Title Priority Date Filing Date
US13/071,487 Active US9265453B2 (en) 2010-03-24 2011-03-24 Medical device inserters and processes of inserting and using medical devices
US13/071,461 Active 2033-03-28 US9215992B2 (en) 2010-03-24 2011-03-24 Medical device inserters and processes of inserting and using medical devices
US13/071,497 Active 2031-07-24 US9186098B2 (en) 2010-03-24 2011-03-24 Medical device inserters and processes of inserting and using medical devices
US13/436,777 Active 2032-03-06 US9687183B2 (en) 2010-03-24 2012-03-30 Medical device inserters and processes of inserting and using medical devices
US13/436,789 Abandoned US20120190942A1 (en) 2010-03-24 2012-03-30 Medical Device Inserters and Processes of Inserting and Using Medical Devices
US13/436,807 Abandoned US20120197098A1 (en) 2010-03-24 2012-03-30 Medical Device Inserters and Processes of Inserting and Using Medical Devices
US13/436,768 Active 2033-03-04 US10010280B2 (en) 2010-03-24 2012-03-30 Medical device inserters and processes of inserting and using medical devices
US13/436,793 Abandoned US20120190943A1 (en) 2010-03-24 2012-03-30 Medical Device Inserters and Processes of Inserting and Using Medical Devices
US13/436,816 Active 2031-04-15 US8764657B2 (en) 2010-03-24 2012-03-30 Medical device inserters and processes of inserting and using medical devices

Family Applications After (26)

Application Number Title Priority Date Filing Date
US14/884,622 Active 2032-04-26 US10292632B2 (en) 2010-03-24 2015-10-15 Medical device inserters and processes of inserting and using medical devices
US14/996,751 Active 2032-06-15 US10881340B2 (en) 2010-03-24 2016-01-15 Medical device inserters and processes of inserting and using medical devices
US16/002,847 Pending US20190076073A1 (en) 2010-03-24 2018-06-07 Medical device inserters and processes of inserting and using medical devices
US29/685,591 Active USD948722S1 (en) 2010-03-24 2019-03-29 Analyte sensor inserter
US16/387,023 Abandoned US20190298240A1 (en) 2010-03-24 2019-04-17 Medical device inserters and processes of inserting and using medical devices
US16/906,811 Active US10772547B1 (en) 2010-03-24 2020-06-19 Medical device inserters and processes of inserting and using medical devices
US17/008,630 Active US10945649B2 (en) 2010-03-24 2020-08-31 Medical device inserters and processes of inserting and using medical devices
US17/017,590 Active US11013440B2 (en) 2010-03-24 2020-09-10 Medical device inserters and processes of inserting and using medical devices
US17/019,110 Active US11266335B2 (en) 2010-03-24 2020-09-11 Medical device inserters and processes of inserting and using medical devices
US17/030,120 Active US10952657B2 (en) 2010-03-24 2020-09-23 Medical device inserters and processes of inserting and using medical devices
US17/030,030 Active US11000216B2 (en) 2010-03-24 2020-09-23 Medical device inserters and processes of inserting and using medical devices
US17/030,053 Active US10881341B1 (en) 2010-03-24 2020-09-23 Medical device inserters and processes of inserting and using medical devices
US17/077,445 Active US10959654B2 (en) 2010-03-24 2020-10-22 Medical device inserters and processes of inserting and using medical devices
US17/138,123 Abandoned US20210204849A1 (en) 2010-03-24 2020-12-30 Medical device inserters and processes of inserting and using medical devices
US17/138,095 Abandoned US20210113126A1 (en) 2010-03-24 2020-12-30 Medical device inserters and processes of inserting and using medical devices
US17/174,958 Active US11246519B2 (en) 2010-03-24 2021-02-12 Medical device inserters and processes of inserting and using medical devices
US17/206,013 Active US11058334B1 (en) 2010-03-24 2021-03-18 Medical device inserters and processes of inserting and using medical devices
US17/211,153 Active US11064922B1 (en) 2010-03-24 2021-03-24 Medical device inserters and processes of inserting and using medical devices
US29/777,141 Active USD987830S1 (en) 2010-03-24 2021-04-02 Analyte sensor inserter
US17/362,529 Pending US20220125358A1 (en) 2010-03-24 2021-06-29 Medical device inserters and processes of inserting and using medical devices
US17/544,536 Pending US20220087580A1 (en) 2010-03-24 2021-12-07 Medical device inserters and processes of inserting and using medical devices
US17/581,691 Pending US20220142533A1 (en) 2010-03-24 2022-01-21 Medical device inserters and processes of inserting and using medical devices
US17/707,515 Abandoned US20220218247A1 (en) 2010-03-24 2022-03-29 Medical device inserters and processes of inserting and using medical devices
US29/843,137 Active USD997362S1 (en) 2010-03-24 2022-06-17 Analyte sensor inserter
US18/087,659 Pending US20230125528A1 (en) 2010-03-24 2022-12-22 Medical device inserters and processes of inserting and using medical devices
US18/372,319 Pending US20240008779A1 (en) 2010-03-24 2023-09-25 Medical device inserters and processes of inserting and using medical devices

Country Status (12)

Country Link
US (36) US9265453B2 (en)
EP (8) EP4248866A3 (en)
JP (4) JP5904500B2 (en)
CN (4) CN102573616B (en)
AU (2) AU2011269796A1 (en)
BR (2) BRPI1105778A2 (en)
CA (8) CA3135001A1 (en)
DK (2) DK3766408T3 (en)
ES (2) ES2924054T3 (en)
IL (3) IL217081A0 (en)
LT (2) LT3622883T (en)
WO (2) WO2011162843A1 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016183493A1 (en) 2015-05-14 2016-11-17 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US9615779B2 (en) 2012-04-04 2017-04-11 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US20170266369A1 (en) * 2016-03-16 2017-09-21 Baxter International Inc. Percutaneous administration device and method for injecting medicinal substances
US20180368772A1 (en) * 2017-06-23 2018-12-27 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US10278732B2 (en) 2015-10-21 2019-05-07 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
USD882432S1 (en) 2009-02-03 2020-04-28 Abbott Diabetes Care Inc. Analyte sensor on body unit
USD902408S1 (en) * 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US10973443B2 (en) 2002-11-05 2021-04-13 Abbott Diabetes Care Inc. Sensor inserter assembly
USD924406S1 (en) * 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
USD926325S1 (en) 2018-06-22 2021-07-27 Dexcom, Inc. Wearable medical monitoring device
US20220080678A1 (en) * 2020-09-15 2022-03-17 Abbott Diabetes Care Inc. Systems, devices, and methods for an analyte sensor
US11296731B2 (en) 2018-03-07 2022-04-05 Phc Holdings Corporation Communication device
US11331019B2 (en) 2017-08-07 2022-05-17 The Research Foundation For The State University Of New York Nanoparticle sensor having a nanofibrous membrane scaffold
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
USD961778S1 (en) 2006-02-28 2022-08-23 Abbott Diabetes Care Inc. Analyte sensor device
USD962446S1 (en) 2009-08-31 2022-08-30 Abbott Diabetes Care, Inc. Analyte sensor device
USD979766S1 (en) 2005-09-30 2023-02-28 Abbott Diabetes Care Inc. Analyte sensor device
USD980986S1 (en) 2015-05-14 2023-03-14 Abbott Diabetes Care Inc. Analyte sensor inserter
USD982762S1 (en) 2020-12-21 2023-04-04 Abbott Diabetes Care Inc. Analyte sensor inserter
USD987830S1 (en) 2010-03-24 2023-05-30 Abbott Diabetes Care Inc. Analyte sensor inserter
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device

Families Citing this family (227)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
ATE380507T1 (en) * 2005-04-08 2007-12-15 Hoffmann La Roche DEVICE FOR PLACING A PROBE IN LIVING TISSUE
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
CA2667639A1 (en) 2006-10-26 2008-05-02 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
EP3533387A3 (en) 2007-06-21 2019-11-13 Abbott Diabetes Care, Inc. Health management devices and methods
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
WO2010095442A1 (en) * 2009-02-18 2010-08-26 パナソニック株式会社 Puncture tool, device for measuring biological sample and system for measuring biological sample
DK3714788T3 (en) * 2009-02-26 2023-04-17 Abbott Diabetes Care Inc Method for manufacturing improved analyte sensors
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
EP3689237B1 (en) 2009-07-23 2021-05-19 Abbott Diabetes Care, Inc. Method of manufacturing and system for continuous analyte measurement
WO2011041531A1 (en) 2009-09-30 2011-04-07 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
EP2335565A1 (en) * 2009-12-18 2011-06-22 Roche Diagnostics GmbH Protective container for holding reusable diagnostic components
US8726266B2 (en) 2010-05-24 2014-05-13 Abbott Diabetes Care Inc. Method and system for updating a medical device
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
JP5748595B2 (en) * 2010-08-30 2015-07-15 アークレイ株式会社 Sensor insertion / recovery device
EP2673023B1 (en) * 2011-02-09 2019-04-03 Becton, Dickinson and Company Subcutaneous infusion device
WO2012108936A1 (en) 2011-02-11 2012-08-16 Abbott Diabetes Care Inc. Data synchronization between two or more analyte detecting devices in a database
WO2012108939A1 (en) 2011-02-11 2012-08-16 Abbott Diabetes Care Inc. Feedback from cloud or hcp to payer or patient via meter or cell phone
WO2012108938A1 (en) 2011-02-11 2012-08-16 Abbott Diabetes Care Inc. Software applications residing on handheld analyte determining devices
CA3177983A1 (en) 2011-02-28 2012-11-15 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US20140295905A1 (en) * 2011-03-18 2014-10-02 Nokia Corporation Switching Cells On And Off On A Need Basis In A Wireless Communications Systems
WO2012142502A2 (en) 2011-04-15 2012-10-18 Dexcom Inc. Advanced analyte sensor calibration and error detection
US9007781B2 (en) 2011-06-17 2015-04-14 Abbott Diabetes Care Inc. Connectors for making connections between analyte sensors and other devices
US9615759B2 (en) * 2011-07-12 2017-04-11 Bard Access Systems, Inc. Devices and methods for ECG guided vascular access
US9949677B2 (en) * 2011-10-21 2018-04-24 Incube Labs, Llc Implantable oximetric measurement apparatus and method of use
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9402570B2 (en) * 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
WO2013137753A1 (en) * 2012-03-15 2013-09-19 Fisher & Paykel Healthcare Limited Respiratory gas humidification system
EP2650031A1 (en) * 2012-04-11 2013-10-16 PharmaSens AG Manual pressure activated application mechanism
GB2572693B (en) 2012-04-27 2020-01-01 Fisher & Paykel Healthcare Ltd Humidification apparatus with a sensor cartridge coupled to a heater base via a spine
US9907967B2 (en) 2012-07-26 2018-03-06 Adi Mashiach Transcutaneous power conveyance device
CA2879955C (en) 2012-07-26 2021-08-10 Adi Mashiach Implant sleep apnea treatment device including an antenna
US9504828B2 (en) 2012-07-26 2016-11-29 Nyxoah SA Electrical contacts on a medical device patch
US9968306B2 (en) * 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
EP2901153A4 (en) 2012-09-26 2016-04-27 Abbott Diabetes Care Inc Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
EP2902056B1 (en) * 2012-09-28 2022-04-27 Terumo Kabushiki Kaisha Puncture device and medical fluid application device
TWI533899B (en) * 2012-11-02 2016-05-21 da-lun Tan A fixed-treating apparatus for the othematoma
US20140188402A1 (en) * 2013-01-03 2014-07-03 Dexcom, Inc. Outlier detection for analyte sensors
JP6366607B2 (en) 2013-01-15 2018-08-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Auxiliary devices attached to medical injection devices to generate usage reports in digital image format for use of injection devices
USD732162S1 (en) * 2013-03-14 2015-06-16 Eli Lilly And Company Automatic injection device
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
EP2967344A4 (en) 2013-03-15 2016-11-23 Abbott Diabetes Care Inc Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
JP6158426B2 (en) * 2013-04-15 2017-07-05 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Biological fluid sampling transfer device and biological fluid separation and inspection system
WO2014179343A1 (en) 2013-04-30 2014-11-06 Abbott Diabetes Care Inc. Systems, devices, and methods for energy efficient electrical device activation
WO2015020895A1 (en) 2013-08-03 2015-02-12 Merit Medical Systems, Inc. Inflation devices with remote displays, methods and kits related thereto
US10046144B2 (en) 2013-08-03 2018-08-14 Merit Medical Systems, Inc. Methods of resetting inflation devices
CN105682718A (en) * 2013-09-30 2016-06-15 麦迪麦珀医疗工程有限公司 Stabilized pen injector
WO2015069563A1 (en) 2013-11-05 2015-05-14 Abbott Diabetes Care Inc. Systems, devices, and methods for control of a power supply connection
CN105792751B (en) 2013-11-27 2019-07-05 雅培糖尿病护理公司 System and method for correcting the programming based on permanent ROM
CN103705217A (en) * 2013-12-20 2014-04-09 深圳中科讯联科技有限公司 Human health monitoring device and method based on radio frequency SIM card
EP3780689A1 (en) 2013-12-27 2021-02-17 Abbott Diabetes Care, Inc. Systems, devices, and methods for authentication in an analyte monitoring environment
CA2934904A1 (en) 2013-12-27 2015-07-02 Abbott Diabetes Care Inc. Application interface and display control in an analyte monitoring environment
CA2933166C (en) 2013-12-31 2020-10-27 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
WO2015122964A1 (en) 2014-02-11 2015-08-20 Dexcom, Inc. Packaging system for analyte sensors
JP6332786B2 (en) * 2014-02-14 2018-05-30 株式会社ライトニックス Medical needle and puncture device
JP6582285B2 (en) * 2014-02-24 2019-10-02 ソニー株式会社 Proximity-based data exchange and user authentication between smart wearable devices
US9610402B2 (en) * 2014-03-24 2017-04-04 Medtronic Minimed, Inc. Transcutaneous conduit insertion mechanism with a living hinge for use with a fluid infusion patch pump device
US20170185748A1 (en) 2014-03-30 2017-06-29 Abbott Diabetes Care Inc. Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems
US10376187B2 (en) * 2014-09-03 2019-08-13 Nova Biomedical Corporation Subcutaneous sensor inserter and method
TWM496457U (en) * 2014-09-11 2015-03-01 Biotest Medical Corp Blood collection device with needle seat guiding structure
WO2016065190A1 (en) 2014-10-23 2016-04-28 Abbott Diabetes Care Inc. Electrodes having at least one sensing structure and methods for making and using the same
US10772556B2 (en) 2014-11-05 2020-09-15 Cláudio Afonso Ambrósio Method and system for monitoring and treating hypoglycemia
AU2015349931B2 (en) 2014-11-19 2020-08-13 Abbott Diabetes Care Inc. Systems, devices, and methods for revising or supplementing ROM-based RF commands
EP3251596B1 (en) 2015-01-27 2020-01-01 Terumo Kabushiki Kaisha Sensor insertion device and sensor insertion device set
US9345833B1 (en) 2015-02-11 2016-05-24 King Saud University Dental instrument
US10251605B2 (en) 2015-02-16 2019-04-09 Verily Life Sciences Llc Bandage type of continuous glucose monitoring system
CA2977683C (en) 2015-03-04 2023-06-13 Merit Medical Systems, Inc. Pull tab assemblies and related methods
CN107205702B (en) * 2015-03-11 2020-05-01 泰尔茂株式会社 Sensor insertion device and replacement member
US10874335B2 (en) * 2015-03-25 2020-12-29 Samsung Electronics Co., Ltd Wearable electronic device
EP3297708B1 (en) * 2015-05-22 2022-02-23 DexCom, Inc. Needle for transcutaneous analyte sensor delivery
EP3097933B1 (en) 2015-05-26 2019-09-04 Roche Diabetes Care GmbH Cartridge and inserter for a medical system
US10292630B2 (en) 2015-06-01 2019-05-21 Verily Life Sciences Llc Optical sensor for bandage type monitoring device
USD794800S1 (en) * 2015-07-09 2017-08-15 Dexcom, Inc. Medical device inserter
USD878575S1 (en) * 2015-11-24 2020-03-17 Visionisti Oy Hand operated medical instrument
WO2017116915A1 (en) * 2015-12-30 2017-07-06 Dexcom, Inc. Transcutaneous analyte sensor systems and methods
ES2899901T3 (en) * 2016-01-25 2022-03-15 Hoffmann La Roche Medical device and process for its manufacture
JP6921760B2 (en) 2016-01-29 2021-08-18 テルモ株式会社 Biometric information detector
DK3199121T3 (en) * 2016-01-29 2018-12-10 Hoffmann La Roche FUNCTIONAL MEDICAL PACKAGING AND MEDICAL DEVICE FOR INSTALLING AT LEAST ONE SUB-SYSTEM IN A HOST
DE202016009190U1 (en) 2016-02-05 2023-08-23 Roche Diabetes Care Gmbh Medical device for detecting at least one analyte in a body fluid
ES2903121T3 (en) * 2016-02-05 2022-03-31 Hoffmann La Roche Medical device for detecting at least one analyte in a body fluid
EP3909506B1 (en) * 2016-02-05 2023-06-07 Roche Diabetes Care GmbH Medical device for detecting at least one analyte in a body fluid
DE202016009188U1 (en) 2016-02-05 2023-08-30 Roche Diabetes Care Gmbh Medical device for detecting at least one analyte in a body fluid
DE202016009189U1 (en) 2016-02-05 2023-08-25 Roche Diabetes Care Gmbh Medical device for detecting at least one analyte in a body fluid
EP3207870A1 (en) 2016-02-16 2017-08-23 Roche Diabetes Care GmbH Body-mountable device, medical sensor assembly and method of use
CA3018351C (en) 2016-03-29 2024-02-13 F. Hoffmann-La Roche Ag Method of operating a receiver for receiving analyte data, receiver and computer program product
US10118696B1 (en) 2016-03-31 2018-11-06 Steven M. Hoffberg Steerable rotating projectile
US20170290535A1 (en) * 2016-04-08 2017-10-12 Medtronic Minimed, Inc. Analyte sensor with indicators
CN109310857B (en) * 2016-06-10 2021-10-22 费森尤斯卡比德国有限公司 Intubation device
CN106236140B (en) * 2016-08-25 2019-11-08 成都优途科技有限公司 A kind of ultrasonic imaging method, apparatus and system
WO2018057236A1 (en) 2016-09-21 2018-03-29 Verily Life Sciences Llc Systems and methods for activating a circuit of an implant device
KR101863451B1 (en) * 2016-10-07 2018-06-11 조효진 Disposable apparatus for injecting insulin
US20180172664A1 (en) * 2016-12-20 2018-06-21 Abbott Diabetes Care Inc. Systems, devices, and methods for wireless communications in analyte monitoring systems
WO2018136898A1 (en) * 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
WO2018152146A1 (en) * 2017-02-14 2018-08-23 Verily Life Sciences Llc Needle alignment for wearable biosensors
WO2018156584A1 (en) 2017-02-21 2018-08-30 Abbott Diabetes Care Inc. Methods, devices, and systems for physiological parameter analysis
WO2018160591A1 (en) * 2017-03-02 2018-09-07 Abbott Diabetes Care Inc. Systems, devices, and methods utilizing secondary communication systems
JP2020517333A (en) * 2017-04-19 2020-06-18 メトロノーム・ヘルス、インコーポレイテッド Sample sensor inserter
WO2018204476A1 (en) 2017-05-03 2018-11-08 Abbott Diabetes Care Inc. Systems, devices, and methods with duration-based adjustment of sensor data
WO2018206552A1 (en) * 2017-05-09 2018-11-15 Ascensia Diabetes Care Holdings Ag Sensor assembly apparatus and methods for continuous glucose monitors
CN107015000B (en) * 2017-05-27 2018-10-12 北京怡唐生物科技有限公司 Dynamic continuous blood sugar monitors the disposable monitoring device of system
CN110869072B (en) 2017-05-30 2021-12-10 西部制药服务有限公司(以色列) Modular drive mechanism for a wearable injector
WO2018222016A1 (en) * 2017-06-02 2018-12-06 주식회사 아이센스 Sensor applicator assembly for continuous glucose monitoring system
WO2018222011A1 (en) * 2017-06-02 2018-12-06 주식회사 아이센스 Sensor applicator assembly for continuous glucose monitoring system
WO2018222014A1 (en) * 2017-06-02 2018-12-06 주식회사 아이센스 Sensor applicator assembly for continuous glucose monitoring system
US11179107B2 (en) * 2017-06-02 2021-11-23 I-Sens, Inc. Sensor applicator assembly for continuous glucose monitoring system
WO2018222015A1 (en) * 2017-06-02 2018-12-06 주식회사 아이센스 Sensor applicator assembly for continuous glucose monitoring system
WO2018222009A1 (en) * 2017-06-02 2018-12-06 주식회사 아이센스 Sensor applicator assembly for continuous glucose monitoring system
WO2018222010A1 (en) * 2017-06-02 2018-12-06 주식회사 아이센스 Sensor applicator assembly for continuous glucose monitoring system
WO2018222013A1 (en) * 2017-06-02 2018-12-06 주식회사 아이센스 Sensor applicator assembly for continuous glucose monitoring system
WO2018222012A1 (en) * 2017-06-02 2018-12-06 주식회사 아이센스 Sensor applicator assembly for continuous glucose monitoring system
US11452466B2 (en) 2017-06-19 2022-09-27 Dexcom, Inc. Applicators for applying transcutaneous analyte sensors and associated methods of manufacture
WO2019006140A1 (en) 2017-06-29 2019-01-03 Abbott Diabetes Care Inc. Systems, devices, and methods for establishing and/or maintaining synchronization between entities in an analyte monitoring environment
US20190015827A1 (en) 2017-07-17 2019-01-17 Tasso, Inc. Apparatus, Systems And Methods For Preparing And Shipping Samples
WO2019054113A1 (en) * 2017-09-14 2019-03-21 テルモ株式会社 Insertion device and detection device
WO2019112895A1 (en) 2017-12-05 2019-06-13 Abbott Diabetes Care Inc. Guard rings for on-body analyte sensors
DE202018006862U1 (en) * 2017-12-21 2023-11-16 Roche Diabetes Care Gmbh Medical system
JP2019115400A (en) * 2017-12-26 2019-07-18 テルモ株式会社 Biological information detection device and base member
US11073838B2 (en) 2018-01-06 2021-07-27 Drivent Llc Self-driving vehicle systems and methods
US10299216B1 (en) * 2018-01-06 2019-05-21 Eric John Wengreen Self-driving vehicle actions in response to a low battery
DE102018101283A1 (en) * 2018-01-22 2019-07-25 Eyesense Gmbh Injector for transcutaneously introducing a sensor into a patient
DE102018101275A1 (en) * 2018-01-22 2019-07-25 Eyesense Gmbh Injector for transcutaneously introducing a sensor into a patient
CA3089356A1 (en) 2018-02-05 2019-08-08 Abbott Diabetes Care Inc. Systems, devices, and methods for power-efficient wireless communications between electronic devices
US11291389B2 (en) 2018-03-13 2022-04-05 Phc Holdings Corporation Sensor insertion device
US11712637B1 (en) 2018-03-23 2023-08-01 Steven M. Hoffberg Steerable disk or ball
WO2019181199A1 (en) * 2018-03-23 2019-09-26 Phcホールディングス株式会社 Sensor insertion device
US11439796B2 (en) 2018-04-26 2022-09-13 Merit Medical Systems, Inc. Inflation devices with proximity pairing and methods and systems related thereto
US20210236028A1 (en) 2018-05-17 2021-08-05 Abbott Diabetes Care Inc. Analyte sensor antimicrobial configurations and adhesives
AU2019280846A1 (en) * 2018-06-07 2021-01-14 Abbott Diabetes Care Inc. Focused sterilization and sterilized sub-assemblies for analyte monitoring systems
EP3801253B1 (en) * 2018-06-07 2023-05-10 Abbott Diabetes Care Inc. Analyte monitoring systems
USD888252S1 (en) 2018-06-18 2020-06-23 Dexcom, Inc. Transcutaneous analyte sensor applicator
KR102200136B1 (en) * 2018-07-31 2021-01-11 주식회사 아이센스 Continuous glucose monitoring system
WO2020027421A1 (en) * 2018-07-31 2020-02-06 주식회사 아이센스 Continuous blood glucose measurement body attachment unit
KR102222045B1 (en) * 2018-07-31 2021-03-04 주식회사 아이센스 Continuous glucose monitoring system
KR102197578B1 (en) * 2018-07-31 2021-01-05 주식회사 아이센스 Sensor unit for continuous glucose monitoring system
WO2020027420A1 (en) * 2018-07-31 2020-02-06 주식회사 아이센스 Continuous glucose monitoring device
KR102200137B1 (en) * 2018-07-31 2021-01-11 주식회사 아이센스 Sensor unit for continuous glucose monitoring system
WO2020027422A1 (en) * 2018-07-31 2020-02-06 주식회사 아이센스 Continuous blood glucose measurement body attachment unit
KR102185833B1 (en) * 2018-07-31 2020-12-03 주식회사 아이센스 Continuous glucose monitoring system
KR102200138B1 (en) * 2018-07-31 2021-01-11 주식회사 아이센스 Continuous glucose monitoring system
WO2020041571A1 (en) 2018-08-23 2020-02-27 Abbott Diabetes Care Inc. Needle assemblies containing oriented acupuncture needles and methods for production thereof
CN112601492A (en) 2018-09-05 2021-04-02 普和希控股公司 Biological information measurement device, biological information measurement system, and plug-in
KR102200142B1 (en) * 2018-09-27 2021-01-11 주식회사 아이센스 Sensor unit for continuous glucose monitoring system
KR102200141B1 (en) * 2018-09-27 2021-01-11 주식회사 아이센스 Sensor unit for continuous glucose monitoring system
US11644833B2 (en) 2018-10-01 2023-05-09 Drivent Llc Self-driving vehicle systems and methods
US11221622B2 (en) 2019-03-21 2022-01-11 Drivent Llc Self-driving vehicle systems and methods
CN109938707A (en) * 2018-10-16 2019-06-28 陕西医链区块链集团有限公司 A kind of intelligent chip that can be implanted into human body monitoring life and health safety
EP3870050A2 (en) 2018-10-26 2021-09-01 Abbott Diabetes Care Inc. Methods, devices, and systems for physiological parameter analysis
JP2022507378A (en) * 2018-11-13 2022-01-18 タッソ インコーポレイテッド Body fluid collection devices including electronic devices and related systems and methods
US10940554B2 (en) * 2018-11-30 2021-03-09 International Business Machines Corporation Planar fabrication of micro-needles
WO2020131406A1 (en) 2018-12-19 2020-06-25 Abbott Diabetes Care Inc. Systems, devices, and methods for rf detection of analyte sensor measurements
EP3927394A1 (en) 2019-02-22 2021-12-29 DEKA Products Limited Partnership Infusion set and inserter assembly systems and methods
CN113347925A (en) * 2019-03-20 2021-09-03 普和希控股公司 Sensor insertion device
EP3955804A4 (en) 2019-04-18 2022-11-23 Abbott Diabetes Care Inc. Systems, devices, and methods for handling wireless communications in an analyte monitoring environment
US11317867B2 (en) 2019-04-23 2022-05-03 Medtronic Minimed, Inc. Flexible physiological characteristic sensor assembly
US11224361B2 (en) * 2019-04-23 2022-01-18 Medtronic Minimed, Inc. Flexible physiological characteristic sensor assembly
KR102237092B1 (en) * 2019-04-30 2021-04-13 주식회사 아이센스 Applicator for continuous glucose monitoring system
JP2022538964A (en) * 2019-05-14 2022-09-07 サンヴィタ メディカル コーポレーション Subcutaneous analyte sensor applicator and continuous measurement system
IT201900008208A1 (en) * 2019-06-06 2020-12-06 Emtesys S R L System and method for telediabetology applications
CN110338888A (en) * 2019-07-18 2019-10-18 浙江荷清柔性电子技术有限公司 It is implanted into applicator
KR102532761B1 (en) * 2019-08-02 2023-05-16 바이오나임 코포레이션 Method for Reducing Measurement Interference of Micro Biosensor
CA3088622C (en) * 2019-08-02 2023-01-03 Chun-Mu Huang Insertion device for a biosensor and insertion method thereof
EP3771408A1 (en) 2019-08-02 2021-02-03 Bionime Corporation Physiological signal monitoring system for fast assembly
TWI735138B (en) * 2019-08-02 2021-08-01 華廣生技股份有限公司 Physiological signal sensing device
US11896804B2 (en) 2019-08-02 2024-02-13 Bionime Corporation Insertion device for a biosensor and insertion method thereof
US11678846B2 (en) 2019-08-02 2023-06-20 Bionime Corporation Insertion device for a biosensor
CA3104716C (en) * 2019-08-02 2023-07-18 Bionime Corporation Physiological signal monitoring device
KR20210016297A (en) * 2019-08-02 2021-02-15 바이오나임 코포레이션 Physiological signal monitoring device
KR102238431B1 (en) * 2019-08-07 2021-04-12 주식회사 아이센스 Insert needle for continuous glucose monitoring system
KR102238432B1 (en) * 2019-08-07 2021-04-12 주식회사 아이센스 Manufacturing method of insert needle for continuous glucose monitoring system
US11602373B2 (en) 2019-08-20 2023-03-14 Ascensia Diabetes Care Holdings Ag Biosensor inserter apparatus and methods
US11707297B2 (en) 2019-08-20 2023-07-25 Ascensia Diabetes Care Holdings Ag Continuous analyte monitor inserter apparatus and methods
CN110946591B (en) * 2019-08-31 2023-06-02 深圳硅基传感科技有限公司 Push device for medical instrument
CN110946590B (en) * 2019-08-31 2022-07-15 深圳硅基传感科技有限公司 Pushing device for medical instrument
EP4025128A4 (en) * 2019-09-03 2023-04-12 Metronom Health, Inc. Analyte sensor applicator
EP4066254A1 (en) 2019-11-25 2022-10-05 Abbott Diabetes Care Inc. Methods, devices, and systems for physiological parameter analysis
AU2020391167A1 (en) 2019-11-25 2022-05-26 Abbott Diabetes Care Inc. Methods, devices, and systems for adjusting laboratory HbA1c values
EP3861934A1 (en) * 2020-02-05 2021-08-11 PKvitality Analyte measurement device comprinsing an adhesive patch
US20230068002A1 (en) * 2020-02-20 2023-03-02 Medtrum Technologies Inc. Highly integrated analyte detection device
KR102331552B1 (en) * 2020-03-03 2021-11-29 주식회사 아이센스 Continuous glucose monitoring system
DE102020110691A1 (en) * 2020-04-20 2021-10-21 KROMA INTERNATIONAL GmbH Method of manufacturing a device for treating a surface
US20210378560A1 (en) * 2020-06-04 2021-12-09 Medtronic Minimed, Inc. Physiological characteristic sensor system
EP4161384A1 (en) 2020-06-08 2023-04-12 Abbott Diabetes Care Inc. Systems, devices, and methods for improved analyte sensor accuracy and fault detection
WO2022011167A1 (en) 2020-07-10 2022-01-13 Abbott Diabetes Care Inc. Systems and methods for background signal reduction in biosensors
USD948723S1 (en) * 2020-08-27 2022-04-12 Medtrum Technologies Inc. Installer for body fluid analyte detection device
CA3187113A1 (en) * 2020-08-31 2022-03-03 Vivek S. RAO Systems, devices, and methods for analyte sensor applicators
US20220071528A1 (en) * 2020-09-07 2022-03-10 Ascensia Diabetes Care Holdings Ag Methods and apparatus enabling coupling of an electronics unit to a base unit of a continuous analyte monitoring device
CA3197412A1 (en) 2020-12-10 2022-06-16 Yi Wang Systems, devices, and methods for analyte sensor insertion
EP4280953A1 (en) 2021-01-21 2023-11-29 Ascensia Diabetes Care Holdings AG Biosensor inserters and methods with reduced medical waste
AU2022212954A1 (en) * 2021-01-26 2023-08-10 Abbott Diabetes Care Inc. Systems, devices, and methods related to ketone sensors
EP4288970A1 (en) 2021-02-03 2023-12-13 Abbott Diabetes Care Inc. Systems, devices, and methods relating to medication dose guidance
KR102557857B1 (en) * 2021-03-04 2023-07-24 주식회사 아이센스 Applicator for continuous glucose monitoring system
CN113082362B (en) * 2021-03-26 2022-09-20 普昂(杭州)健康管理有限公司 Split type subcutaneous soft needle and puncture method
USD985774S1 (en) * 2021-03-30 2023-05-09 Ascensia Diabetes Care Holdings Ag Aanalyte monitoring device
EP4327330A1 (en) 2021-04-21 2024-02-28 Abbott Diabetes Care Inc. Systems and methods for diabetes management
KR102592776B1 (en) * 2021-06-29 2023-10-25 주식회사 아이센스 Needle for transcutaneous sensor insertion and needle assembly having the same
CA3222449A1 (en) 2021-07-16 2023-01-19 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte monitoring
WO2023006437A1 (en) * 2021-07-27 2023-02-02 Uneeg Medical A/S Retaining device for retaining a wearable monitoring device
KR102614603B1 (en) * 2021-09-01 2023-12-19 주식회사 아이센스 Protective sheet for on-body type device and on-body type device having the same
WO2023044893A1 (en) * 2021-09-27 2023-03-30 Medtrum Technologies Inc. Installation unit of analyte detection device
WO2023044888A1 (en) * 2021-09-27 2023-03-30 Medtrum Technologies Inc. Installation unit of analyte detection device
WO2023044890A1 (en) * 2021-09-27 2023-03-30 Medtrum Technologies Inc. Installation unit of analyte detection device
US11672965B2 (en) 2021-09-28 2023-06-13 Biolinq Incorporated Microneedle enclosure and applicator device for microneedle array based continuous analyte monitoring device
US20230215521A1 (en) 2021-11-05 2023-07-06 Abbott Diabetes Care Inc. Methods, devices, and systems for adjusting laboratory hba1c values
CN116195994A (en) * 2021-11-30 2023-06-02 上海微创生命科技有限公司 Sterilization box assembly, implanter and implantation system
WO2023133468A1 (en) * 2022-01-05 2023-07-13 Biolinq Incorporated Wearable analyte monitoring device
KR20230108828A (en) * 2022-01-12 2023-07-19 주식회사 아이센스 Applicator for medical device and applicator assembly
WO2023163957A1 (en) * 2022-02-22 2023-08-31 Metronom Health, Inc. Analyte sensor applicator
EP4248860A1 (en) * 2022-03-24 2023-09-27 Roche Diabetes Care GmbH Insertion device, insertion system and method for inserting a medical device
WO2023180351A1 (en) * 2022-03-24 2023-09-28 F. Hoffmann-La Roche Ag Insertion device, insertion system and method for inserting a medical device
WO2023244064A1 (en) * 2022-06-17 2023-12-21 에스디바이오센서 주식회사 Insertion apparatus for analyte monitoring apparatus
WO2024025942A1 (en) 2022-07-27 2024-02-01 Abbott Diabetes Care Inc. Systems and methods for diabetes management

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100040A1 (en) * 1997-12-05 2003-05-29 Therasense Inc. Blood analyte monitoring through subcutaneous measurement
US20060222866A1 (en) * 2003-02-26 2006-10-05 Tsuyoshi Nakamura Silsesquioxane resin, positive resist composition,layered product including resist and method of forming resist pattern
US20080114280A1 (en) * 2006-10-23 2008-05-15 Gary Ashley Stafford Variable speed sensor insertion devices and methods of use
US20110021889A1 (en) * 2009-07-23 2011-01-27 Abbott Diabetes Care Inc. Continuous Analyte Measurement Systems and Systems and Methods for Implanting Them
WO2011119898A1 (en) * 2010-03-24 2011-09-29 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US20130267811A1 (en) * 2012-04-04 2013-10-10 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods

Family Cites Families (983)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2008A (en) 1841-03-18 Gas-lamp eok conducting gas pkom ah elevated buhner to one below it
US3123790A (en) 1964-03-03 tyler
US3260656A (en) 1962-09-27 1966-07-12 Corning Glass Works Method and apparatus for electrolytically determining a species in a fluid
US3517670A (en) * 1967-11-09 1970-06-30 Propper Mfg Co Inc Blood-letting lancet
GB1191363A (en) 1968-02-19 1970-05-13 Pavelle Ltd Improvements in or relating to Electronic Thermostats.
US3522807A (en) 1968-10-02 1970-08-04 Bluma Millenbach Fecal receptacle
US3653841A (en) 1969-12-19 1972-04-04 Hoffmann La Roche Methods and compositions for determining glucose in blood
US3670727A (en) 1970-04-16 1972-06-20 American Hospital Supply Corp Medical infusion set
US3776832A (en) 1970-11-10 1973-12-04 Energetics Science Electrochemical detection cell
US3719564A (en) 1971-05-10 1973-03-06 Philip Morris Inc Method of determining a reducible gas concentration and sensor therefor
US3837339A (en) 1972-02-03 1974-09-24 Whittaker Corp Blood glucose level monitoring-alarm system and method therefor
US3949388A (en) 1972-11-13 1976-04-06 Monitron Industries, Inc. Physiological sensor and transmitter
US3908657A (en) 1973-01-15 1975-09-30 Univ Johns Hopkins System for continuous withdrawal of blood
US4100048A (en) 1973-09-20 1978-07-11 U.S. Philips Corporation Polarographic cell
US3926760A (en) 1973-09-28 1975-12-16 Du Pont Process for electrophoretic deposition of polymer
US3972320A (en) 1974-08-12 1976-08-03 Gabor Ujhelyi Kalman Patient monitoring system
US4245634A (en) 1975-01-22 1981-01-20 Hospital For Sick Children Artificial beta cell
US4036749A (en) 1975-04-30 1977-07-19 Anderson Donald R Purification of saline water
US3979274A (en) 1975-09-24 1976-09-07 The Yellow Springs Instrument Company, Inc. Membrane for enzyme electrodes
DE2645048A1 (en) 1975-10-08 1977-04-21 Gen Electric PLANTABLE ELECTROCHEMICAL SENSOR
US4016866A (en) 1975-12-18 1977-04-12 General Electric Company Implantable electrochemical sensor
US4055175A (en) 1976-05-07 1977-10-25 Miles Laboratories, Inc. Blood glucose control apparatus
DE2625834B2 (en) 1976-06-09 1978-10-12 Boehringer Mannheim Gmbh, 6800 Mannheim Method for the determination of substrates or enzyme activities
US4059406A (en) 1976-07-12 1977-11-22 E D T Supplies Limited Electrochemical detector system
US4076596A (en) 1976-10-07 1978-02-28 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
US4129128A (en) 1977-02-23 1978-12-12 Mcfarlane Richard H Securing device for catheter placement assembly
FR2387659A1 (en) 1977-04-21 1978-11-17 Armines GLYCEMIA CONTROL AND REGULATION DEVICE
US4098574A (en) 1977-08-01 1978-07-04 Eastman Kodak Company Glucose detection system free from fluoride-ion interference
US4178916A (en) 1977-09-26 1979-12-18 Mcnamara Elger W Diabetic insulin alarm system
JPS5912135B2 (en) 1977-09-28 1984-03-21 松下電器産業株式会社 enzyme electrode
US4151845A (en) 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
DK151000C (en) 1978-02-17 1988-06-13 Radiometer As PROCEDURE AND APPARATUS FOR DETERMINING A PATIENT'S IN VIVO PLASMA-PH VALUE
FR2420331A1 (en) 1978-03-23 1979-10-19 Claude Bernard COMBINED MEASURING HEAD, INTENDED TO BE PLACED ON OR IN BODY PARTS, ALLOWING THE SIMULTANEOUS OBTAINING OF MEASUREMENT SIGNALS RELATING TO AN ELECTRICAL ACTIVITY ON THE ONE HAND AND AN IONIC ACTIVITY ON THE OTHER HAND
US4172770A (en) 1978-03-27 1979-10-30 Technicon Instruments Corporation Flow-through electrochemical system analytical method
DE2817363C2 (en) 1978-04-20 1984-01-26 Siemens AG, 1000 Berlin und 8000 München Method for determining the concentration of sugar and a suitable electrocatalytic sugar sensor
US4344438A (en) 1978-08-02 1982-08-17 The United States Of America As Represented By The Department Of Health, Education And Welfare Optical sensor of plasma constituents
HU177369B (en) 1978-09-08 1981-09-28 Radelkis Electrokemiai Industrial molecule-selective sensing device and method for producing same
US4240438A (en) 1978-10-02 1980-12-23 Wisconsin Alumni Research Foundation Method for monitoring blood glucose levels and elements
AU530979B2 (en) 1978-12-07 1983-08-04 Aus. Training Aids Pty. Ltd., Detecting position of bullet fired at target
US4247297A (en) 1979-02-23 1981-01-27 Miles Laboratories, Inc. Test means and method for interference resistant determination of oxidizing substances
US4573994A (en) 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4373527B1 (en) 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4365637A (en) 1979-07-05 1982-12-28 Dia-Med, Inc. Perspiration indicating alarm for diabetics
US4401122A (en) 1979-08-02 1983-08-30 Children's Hospital Medical Center Cutaneous methods of measuring body substances
US4458686A (en) 1979-08-02 1984-07-10 Children's Hospital Medical Center Cutaneous methods of measuring body substances
GB2067764B (en) 1980-01-09 1984-01-25 Nat Res Dev Transcutaneous gas sensor
US4450842A (en) 1980-04-25 1984-05-29 Cordis Corporation Solid state reference electrode
US4340458A (en) 1980-06-02 1982-07-20 Joslin Diabetes Center, Inc. Glucose sensor
US4356074A (en) 1980-08-25 1982-10-26 The Yellow Springs Instrument Company, Inc. Substrate specific galactose oxidase enzyme electrodes
US4404066A (en) 1980-08-25 1983-09-13 The Yellow Springs Instrument Company Method for quantitatively determining a particular substrate catalyzed by a multisubstrate enzyme
US4352960A (en) 1980-09-30 1982-10-05 Baptist Medical Center Of Oklahoma, Inc. Magnetic transcutaneous mount for external device of an associated implant
USRE32947E (en) 1980-09-30 1989-06-13 Baptist Medical Center Of Oklahoma, Inc. Magnetic transcutaneous mount for external device of an associated implant
US4425920A (en) 1980-10-24 1984-01-17 Purdue Research Foundation Apparatus and method for measurement and control of blood pressure
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4390621A (en) 1980-12-15 1983-06-28 Miles Laboratories, Inc. Method and device for detecting glucose concentration
US4436094A (en) 1981-03-09 1984-03-13 Evreka, Inc. Monitor for continuous in vivo measurement of glucose concentration
AT369254B (en) 1981-05-07 1982-12-27 Otto Dipl Ing Dr Tech Prohaska MEDICAL PROBE
FR2508305B1 (en) 1981-06-25 1986-04-11 Slama Gerard DEVICE FOR CAUSING A LITTLE BITE TO COLLECT A BLOOD DROP
US4440175A (en) 1981-08-10 1984-04-03 University Patents, Inc. Membrane electrode for non-ionic species
DE3138194A1 (en) 1981-09-25 1983-04-14 Basf Ag, 6700 Ludwigshafen WATER-INSOLUBLE POROESES PROTEIN MATERIAL, THEIR PRODUCTION AND USE
DE3278334D1 (en) 1981-10-23 1988-05-19 Genetics Int Inc Sensor for components of a liquid mixture
US4431004A (en) 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4418148A (en) 1981-11-05 1983-11-29 Miles Laboratories, Inc. Multilayer enzyme electrode membrane
US4494950A (en) 1982-01-19 1985-01-22 The Johns Hopkins University Plural module medication delivery system
JPS58153154A (en) 1982-03-09 1983-09-12 Ajinomoto Co Inc Qualified electrode
US4581336A (en) 1982-04-26 1986-04-08 Uop Inc. Surface-modified electrodes
FI831399L (en) 1982-04-29 1983-10-30 Agripat Sa KONTAKTLINS AV HAERDAD POLYVINYL ALCOHOL
DE3221339A1 (en) 1982-06-05 1983-12-08 Basf Ag, 6700 Ludwigshafen METHOD FOR THE ELECTROCHEMICAL HYDRATION OF NICOTINAMIDADENINE-DINUCLEOTIDE
US4427770A (en) 1982-06-14 1984-01-24 Miles Laboratories, Inc. High glucose-determining analytical element
US4509531A (en) 1982-07-28 1985-04-09 Teledyne Industries, Inc. Personal physiological monitor
DE3228551A1 (en) 1982-07-30 1984-02-02 Siemens AG, 1000 Berlin und 8000 München METHOD FOR DETERMINING SUGAR CONCENTRATION
US4534356A (en) 1982-07-30 1985-08-13 Diamond Shamrock Chemicals Company Solid state transcutaneous blood gas sensors
US4571292A (en) 1982-08-12 1986-02-18 Case Western Reserve University Apparatus for electrochemical measurements
US4552840A (en) 1982-12-02 1985-11-12 California And Hawaiian Sugar Company Enzyme electrode and method for dextran analysis
US4527240A (en) 1982-12-29 1985-07-02 Kvitash Vadim I Balascopy method for detecting and rapidly evaluating multiple imbalances within multi-parametric systems
JPS59138086A (en) 1983-01-25 1984-08-08 シャープ株式会社 Substrate connecting method
US4461691A (en) 1983-02-10 1984-07-24 The United States Of America As Represented By The United States Department Of Energy Organic conductive films for semiconductor electrodes
US4679562A (en) 1983-02-16 1987-07-14 Cardiac Pacemakers, Inc. Glucose sensor
IT1170375B (en) 1983-04-19 1987-06-03 Giuseppe Bombardieri Implantable device for measuring body fluid parameters
US5682884A (en) 1983-05-05 1997-11-04 Medisense, Inc. Strip electrode with screen printing
US5509410A (en) 1983-06-06 1996-04-23 Medisense, Inc. Strip electrode including screen printing of a single layer
CA1219040A (en) 1983-05-05 1987-03-10 Elliot V. Plotkin Measurement of enzyme-catalysed reactions
CA1218704A (en) 1983-05-05 1987-03-03 Graham Davis Assay systems using more than one enzyme
US4484987A (en) 1983-05-19 1984-11-27 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4650547A (en) 1983-05-19 1987-03-17 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4675346A (en) 1983-06-20 1987-06-23 Loctite Corporation UV curable silicone rubber compositions
US4524114A (en) 1983-07-05 1985-06-18 Allied Corporation Bifunctional air electrode
US4538616A (en) 1983-07-25 1985-09-03 Robert Rogoff Blood sugar level sensing and monitoring transducer
US4543955A (en) 1983-08-01 1985-10-01 Cordis Corporation System for controlling body implantable action device
US4655880A (en) 1983-08-01 1987-04-07 Case Western Reserve University Apparatus and method for sensing species, substances and substrates using oxidase
SE8305704D0 (en) 1983-10-18 1983-10-18 Leo Ab Cuvette
US4560534A (en) 1983-11-02 1985-12-24 Miles Laboratories, Inc. Polymer catalyst transducers
US4522690A (en) 1983-12-01 1985-06-11 Honeywell Inc. Electrochemical sensing of carbon monoxide
US6017335A (en) 1983-12-12 2000-01-25 Burnham; Warren R. Method for making a tubular product, especially a catheter, and article made thereby
WO1985002627A1 (en) 1983-12-16 1985-06-20 Genetics International, Inc. Assay for nucleic acids
DE3571456D1 (en) 1984-04-30 1989-08-17 Stiftung R E Process for the sensitization of an oxidoreduction photocalatyst, and photocatalyst thus obtained
US5141868A (en) 1984-06-13 1992-08-25 Internationale Octrooi Maatschappij "Octropa" Bv Device for use in chemical test procedures
DK8601218A (en) 1984-07-18 1986-03-17
DE3429596A1 (en) 1984-08-10 1986-02-20 Siemens AG, 1000 Berlin und 8000 München DEVICE FOR THE PHYSIOLOGICAL FREQUENCY CONTROL OF A PACEMAKER PROVIDED WITH A PICTURE ELECTRODE
US4820399A (en) 1984-08-31 1989-04-11 Shimadzu Corporation Enzyme electrodes
CA1254091A (en) 1984-09-28 1989-05-16 Vladimir Feingold Implantable medication infusion system
JPS61111428A (en) 1984-11-06 1986-05-29 Terumo Corp Electronic clinical thermometer
US4690675A (en) 1984-11-19 1987-09-01 William Katz Intravenous needle assembly
US4627842A (en) 1984-11-19 1986-12-09 William Katz Intravenous needle assembly
US4721601A (en) 1984-11-23 1988-01-26 Massachusetts Institute Of Technology Molecule-based microelectronic devices
US4717673A (en) 1984-11-23 1988-01-05 Massachusetts Institute Of Technology Microelectrochemical devices
JPH0617889B2 (en) 1984-11-27 1994-03-09 株式会社日立製作所 Biochemical sensor
EP0186210B1 (en) 1984-12-28 1992-04-22 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Ion sensor
GB8500729D0 (en) 1985-01-11 1985-02-13 Hill H A O Surface-modified electrode
DE3502913C1 (en) 1985-01-29 1986-07-03 Günter Prof. Dr.rer.nat. 5100 Aachen Rau Sensor for non-invasive detection of electrophysiological values
AU5481786A (en) 1985-03-20 1986-09-25 Hochmair, E.S. Transcutaneous power and signal transmission system
US4627445A (en) * 1985-04-08 1986-12-09 Garid, Inc. Glucose medical monitoring system
US5279294A (en) 1985-04-08 1994-01-18 Cascade Medical, Inc. Medical diagnostic system
US4781798A (en) 1985-04-19 1988-11-01 The Regents Of The University Of California Transparent multi-oxygen sensor array and method of using same
US4671288A (en) 1985-06-13 1987-06-09 The Regents Of The University Of California Electrochemical cell sensor for continuous short-term use in tissues and blood
DE3687646T3 (en) 1985-06-21 2001-05-31 Matsushita Electric Ind Co Ltd BIOSENSOR AND THEIR PRODUCTION.
US4938860A (en) 1985-06-28 1990-07-03 Miles Inc. Electrode for electrochemical sensors
US4796634A (en) 1985-08-09 1989-01-10 Lawrence Medical Systems, Inc. Methods and apparatus for monitoring cardiac output
US4805624A (en) 1985-09-09 1989-02-21 The Montefiore Hospital Association Of Western Pa Low-potential electrochemical redox sensors
US4680268A (en) 1985-09-18 1987-07-14 Children's Hospital Medical Center Implantable gas-containing biosensor and method for measuring an analyte such as glucose
US4890620A (en) 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4627908A (en) 1985-10-24 1986-12-09 Chevron Research Company Process for stabilizing lube base stocks derived from bright stock
US4830959A (en) 1985-11-11 1989-05-16 Medisense, Inc. Electrochemical enzymic assay procedures
GB8529300D0 (en) 1985-11-28 1986-01-02 Ici Plc Membrane
US4755173A (en) 1986-02-25 1988-07-05 Pacesetter Infusion, Ltd. Soft cannula subcutaneous injection set
US4776944A (en) 1986-03-20 1988-10-11 Jiri Janata Chemical selective sensors utilizing admittance modulated membranes
US4685463A (en) 1986-04-03 1987-08-11 Williams R Bruce Device for continuous in vivo measurement of blood glucose concentrations
US4726378A (en) 1986-04-11 1988-02-23 Minnesota Mining And Manufacturing Company Adjustable magnetic supercutaneous device and transcutaneous coupling apparatus
US4757022A (en) 1986-04-15 1988-07-12 Markwell Medical Institute, Inc. Biological fluid measuring device
US4994167A (en) 1986-04-15 1991-02-19 Markwell Medical Institute, Inc. Biological fluid measuring device
US4711247A (en) 1986-04-18 1987-12-08 Henry Fishman Allergy testing method and apparatus
US4909908A (en) 1986-04-24 1990-03-20 Pepi Ross Electrochemical cncentration detector method
DE3614821A1 (en) 1986-05-02 1987-11-05 Siemens Ag IMPLANTABLE, CALIBRABLE MEASURING DEVICE FOR A BODY SUBSTANCE AND CALIBRATION METHOD
US4703756A (en) 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
US4731726A (en) 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
DE3617161A1 (en) 1986-05-22 1987-11-26 Boehringer Mannheim Gmbh SYSTEM FOR DETERMINING THE CONCENTRATION OF INGREDIENTS OF BODY LIQUIDS
GB8612861D0 (en) 1986-05-27 1986-07-02 Cambridge Life Sciences Immobilised enzyme biosensors
US4698057A (en) 1986-06-09 1987-10-06 Joishy Suresh K Built in assembly for stabilizing and securing intravascular needle or catheter like device
US4969468A (en) 1986-06-17 1990-11-13 Alfred E. Mann Foundation For Scientific Research Electrode array for use in connection with a living body and method of manufacture
AU598820B2 (en) 1986-06-20 1990-07-05 Molecular Devices Corporation Zero volume electrochemical cell
US5001054A (en) 1986-06-26 1991-03-19 Becton, Dickinson And Company Method for monitoring glucose
JPS636451A (en) 1986-06-27 1988-01-12 Terumo Corp Enzyme sensor
US4764416A (en) 1986-07-01 1988-08-16 Mitsubishi Denki Kabushiki Kaisha Electric element circuit using oxidation-reduction substances
US4917800A (en) 1986-07-07 1990-04-17 Bend Research, Inc. Functional, photochemically active, and chemically asymmetric membranes by interfacial polymerization of derivatized multifunctional prepolymers
US4784736A (en) 1986-07-07 1988-11-15 Bend Research, Inc. Functional, photochemically active, and chemically asymmetric membranes by interfacial polymerization of derivatized multifunctional prepolymers
US4726716A (en) 1986-07-21 1988-02-23 Mcguire Thomas V Fastener for catheter
US4894137A (en) 1986-09-12 1990-01-16 Omron Tateisi Electronics Co. Enzyme electrode
US5055171A (en) 1986-10-06 1991-10-08 T And G Corporation Ionic semiconductor materials and applications thereof
US4897162A (en) 1986-11-14 1990-01-30 The Cleveland Clinic Foundation Pulse voltammetry
DE3700119A1 (en) 1987-01-03 1988-07-14 Inst Diabetestechnologie Gemei IMPLANTABLE ELECTROCHEMICAL SENSOR
US4934369A (en) 1987-01-30 1990-06-19 Minnesota Mining And Manufacturing Company Intravascular blood parameter measurement system
GB2201248B (en) 1987-02-24 1991-04-17 Ici Plc Enzyme electrode sensors
US4777953A (en) 1987-02-25 1988-10-18 Ash Medical Systems, Inc. Capillary filtration and collection method for long-term monitoring of blood constituents
US4854322A (en) 1987-02-25 1989-08-08 Ash Medical Systems, Inc. Capillary filtration and collection device for long-term monitoring of blood constituents
US4848351A (en) 1987-03-04 1989-07-18 Sentry Medical Products, Inc. Medical electrode assembly
US4923586A (en) 1987-03-31 1990-05-08 Daikin Industries, Ltd. Enzyme electrode unit
US4935345A (en) 1987-04-07 1990-06-19 Arizona Board Of Regents Implantable microelectronic biochemical sensor incorporating thin film thermopile
US5352348A (en) 1987-04-09 1994-10-04 Nova Biomedical Corporation Method of using enzyme electrode
US4759828A (en) 1987-04-09 1988-07-26 Nova Biomedical Corporation Glucose electrode and method of determining glucose
US4749985A (en) 1987-04-13 1988-06-07 United States Of America As Represented By The United States Department Of Energy Functional relationship-based alarm processing
US4781683A (en) 1987-04-22 1988-11-01 The Johns Hopkins University Single-use, self-annulling injection syringe
EP0290683A3 (en) 1987-05-01 1988-12-14 Diva Medical Systems B.V. Diabetes management system and apparatus
US5286364A (en) 1987-06-08 1994-02-15 Rutgers University Surface-modified electochemical biosensor
US4822337A (en) 1987-06-22 1989-04-18 Stanley Newhouse Insulin delivery method and apparatus
JPH07122624B2 (en) 1987-07-06 1995-12-25 ダイキン工業株式会社 Biosensor
GB8718430D0 (en) 1987-08-04 1987-09-09 Ici Plc Sensor
US4874500A (en) 1987-07-15 1989-10-17 Sri International Microelectrochemical sensor and sensor array
JPS6423155A (en) 1987-07-17 1989-01-25 Daikin Ind Ltd Electrode refreshing device for biosensor
DE3854650T2 (en) 1987-08-11 1996-03-21 Terumo Corp AUTOMATIC SPHYGMOMANOMETER.
US4974929A (en) 1987-09-22 1990-12-04 Baxter International, Inc. Fiber optical probe connector for physiologic measurement devices
NL8702370A (en) 1987-10-05 1989-05-01 Groningen Science Park METHOD AND SYSTEM FOR GLUCOSE DETERMINATION AND USEABLE MEASURING CELL ASSEMBLY.
US4815469A (en) 1987-10-08 1989-03-28 Siemens-Pacesetter, Inc. Implantable blood oxygen sensor and method of use
GB8725936D0 (en) 1987-11-05 1987-12-09 Genetics Int Inc Sensing system
JPH01140054A (en) 1987-11-26 1989-06-01 Nec Corp Glucose sensor
US5006110A (en) 1987-12-01 1991-04-09 Pacesetter Infusion, Ltd. Air-in-line detector infusion system
US4813424A (en) 1987-12-23 1989-03-21 University Of New Mexico Long-life membrane electrode for non-ionic species
US4856648A (en) * 1987-12-31 1989-08-15 Steri-Oss, Inc. Packaging & installing implants
US5108564A (en) 1988-03-15 1992-04-28 Tall Oak Ventures Method and apparatus for amperometric diagnostic analysis
DE68924026T3 (en) 1988-03-31 2008-01-10 Matsushita Electric Industrial Co., Ltd., Kadoma BIOSENSOR AND ITS MANUFACTURE.
US4921199A (en) 1988-04-25 1990-05-01 Villaveces James W Device for aiding in preparation of intravenous therapy
GB8817421D0 (en) 1988-07-21 1988-08-24 Medisense Inc Bioelectrochemical electrodes
US4925268A (en) 1988-07-25 1990-05-15 Abbott Laboratories Fiber-optic physiological probes
US4954129A (en) 1988-07-25 1990-09-04 Abbott Laboratories Hydrodynamic clot flushing
EP0353328A1 (en) 1988-08-03 1990-02-07 Dräger Nederland B.V. A polarographic-amperometric three-electrode sensor
US5340722A (en) 1988-08-24 1994-08-23 Avl Medical Instruments Ag Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method
US5264106A (en) 1988-10-07 1993-11-23 Medisense, Inc. Enhanced amperometric sensor
US5108889A (en) 1988-10-12 1992-04-28 Thorne, Smith, Astill Technologies, Inc. Assay for determining analyte using mercury release followed by detection via interaction with aluminum
US4895147A (en) 1988-10-28 1990-01-23 Sherwood Medical Company Lancet injector
US5360404A (en) 1988-12-14 1994-11-01 Inviro Medical Devices Ltd. Needle guard and needle assembly for syringe
EP0384504A1 (en) 1989-02-24 1990-08-29 Duphar International Research B.V Detection strip for detecting and identifying chemical air contaminants, and portable detection kit comprising said strips
DE69027233T2 (en) 1989-03-03 1996-10-10 Edward W Stark Signal processing method and apparatus
US5205920A (en) 1989-03-03 1993-04-27 Noboru Oyama Enzyme sensor and method of manufacturing the same
JPH02298855A (en) 1989-03-20 1990-12-11 Assoc Univ Inc Electrochemical biosensor using immobilized enzyme and redox polymer
US5089112A (en) 1989-03-20 1992-02-18 Associated Universities, Inc. Electrochemical biosensor based on immobilized enzymes and redox polymers
US4953552A (en) 1989-04-21 1990-09-04 Demarzo Arthur P Blood glucose monitoring system
EP0396788A1 (en) 1989-05-08 1990-11-14 Dräger Nederland B.V. Process and sensor for measuring the glucose content of glucosecontaining fluids
US4988341A (en) 1989-06-05 1991-01-29 Eastman Kodak Company Sterilizing dressing device and method for skin puncture
US5198367A (en) 1989-06-09 1993-03-30 Masuo Aizawa Homogeneous amperometric immunoassay
FR2648353B1 (en) 1989-06-16 1992-03-27 Europhor Sa MICRODIALYSIS PROBE
CH677149A5 (en) 1989-07-07 1991-04-15 Disetronic Ag
US5431160A (en) 1989-07-19 1995-07-11 University Of New Mexico Miniature implantable refillable glucose sensor and material therefor
US4986271A (en) 1989-07-19 1991-01-22 The University Of New Mexico Vivo refillable glucose sensor
US5013161A (en) 1989-07-28 1991-05-07 Becton, Dickinson And Company Electronic clinical thermometer
US5264104A (en) 1989-08-02 1993-11-23 Gregg Brian A Enzyme electrodes
US5262035A (en) 1989-08-02 1993-11-16 E. Heller And Company Enzyme electrodes
US5264105A (en) 1989-08-02 1993-11-23 Gregg Brian A Enzyme electrodes
US5320725A (en) 1989-08-02 1994-06-14 E. Heller & Company Electrode and method for the detection of hydrogen peroxide
US4944299A (en) 1989-08-08 1990-07-31 Siemens-Pacesetter, Inc. High speed digital telemetry system for implantable device
US5101814A (en) 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5190041A (en) 1989-08-11 1993-03-02 Palti Yoram Prof System for monitoring and controlling blood glucose
US5095904A (en) 1989-09-08 1992-03-17 Cochlear Pty. Ltd. Multi-peak speech procession
US5050612A (en) 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
FR2652736A1 (en) 1989-10-06 1991-04-12 Neftel Frederic IMPLANTABLE DEVICE FOR EVALUATING THE RATE OF GLUCOSE.
US5036860A (en) 1989-11-24 1991-08-06 Medical Device Technologies, Inc. Disposable soft tissue biopsy apparatus
EP0429076B1 (en) 1989-11-24 1996-01-31 Matsushita Electric Industrial Co., Ltd. Preparation of biosensor
US5082550A (en) 1989-12-11 1992-01-21 The United States Of America As Represented By The Department Of Energy Enzyme electrochemical sensor electrode and method of making it
US5140985A (en) 1989-12-11 1992-08-25 Schroeder Jon M Noninvasive blood glucose measuring device
US5342789A (en) 1989-12-14 1994-08-30 Sensor Technologies, Inc. Method and device for detecting and quantifying glucose in body fluids
AU634863B2 (en) 1989-12-15 1993-03-04 Roche Diagnostics Operations Inc. Redox mediator reagent and biosensor
US5286362A (en) 1990-02-03 1994-02-15 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
US5109850A (en) 1990-02-09 1992-05-05 Massachusetts Institute Of Technology Automatic blood monitoring for medication delivery method and apparatus
US5162407A (en) 1990-03-06 1992-11-10 Investors Diversified Capital, Inc. Silicone rubber sealant composition
US5161532A (en) 1990-04-19 1992-11-10 Teknekron Sensor Development Corporation Integral interstitial fluid sensor
US5165407A (en) 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
US5202261A (en) 1990-07-19 1993-04-13 Miles Inc. Conductive sensors and their use in diagnostic assays
US5250439A (en) 1990-07-19 1993-10-05 Miles Inc. Use of conductive sensors in diagnostic assays
EP0550641B1 (en) 1990-09-28 1994-05-25 Pfizer Inc. Dispensing device containing a hydrophobic medium
US5058592A (en) 1990-11-02 1991-10-22 Whisler G Douglas Adjustable mountable doppler ultrasound transducer device
DE69126885T3 (en) 1990-12-12 2001-10-18 Sherwood Serv Ag CALIBRATION OF AN INFRARED THERMOMETER BY MEANS OF AREA CALIBRATION DISPLAY
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
US5228449A (en) 1991-01-22 1993-07-20 Athanasios G. Christ System and method for detecting out-of-hospital cardiac emergencies and summoning emergency assistance
AU1356792A (en) 1991-01-25 1992-08-27 Markwell Medical Institute, Inc. Implantable biological fluid measuring device
FR2673289B1 (en) 1991-02-21 1994-06-17 Asulab Sa SENSOR FOR MEASURING THE QUANTITY OF A COMPONENT IN SOLUTION.
JPH04278450A (en) 1991-03-04 1992-10-05 Adam Heller Biosensor and method for analyzing subject
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5262305A (en) 1991-03-04 1993-11-16 E. Heller & Company Interferant eliminating biosensors
US5469855A (en) 1991-03-08 1995-11-28 Exergen Corporation Continuous temperature monitor
US5238729A (en) 1991-04-05 1993-08-24 Minnesota Mining And Manufacturing Company Sensors based on nanosstructured composite films
US5208154A (en) 1991-04-08 1993-05-04 The United States Of America As Represented By The Department Of Energy Reversibly immobilized biological materials in monolayer films on electrodes
US5192416A (en) 1991-04-09 1993-03-09 New Mexico State University Technology Transfer Corporation Method and apparatus for batch injection analysis
US5293546A (en) 1991-04-17 1994-03-08 Martin Marietta Corporation Oxide coated metal grid electrode structure in display devices
US5122925A (en) 1991-04-22 1992-06-16 Control Products, Inc. Package for electronic components
JP3118015B2 (en) 1991-05-17 2000-12-18 アークレイ株式会社 Biosensor and separation and quantification method using the same
US5209229A (en) 1991-05-20 1993-05-11 Telectronics Pacing Systems, Inc. Apparatus and method employing plural electrode configurations for cardioversion of atrial fibrillation in an arrhythmia control system
FI88223C (en) 1991-05-22 1993-04-13 Polar Electro Oy Telemetric transmitter unit
JP2816262B2 (en) 1991-07-09 1998-10-27 工業技術院長 Carbon microsensor electrode and method of manufacturing the same
US5284156A (en) 1991-08-30 1994-02-08 M3 Systems, Inc. Automatic tissue sampling apparatus
GB9120144D0 (en) 1991-09-20 1991-11-06 Imperial College A dialysis electrode device
US5234835A (en) 1991-09-26 1993-08-10 C.R. Bard, Inc. Precalibrated fiber optic sensing method
US5322063A (en) 1991-10-04 1994-06-21 Eli Lilly And Company Hydrophilic polyurethane membranes for electrochemical glucose sensors
US5264103A (en) 1991-10-18 1993-11-23 Matsushita Electric Industrial Co., Ltd. Biosensor and a method for measuring a concentration of a substrate in a sample
US5217595A (en) 1991-10-25 1993-06-08 The Yellow Springs Instrument Company, Inc. Electrochemical gas sensor
US5415164A (en) 1991-11-04 1995-05-16 Biofield Corp. Apparatus and method for screening and diagnosing trauma or disease in body tissues
DE4139122C1 (en) 1991-11-28 1993-04-08 Fenzlein, Paul-Gerhard, 8500 Nuernberg, De
US5372427A (en) 1991-12-19 1994-12-13 Texas Instruments Incorporated Temperature sensor
US5271815A (en) 1991-12-26 1993-12-21 Via Medical Corporation Method for measuring glucose
US5285792A (en) 1992-01-10 1994-02-15 Physio-Control Corporation System for producing prioritized alarm messages in a medical instrument
US5246867A (en) 1992-01-17 1993-09-21 University Of Maryland At Baltimore Determination and quantification of saccharides by luminescence lifetimes and energy transfer
NL9200207A (en) 1992-02-05 1993-09-01 Nedap Nv IMPLANTABLE BIOMEDICAL SENSOR DEVICE, IN PARTICULAR FOR MEASUREMENT OF THE GLUCOSE CONCENTRATION.
US5328927A (en) 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
US5711001A (en) 1992-05-08 1998-01-20 Motorola, Inc. Method and circuit for acquisition by a radio receiver
GB9211402D0 (en) 1992-05-29 1992-07-15 Univ Manchester Sensor devices
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
US5400782A (en) 1992-10-07 1995-03-28 Graphic Controls Corporation Integral medical electrode including a fusible conductive substrate
US5421816A (en) 1992-10-14 1995-06-06 Endodermic Medical Technologies Company Ultrasonic transdermal drug delivery system
US5387327A (en) 1992-10-19 1995-02-07 Duquesne University Of The Holy Ghost Implantable non-enzymatic electrochemical glucose sensor
US5320098A (en) 1992-10-20 1994-06-14 Sun Microsystems, Inc. Optical transdermal link
WO1994010553A1 (en) 1992-10-23 1994-05-11 Optex Biomedical, Inc. Fibre-optic probe for the measurement of fluid parameters
US5899855A (en) 1992-11-17 1999-05-04 Health Hero Network, Inc. Modular microprocessor-based health monitoring system
US5918603A (en) 1994-05-23 1999-07-06 Health Hero Network, Inc. Method for treating medical conditions using a microprocessor-based video game
US5601435A (en) 1994-11-04 1997-02-11 Intercare Method and apparatus for interactively monitoring a physiological condition and for interactively providing health related information
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
ZA938555B (en) 1992-11-23 1994-08-02 Lilly Co Eli Technique to improve the performance of electrochemical sensors
DK148592D0 (en) 1992-12-10 1992-12-10 Novo Nordisk As APPARATUS
US5299571A (en) 1993-01-22 1994-04-05 Eli Lilly And Company Apparatus and method for implantation of sensors
FR2701117B1 (en) 1993-02-04 1995-03-10 Asulab Sa Electrochemical measurement system with multizone sensor, and its application to glucose measurement.
GB9304306D0 (en) 1993-03-03 1993-04-21 Univ Alberta Glucose sensor
DE59410066D1 (en) 1993-04-23 2002-04-11 Boehringer Mannheim Gmbh System for analyzing the contents of liquid samples
US5540664A (en) 1993-05-27 1996-07-30 Washington Biotech Corporation Reloadable automatic or manual emergency injection system
DE4318519C2 (en) 1993-06-03 1996-11-28 Fraunhofer Ges Forschung Electrochemical sensor
US5575563A (en) 1993-07-15 1996-11-19 Chiu; Job Multiusage thermometer
DE4329898A1 (en) 1993-09-04 1995-04-06 Marcus Dr Besson Wireless medical diagnostic and monitoring device
US5582184A (en) 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
US6336269B1 (en) 1993-11-16 2002-01-08 Benjamin N. Eldridge Method of fabricating an interconnection element
US5997501A (en) 1993-11-18 1999-12-07 Elan Corporation, Plc Intradermal drug delivery device
US5791344A (en) 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
US5497772A (en) 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5724968A (en) 1993-12-29 1998-03-10 First Opinion Corporation Computerized medical diagnostic system including meta function
US5589326A (en) 1993-12-30 1996-12-31 Boehringer Mannheim Corporation Osmium-containing redox mediator
US5320715A (en) 1994-01-14 1994-06-14 Lloyd Berg Separation of 1-pentanol from cyclopentanol by extractive distillation
DE4401400A1 (en) 1994-01-19 1995-07-20 Ernst Prof Dr Pfeiffer Method and arrangement for continuously monitoring the concentration of a metabolite
US5437999A (en) 1994-02-22 1995-08-01 Boehringer Mannheim Corporation Electrochemical sensor
US5506458A (en) 1994-03-04 1996-04-09 Quantum Corporation Low cost permanent magnet disk spindle motor
US5543326A (en) 1994-03-04 1996-08-06 Heller; Adam Biosensor including chemically modified enzymes
US5536249A (en) 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
US5390671A (en) 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5391250A (en) 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5609575A (en) 1994-04-11 1997-03-11 Graseby Medical Limited Infusion pump and method with dose-rate calculation
US5569186A (en) 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
JP3061351B2 (en) 1994-04-25 2000-07-10 松下電器産業株式会社 Method and apparatus for quantifying specific compounds
DE4415896A1 (en) 1994-05-05 1995-11-09 Boehringer Mannheim Gmbh Analysis system for monitoring the concentration of an analyte in the blood of a patient
US5545191A (en) 1994-05-06 1996-08-13 Alfred E. Mann Foundation For Scientific Research Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body
US5482473A (en) 1994-05-09 1996-01-09 Minimed Inc. Flex circuit connector
US5472317A (en) 1994-06-03 1995-12-05 Minimed Inc. Mounting clip for a medication infusion pump
US5494562A (en) 1994-06-27 1996-02-27 Ciba Corning Diagnostics Corp. Electrochemical sensors
US5549568A (en) 1994-08-22 1996-08-27 Shields; Jack W. Elastomeric needle shield and hub-cap
CA2159052C (en) 1994-10-28 2007-03-06 Rainer Alex Injection device
US5516832A (en) 1994-11-03 1996-05-14 Dow Corning Corporation Curable silicone rubber composition
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US5632557A (en) 1994-12-16 1997-05-27 Weed Instrument Company, Inc. Modular temperature sensing apparatus
US5562713A (en) 1995-01-18 1996-10-08 Pacesetter, Inc. Bidirectional telemetry apparatus and method for implantable device
US5551427A (en) 1995-02-13 1996-09-03 Altman; Peter A. Implantable device for the effective elimination of cardiac arrhythmogenic sites
US5568806A (en) 1995-02-16 1996-10-29 Minimed Inc. Transcutaneous sensor insertion set
US5586553A (en) 1995-02-16 1996-12-24 Minimed Inc. Transcutaneous sensor insertion set
US5651869A (en) 1995-02-28 1997-07-29 Matsushita Electric Industrial Co., Ltd. Biosensor
US5596150A (en) 1995-03-08 1997-01-21 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Capacitance probe for fluid flow and volume measurements
JPH08247987A (en) 1995-03-15 1996-09-27 Omron Corp Portable measuring instrument
US5582697A (en) 1995-03-17 1996-12-10 Matsushita Electric Industrial Co., Ltd. Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same
US5788833A (en) 1995-03-27 1998-08-04 California Institute Of Technology Sensors for detecting analytes in fluids
US5628310A (en) 1995-05-19 1997-05-13 Joseph R. Lakowicz Method and apparatus to perform trans-cutaneous analyte monitoring
US5567302A (en) 1995-06-07 1996-10-22 Molecular Devices Corporation Electrochemical system for rapid detection of biochemical agents that catalyze a redox potential change
US5638832A (en) 1995-06-07 1997-06-17 Interval Research Corporation Programmable subcutaneous visible implant
US5584813A (en) 1995-06-07 1996-12-17 Minimed Inc. Subcutaneous injection set
US5995860A (en) 1995-07-06 1999-11-30 Thomas Jefferson University Implantable sensor and system for measurement and control of blood constituent levels
US5536259A (en) * 1995-07-28 1996-07-16 Medisystems Technology Corp Hypodermic cannula
US6001065A (en) 1995-08-02 1999-12-14 Ibva Technologies, Inc. Method and apparatus for measuring and analyzing physiological signals for active or passive control of physical and virtual spaces and the contents therein
US5766131A (en) 1995-08-04 1998-06-16 Seiko Epson Corporation Pulse-wave measuring apparatus
US5749656A (en) 1995-08-11 1998-05-12 General Motors Corporation Thermal probe assembly with mold-over crimp sensor packaging
DE19530376C2 (en) 1995-08-18 1999-09-02 Fresenius Ag Biosensor
US5682233A (en) 1995-09-08 1997-10-28 Integ, Inc. Interstitial fluid sampler
IE77523B1 (en) 1995-09-11 1997-12-17 Elan Med Tech Medicament delivery device
US5735273A (en) 1995-09-12 1998-04-07 Cygnus, Inc. Chemical signal-impermeable mask
DE19534887B4 (en) 1995-09-20 2004-04-15 Robert Bosch Gmbh temperature sensor
US5628890A (en) 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
US5665222A (en) 1995-10-11 1997-09-09 E. Heller & Company Soybean peroxidase electrochemical sensor
US5972199A (en) 1995-10-11 1999-10-26 E. Heller & Company Electrochemical analyte sensors using thermostable peroxidase
ES2121525B1 (en) 1995-10-11 1999-09-16 Krebs & Co Ag Krebs & Co Sa Kr SALT PRODUCTION SYSTEM BY FORCED EVAPORATION.
US5741211A (en) 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US5711861A (en) 1995-11-22 1998-01-27 Ward; W. Kenneth Device for monitoring changes in analyte concentration
ZA9610374B (en) 1995-12-11 1997-06-23 Elan Med Tech Cartridge-based drug delivery device
US5827184A (en) 1995-12-29 1998-10-27 Minnesota Mining And Manufacturing Company Self-packaging bioelectrodes
US5746697A (en) 1996-02-09 1998-05-05 Nellcor Puritan Bennett Incorporated Medical diagnostic apparatus with sleep mode
FI118509B (en) 1996-02-12 2007-12-14 Nokia Oyj A method and apparatus for predicting blood glucose levels in a patient
FI960636A (en) 1996-02-12 1997-08-13 Nokia Mobile Phones Ltd A procedure for monitoring the health of a patient
US5708247A (en) 1996-02-14 1998-01-13 Selfcare, Inc. Disposable glucose test strips, and methods and compositions for making same
WO1997037618A1 (en) 1996-04-08 1997-10-16 Medtronic, Inc. Method of fixing a physiologic mitral valve bioprosthesis
DE19618597B4 (en) 1996-05-09 2005-07-21 Institut für Diabetestechnologie Gemeinnützige Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm Method for determining the concentration of tissue glucose
US5879311A (en) * 1996-05-17 1999-03-09 Mercury Diagnostics, Inc. Body fluid sampling device and methods of use
US5954685A (en) 1996-05-24 1999-09-21 Cygnus, Inc. Electrochemical sensor with dual purpose electrode
US5735285A (en) 1996-06-04 1998-04-07 Data Critical Corp. Method and hand-held apparatus for demodulating and viewing frequency modulated biomedical signals
US5613978A (en) 1996-06-04 1997-03-25 Palco Laboratories Adjustable tip for lancet device
US6230051B1 (en) 1996-06-18 2001-05-08 Alza Corporation Device for enhancing transdermal agent delivery or sampling
AU3596597A (en) 1996-07-08 1998-02-02 Animas Corporation Implantable sensor and system for in vivo measurement and control of fluid constituent levels
US5771001A (en) 1996-11-18 1998-06-23 Cobb; Marlon J. Personal alarm system
US6004278A (en) 1996-12-05 1999-12-21 Mdc Investment Holdings, Inc. Fluid collection device with retractable needle
US6071249A (en) 1996-12-06 2000-06-06 Abbott Laboratories Method and apparatus for obtaining blood for diagnostic tests
US5964993A (en) 1996-12-19 1999-10-12 Implanted Biosystems Inc. Glucose sensor
US6122351A (en) 1997-01-21 2000-09-19 Med Graph, Inc. Method and system aiding medical diagnosis and treatment
US7329239B2 (en) 1997-02-05 2008-02-12 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US6607509B2 (en) 1997-12-31 2003-08-19 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US20070142776A9 (en) 1997-02-05 2007-06-21 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US6093172A (en) * 1997-02-05 2000-07-25 Minimed Inc. Injector for a subcutaneous insertion set
US5851197A (en) 1997-02-05 1998-12-22 Minimed Inc. Injector for a subcutaneous infusion set
EP0958495B1 (en) 1997-02-06 2002-11-13 Therasense, Inc. Small volume in vitro analyte sensor
EP1011426A1 (en) 1997-02-26 2000-06-28 Diasense, Inc. Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose
US6159147A (en) 1997-02-28 2000-12-12 Qrs Diagnostics, Llc Personal computer card for collection of real-time biological data
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US20050033132A1 (en) 1997-03-04 2005-02-10 Shults Mark C. Analyte measuring device
US6001067A (en) 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US6741877B1 (en) 1997-03-04 2004-05-25 Dexcom, Inc. Device and method for determining analyte levels
US6862465B2 (en) 1997-03-04 2005-03-01 Dexcom, Inc. Device and method for determining analyte levels
US7192450B2 (en) 2003-05-21 2007-03-20 Dexcom, Inc. Porous membranes for use with implantable devices
US6558321B1 (en) 1997-03-04 2003-05-06 Dexcom, Inc. Systems and methods for remote monitoring and modulation of medical devices
US7657297B2 (en) 2004-05-03 2010-02-02 Dexcom, Inc. Implantable analyte sensor
US6554795B2 (en) 1997-03-06 2003-04-29 Medtronic Ave, Inc. Balloon catheter and method of manufacture
US6270455B1 (en) 1997-03-28 2001-08-07 Health Hero Network, Inc. Networked system for interactive communications and remote monitoring of drug delivery
KR100236035B1 (en) 1997-03-31 1999-12-15 전주범 Method of scheduling virtual channels by using subtables in an atm nic
US6026321A (en) 1997-04-02 2000-02-15 Suzuki Motor Corporation Apparatus and system for measuring electrical potential variations in human body
US5961451A (en) 1997-04-07 1999-10-05 Motorola, Inc. Noninvasive apparatus having a retaining member to retain a removable biosensor
US5987353A (en) 1997-04-10 1999-11-16 Khatchatrian; Robert G. Diagnostic complex for measurement of the condition of biological tissues and liquids
US6186982B1 (en) 1998-05-05 2001-02-13 Elan Corporation, Plc Subcutaneous drug delivery device with improved filling system
US5779665A (en) 1997-05-08 1998-07-14 Minimed Inc. Transdermal introducer assembly
US5954643A (en) 1997-06-09 1999-09-21 Minimid Inc. Insertion set for a transcutaneous sensor
US7267665B2 (en) 1999-06-03 2007-09-11 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
CA2294610A1 (en) 1997-06-16 1998-12-23 George Moshe Katz Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods
US5865804A (en) 1997-07-16 1999-02-02 Bachynsky; Nicholas Rotary cam syringe
US5823802A (en) 1997-07-30 1998-10-20 General Motors Corporation Electrical connector with combination seal and contact member
US6232950B1 (en) 1997-08-28 2001-05-15 E Ink Corporation Rear electrode structures for displays
US6764581B1 (en) 1997-09-05 2004-07-20 Abbott Laboratories Electrode with thin working layer
US6071391A (en) 1997-09-12 2000-06-06 Nok Corporation Enzyme electrode structure
US6117290A (en) 1997-09-26 2000-09-12 Pepex Biomedical, Llc System and method for measuring a bioanalyte such as lactate
US20020013538A1 (en) 1997-09-30 2002-01-31 David Teller Method and apparatus for health signs monitoring
US5904671A (en) 1997-10-03 1999-05-18 Navot; Nir Tampon wetness detection system
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6119028A (en) 1997-10-20 2000-09-12 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
US6088608A (en) 1997-10-20 2000-07-11 Alfred E. Mann Foundation Electrochemical sensor and integrity tests therefor
FI107080B (en) 1997-10-27 2001-05-31 Nokia Mobile Phones Ltd measuring device
US6068399A (en) 1997-11-12 2000-05-30 K-Jump Health Co., Ltd. Cost-effective electronic thermometer
CA2305366C (en) 1997-11-12 2007-10-16 Lightouch Medical, Inc. Method for non-invasive measurement of an analyte
US6482176B1 (en) 1997-11-27 2002-11-19 Disetronic Licensing Ag Method and device for controlling the introduction depth of an injection needle
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
KR100557261B1 (en) 1997-12-11 2006-03-07 알자 코포레이션 Device for enhancing transdermal agent flux
CA2312919C (en) 1997-12-31 2004-12-14 Minimed, Inc. Insertion device for an insertion set and method of using the same
DK1743667T3 (en) 1997-12-31 2012-06-18 Medtronic Minimed Inc Insertion device for an insertion set
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6056718A (en) 1998-03-04 2000-05-02 Minimed Inc. Medication infusion set
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6024699A (en) 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6197181B1 (en) 1998-03-20 2001-03-06 Semitool, Inc. Apparatus and method for electrolytically depositing a metal on a microelectronic workpiece
US6091975A (en) * 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
US6728560B2 (en) 1998-04-06 2004-04-27 The General Hospital Corporation Non-invasive tissue glucose level monitoring
JPH11296598A (en) 1998-04-07 1999-10-29 Seizaburo Arita System and method for predicting blood-sugar level and record medium where same method is recorded
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
GB2337122B (en) 1998-05-08 2002-11-13 Medisense Inc Test strip
CA2311487C (en) 1998-05-13 2004-02-10 Cygnus, Inc. Signal processing for measurement of physiological analytes
US6121611A (en) 1998-05-20 2000-09-19 Molecular Imaging Corporation Force sensing probe for scanning probe microscopy
TW406018B (en) 1998-05-21 2000-09-21 Elan Corp Plc Improved adhesive system for medical devices
US6837885B2 (en) 1998-05-22 2005-01-04 Scimed Life Systems, Inc. Surgical probe for supporting inflatable therapeutic devices in contact with tissue in or around body orifices and within tumors
GB9812472D0 (en) 1998-06-11 1998-08-05 Owen Mumford Ltd A dose setting device for medical injectors
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US5993423A (en) 1998-08-18 1999-11-30 Choi; Soo Bong Portable automatic syringe device and injection needle unit thereof
US6248067B1 (en) 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same
US6558320B1 (en) 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6304766B1 (en) 1998-08-26 2001-10-16 Sensors For Medicine And Science Optical-based sensing devices, especially for in-situ sensing in humans
US7536478B2 (en) 1998-09-11 2009-05-19 Rpx-Lv Acquisition Llc Method and apparatus for opening and launching a web browser in response to an audible signal
US5951521A (en) 1998-09-25 1999-09-14 Minimed Inc. Subcutaneous implantable sensor set having the capability to remove deliver fluids to an insertion site
US6254586B1 (en) 1998-09-25 2001-07-03 Minimed Inc. Method and kit for supplying a fluid to a subcutaneous placement site
DK1102559T3 (en) 1998-09-30 2003-09-29 Cygnus Therapeutic Systems Method and apparatus for predicting physiological values
AU6255699A (en) 1998-10-08 2000-04-26 Minimed, Inc. Telemetered characteristic monitor system
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US5948006A (en) 1998-10-14 1999-09-07 Advanced Bionics Corporation Transcutaneous transmission patch
EP1130996B1 (en) 1998-11-20 2005-04-13 The University of Connecticut Generic integrated implantable potentiostat telemetry unit for electrochemical sensors
USD431864S (en) * 1998-11-24 2000-10-10 Becton Dickinson And Company Tamper evident cap for a tip cap
US6773671B1 (en) 1998-11-30 2004-08-10 Abbott Laboratories Multichemistry measuring device and test strips
US6022368A (en) 1998-11-30 2000-02-08 Gavronsky; Stas Acupuncture method and device
US6377894B1 (en) 1998-11-30 2002-04-23 Abbott Laboratories Analyte test instrument having improved calibration and communication processes
US6161095A (en) 1998-12-16 2000-12-12 Health Hero Network, Inc. Treatment regimen compliance and efficacy with feedback
US6433728B1 (en) 1999-01-22 2002-08-13 Lear Automotive Dearborn, Inc. Integrally molded remote entry transmitter
CA2365609A1 (en) 1999-02-12 2000-08-17 Cygnus, Inc. Devices and methods for frequent measurement of an analyte present in a biological system
US6360888B1 (en) 1999-02-25 2002-03-26 Minimed Inc. Glucose sensor package system
US6424847B1 (en) 1999-02-25 2002-07-23 Medtronic Minimed, Inc. Glucose monitor calibration methods
ATE552771T1 (en) 1999-02-25 2012-04-15 Medtronic Minimed Inc TEST PLUG AND CABLE FOR GLUCOSE MONITORING DEVICE
US6959211B2 (en) 1999-03-10 2005-10-25 Optiscan Biomedical Corp. Device for capturing thermal spectra from tissue
GB9907815D0 (en) 1999-04-06 1999-06-02 Univ Cambridge Tech Implantable sensor
US6285897B1 (en) 1999-04-07 2001-09-04 Endonetics, Inc. Remote physiological monitoring system
AU4335700A (en) 1999-04-07 2000-10-23 Endonetics, Inc. Implantable monitoring probe
US6231531B1 (en) * 1999-04-09 2001-05-15 Agilent Technologies, Inc. Apparatus and method for minimizing pain perception
US6200265B1 (en) 1999-04-16 2001-03-13 Medtronic, Inc. Peripheral memory patch and access method for use with an implantable medical device
FR2793021B1 (en) 1999-04-30 2001-08-03 Siemens Automotive Sa TEMPERATURE SENSOR AND METHOD FOR MANUFACTURING SUCH A SENSOR
US6669663B1 (en) 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US6359444B1 (en) 1999-05-28 2002-03-19 University Of Kentucky Research Foundation Remote resonant-circuit analyte sensing apparatus with sensing structure and associated method of sensing
US7806886B2 (en) 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
WO2000078992A2 (en) 1999-06-18 2000-12-28 Therasense, Inc. Mass transport limited in vivo analyte sensor
GB2351153B (en) 1999-06-18 2003-03-26 Abbott Lab Electrochemical sensor for analysis of liquid samples
US6423035B1 (en) 1999-06-18 2002-07-23 Animas Corporation Infusion pump with a sealed drive mechanism and improved method of occlusion detection
US6368274B1 (en) 1999-07-01 2002-04-09 Medtronic Minimed, Inc. Reusable analyte sensor site and method of using the same
US6168606B1 (en) * 1999-11-10 2001-01-02 Palco Labs, Inc. Single-use lancet device
US6413393B1 (en) 1999-07-07 2002-07-02 Minimed, Inc. Sensor including UV-absorbing polymer and method of manufacture
US6514460B1 (en) 1999-07-28 2003-02-04 Abbott Laboratories Luminous glucose monitoring device
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US6102896A (en) 1999-09-08 2000-08-15 Cambridge Biostability Limited Disposable injector device
AT408182B (en) 1999-09-17 2001-09-25 Schaupp Lukas Dipl Ing Dr Tech DEVICE FOR VIVO MEASURING SIZES IN LIVING ORGANISMS
EP1217942A1 (en) 1999-09-24 2002-07-03 Healthetech, Inc. Physiological monitor and associated computation, display and communication unit
US6478736B1 (en) 1999-10-08 2002-11-12 Healthetech, Inc. Integrated calorie management system
DE19948759A1 (en) 1999-10-09 2001-04-12 Roche Diagnostics Gmbh Blood lancet device for drawing blood for diagnostic purposes
US6283982B1 (en) 1999-10-19 2001-09-04 Facet Technologies, Inc. Lancing device and method of sample collection
US6593356B2 (en) 1999-10-20 2003-07-15 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US20060091006A1 (en) 1999-11-04 2006-05-04 Yi Wang Analyte sensor with insertion monitor, and methods
JP3985022B2 (en) 1999-11-08 2007-10-03 アークレイ株式会社 Body fluid measuring device and insertion body used by being inserted into the body fluid measuring device
DK1230249T3 (en) 1999-11-15 2004-08-30 Therasense Inc Transition metal complexes with bidentate ligand having an imidazole ring
US6522927B1 (en) 1999-12-01 2003-02-18 Vertis Neuroscience, Inc. Electrode assembly for a percutaneous electrical therapy system
ATE508687T1 (en) 1999-12-13 2011-05-15 Arkray Inc BODY FLUID MEASUREMENT DEVICE WITH LANCET AND LANCET HOLDER USED THEREFOR
WO2001052935A1 (en) 2000-01-21 2001-07-26 Medical Research Group, Inc. Ambulatory medical apparatus and method having telemetry modifiable control software
US6733446B2 (en) 2000-01-21 2004-05-11 Medtronic Minimed, Inc. Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US7369635B2 (en) 2000-01-21 2008-05-06 Medtronic Minimed, Inc. Rapid discrimination preambles and methods for using the same
JP4703083B2 (en) 2000-01-21 2011-06-15 メドトロニック ミニメド インコーポレイテッド Medical system
US7003336B2 (en) 2000-02-10 2006-02-21 Medtronic Minimed, Inc. Analyte sensor method of making the same
US6484045B1 (en) 2000-02-10 2002-11-19 Medtronic Minimed, Inc. Analyte sensor and method of making the same
CA2395868C (en) 2000-02-10 2009-07-14 Medtronic Minimed, Inc. Improved analyte sensor and method of making the same
US6895263B2 (en) 2000-02-23 2005-05-17 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US7890295B2 (en) 2000-02-23 2011-02-15 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US6706159B2 (en) 2000-03-02 2004-03-16 Diabetes Diagnostics Combined lancet and electrochemical analyte-testing apparatus
DE10010587A1 (en) 2000-03-03 2001-09-06 Roche Diagnostics Gmbh System for the determination of analyte concentrations in body fluids
US6510344B1 (en) 2000-03-22 2003-01-21 Ge Medical Systems Information Technologies, Inc. Procedure alarm silence feature for medical telemetry system
US6610012B2 (en) 2000-04-10 2003-08-26 Healthetech, Inc. System and method for remote pregnancy monitoring
US6440068B1 (en) 2000-04-28 2002-08-27 International Business Machines Corporation Measuring user health as measured by multiple diverse health measurement devices utilizing a personal storage device
US7404815B2 (en) 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
US20020010390A1 (en) 2000-05-10 2002-01-24 Guice David Lehmann Method and system for monitoring the health and status of livestock and other animals
AU2001263022A1 (en) 2000-05-12 2001-11-26 Therasense, Inc. Electrodes with multilayer membranes and methods of using and making the electrodes
USD457247S1 (en) * 2000-05-12 2002-05-14 Gen-Probe Incorporated Cap
US7181261B2 (en) 2000-05-15 2007-02-20 Silver James H Implantable, retrievable, thrombus minimizing sensors
US6442413B1 (en) 2000-05-15 2002-08-27 James H. Silver Implantable sensor
WO2001091902A2 (en) 2000-05-30 2001-12-06 Massachusetts Institute Of Technology Methods and devices for sealing microchip reservoir devices
US6607543B2 (en) * 2000-06-13 2003-08-19 Bayer Corporation Lancing mechanism
US6604050B2 (en) 2000-06-16 2003-08-05 Bayer Corporation System, method and biosensor apparatus for data communications with a personal data assistant
DE10030410C1 (en) 2000-06-21 2002-01-24 Roche Diagnostics Gmbh Blood lancet device for drawing blood for diagnostic purposes
US6699188B2 (en) 2000-06-22 2004-03-02 Guidance Interactive Technologies Interactive reward devices and methods
US6540675B2 (en) 2000-06-27 2003-04-01 Rosedale Medical, Inc. Analyte monitor
US7530964B2 (en) 2000-06-30 2009-05-12 Elan Pharma International Limited Needle device and method thereof
US6589229B1 (en) 2000-07-31 2003-07-08 Becton, Dickinson And Company Wearable, self-contained drug infusion device
WO2002015778A1 (en) 2000-08-18 2002-02-28 Cygnus, Inc. Analyte monitoring device alarm augmentation system
US6633772B2 (en) 2000-08-18 2003-10-14 Cygnus, Inc. Formulation and manipulation of databases of analyte and associated values
CA2408338C (en) 2000-08-18 2009-09-08 Cygnus, Inc. Methods and devices for prediction of hypoglycemic events
EP1311189A4 (en) 2000-08-21 2005-03-09 Euro Celtique Sa Near infrared blood glucose monitoring system
US6827899B2 (en) 2000-08-30 2004-12-07 Hypoguard Limited Test device
EP1335764B1 (en) 2000-09-08 2007-06-06 Insulet Corporation Device and system for patient infusion
US7348183B2 (en) 2000-10-16 2008-03-25 Board Of Trustees Of The University Of Arkansas Self-contained microelectrochemical bioassay platforms and methods
US6603995B1 (en) 2000-10-19 2003-08-05 Reynolds Medical Limited Body monitoring apparatus
EP1330178A1 (en) 2000-11-01 2003-07-30 3M Innovative Properties Company Electrical sensing and/or signal application device
US6695860B1 (en) 2000-11-13 2004-02-24 Isense Corp. Transcutaneous sensor insertion device
CA2430590C (en) 2000-11-30 2012-08-14 Biovalve Technologies, Inc. Fluid delivery and measurement systems and methods
US6439446B1 (en) 2000-12-01 2002-08-27 Stephen J. Perry Safety lockout for actuator shaft
US7052483B2 (en) 2000-12-19 2006-05-30 Animas Corporation Transcutaneous inserter for low-profile infusion sets
GB0030929D0 (en) * 2000-12-19 2001-01-31 Inverness Medical Ltd Analyte measurement
US6416332B1 (en) 2000-12-20 2002-07-09 Nortel Networks Limited Direct BGA socket for high speed use
EP1353594B1 (en) 2000-12-29 2008-10-29 Ares Medical, Inc. Sleep apnea risk evaluation
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US20020151770A1 (en) 2001-01-04 2002-10-17 Noll Austin F. Implantable medical device with sensor
US7131984B2 (en) * 2001-01-12 2006-11-07 Arkray, Inc. Lancing device, method of making lancing device, pump mechanism, and sucking device
CN100593390C (en) 2001-01-19 2010-03-10 松下电器产业株式会社 Lancet-integrated sensor
AU2002247008B2 (en) 2001-01-22 2006-02-09 F. Hoffmann-La Roche Ag Lancet device having capillary action
ITMI20010253A1 (en) 2001-02-08 2002-08-08 Negri Bossi Spa INJECTION GROUP FOR INJECTION PRESSES OF PLASTIC MATERIALS
US20030023461A1 (en) 2001-03-14 2003-01-30 Dan Quintanilla Internet based therapy management system
US6968294B2 (en) 2001-03-15 2005-11-22 Koninklijke Philips Electronics N.V. Automatic system for monitoring person requiring care and his/her caretaker
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
DK3210637T3 (en) 2001-04-06 2021-04-06 Hoffmann La Roche Infusion set
SE0101379D0 (en) 2001-04-18 2001-04-18 Diabact Ab Composition that inhibits gastric acid secretion
US6535764B2 (en) 2001-05-01 2003-03-18 Intrapace, Inc. Gastric treatment and diagnosis device and method
JP2004532526A (en) 2001-05-03 2004-10-21 マシモ・コーポレイション Flex circuit shield optical sensor and method of manufacturing the flex circuit shield optical sensor
US6613379B2 (en) 2001-05-08 2003-09-02 Isense Corp. Implantable analyte sensor
US6676816B2 (en) 2001-05-11 2004-01-13 Therasense, Inc. Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes
US6932894B2 (en) 2001-05-15 2005-08-23 Therasense, Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US6837988B2 (en) 2001-06-12 2005-01-04 Lifescan, Inc. Biological fluid sampling and analyte measurement devices and methods
US7179226B2 (en) 2001-06-21 2007-02-20 Animas Corporation System and method for managing diabetes
US20030002682A1 (en) 2001-07-02 2003-01-02 Phonex Broadband Corporation Wireless audio/mechanical vibration transducer and audio/visual transducer
US8016847B2 (en) 2001-07-11 2011-09-13 Arkray, Inc. Lancet and lancing apparatus
US6702857B2 (en) 2001-07-27 2004-03-09 Dexcom, Inc. Membrane for use with implantable devices
US20030032874A1 (en) 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
CN1311781C (en) 2001-08-20 2007-04-25 因弗内斯医疗有限公司 Wireless diabetes management devices and methods for using the same
US6740072B2 (en) 2001-09-07 2004-05-25 Medtronic Minimed, Inc. System and method for providing closed loop infusion formulation delivery
US7025760B2 (en) 2001-09-07 2006-04-11 Medtronic Minimed, Inc. Method and system for non-vascular sensor implantation
JP2003084101A (en) 2001-09-17 2003-03-19 Dainippon Printing Co Ltd Resin composition for optical device, optical device and projection screen
US7052591B2 (en) 2001-09-21 2006-05-30 Therasense, Inc. Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking
CN1202872C (en) 2001-09-24 2005-05-25 崔秀峯 Portable automatic insulin injector with blood sugar detection function
US6830562B2 (en) 2001-09-27 2004-12-14 Unomedical A/S Injector device for placing a subcutaneous infusion set
US6613015B2 (en) 2001-10-04 2003-09-02 Deltec, Inc. Right angle safety needle
US20030069510A1 (en) 2001-10-04 2003-04-10 Semler Herbert J. Disposable vital signs monitor
US6939310B2 (en) * 2001-10-10 2005-09-06 Lifescan, Inc. Devices for physiological fluid sampling and methods of using the same
US6748254B2 (en) 2001-10-12 2004-06-08 Nellcor Puritan Bennett Incorporated Stacked adhesive optical sensor
US7010356B2 (en) * 2001-10-31 2006-03-07 London Health Sciences Centre Research Inc. Multichannel electrode and methods of using same
AU2002346399A1 (en) 2001-11-14 2003-05-26 Medical Instill Technologies, Inc. Intradermal delivery device and method
GB0130684D0 (en) 2001-12-21 2002-02-06 Oxford Biosensors Ltd Micro-band electrode
US7399277B2 (en) 2001-12-27 2008-07-15 Medtronic Minimed, Inc. System for monitoring physiological characteristics
ITTO20011228A1 (en) 2001-12-28 2003-06-28 Cane Srl DISPOSABLE NEEDLE CONTAINER.
US20030145062A1 (en) 2002-01-14 2003-07-31 Dipanshu Sharma Data conversion server for voice browsing system
US20030155656A1 (en) 2002-01-18 2003-08-21 Chiu Cindy Chia-Wen Anisotropically conductive film
US7004928B2 (en) 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7613491B2 (en) 2002-05-22 2009-11-03 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
DE10208575C1 (en) 2002-02-21 2003-08-14 Hartmann Paul Ag Blood analyzer device comprises needles, test media, analyzer and display, and has carrier turned with respect to main body, to position needle and test media
AU2003213638A1 (en) 2002-02-26 2003-09-09 Sterling Medivations, Inc. Insertion device for an insertion set and method of using the same
US20030212379A1 (en) 2002-02-26 2003-11-13 Bylund Adam David Systems and methods for remotely controlling medication infusion and analyte monitoring
DE10392369B4 (en) 2002-03-06 2011-12-15 HTL-STREFA Spólka z o. o. Device for puncturing the skin of a patient
US6998247B2 (en) 2002-03-08 2006-02-14 Sensys Medical, Inc. Method and apparatus using alternative site glucose determinations to calibrate and maintain noninvasive and implantable analyzers
US6936006B2 (en) 2002-03-22 2005-08-30 Novo Nordisk, A/S Atraumatic insertion of a subcutaneous device
GB2388898B (en) 2002-04-02 2005-10-05 Inverness Medical Ltd Integrated sample testing meter
US7410468B2 (en) 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7485128B2 (en) 2002-04-19 2009-02-03 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7141058B2 (en) 2002-04-19 2006-11-28 Pelikan Technologies, Inc. Method and apparatus for a body fluid sampling device using illumination
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7226978B2 (en) 2002-05-22 2007-06-05 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US8641715B2 (en) 2002-05-31 2014-02-04 Vidacare Corporation Manual intraosseous device
WO2004004565A1 (en) * 2002-07-02 2004-01-15 Arkray, Inc. Unit for piercing, and piercing device
JP4308483B2 (en) 2002-07-02 2009-08-05 アークレイ株式会社 Puncture unit and puncture device
US20040010207A1 (en) 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
AU2003302720B9 (en) 2002-07-19 2008-08-21 Smiths Detection-Pasadena, Inc. Non-specific sensor array detectors
US7220387B2 (en) 2002-07-23 2007-05-22 Apieron Biosystems Corp. Disposable sensor for use in measuring an analyte in a gaseous sample
US7278983B2 (en) 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
US7637891B2 (en) 2002-09-12 2009-12-29 Children's Hospital Medical Center Method and device for painless injection of medication
US20040061232A1 (en) 2002-09-27 2004-04-01 Medtronic Minimed, Inc. Multilayer substrate
US7736309B2 (en) 2002-09-27 2010-06-15 Medtronic Minimed, Inc. Implantable sensor method and system
US7192405B2 (en) 2002-09-30 2007-03-20 Becton, Dickinson And Company Integrated lancet and bodily fluid sensor
WO2004030726A1 (en) * 2002-10-07 2004-04-15 Novo Nordisk A/S Needle device comprising a plurality of needles
TW557352B (en) 2002-10-07 2003-10-11 Actherm Inc Electronic clinical thermometer with rapid response
US7014625B2 (en) * 2002-10-07 2006-03-21 Novo Nordick A/S Needle insertion device
US20040138688A1 (en) 2002-10-09 2004-07-15 Jean Pierre Giraud Lancet system including test strips and cassettes for drawing and sampling bodily material
DK1575656T3 (en) 2002-10-11 2009-09-14 Becton Dickinson Co Insulin delivery system with sensor
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US7572237B2 (en) 2002-11-06 2009-08-11 Abbott Diabetes Care Inc. Automatic biological analyte testing meter with integrated lancing device and methods of use
US6676290B1 (en) 2002-11-15 2004-01-13 Hsueh-Yu Lu Electronic clinical thermometer
JP2006507196A (en) 2002-11-21 2006-03-02 エス.シー. ジョンソン アンド サン、インコーポレイテッド Products with RFID tags for providing information to product consumers
EP1618920A3 (en) 2002-12-16 2007-05-30 Meagan Medical, Inc. Controlling the depth of percuataneous applications
US20040116866A1 (en) 2002-12-17 2004-06-17 William Gorman Skin attachment apparatus and method for patient infusion device
US20040122353A1 (en) 2002-12-19 2004-06-24 Medtronic Minimed, Inc. Relay device for transferring information between a sensor system and a fluid delivery system
US7395117B2 (en) 2002-12-23 2008-07-01 Cardiac Pacemakers, Inc. Implantable medical device having long-term wireless capabilities
JP2004214014A (en) 2002-12-27 2004-07-29 Shin Etsu Polymer Co Ltd Electric connector
US20040127818A1 (en) 2002-12-27 2004-07-01 Roe Steven N. Precision depth control lancing tip
EP1578262A4 (en) 2002-12-31 2007-12-05 Therasense Inc Continuous glucose monitoring system and methods of use
US7228162B2 (en) 2003-01-13 2007-06-05 Isense Corporation Analyte sensor
US20040138544A1 (en) 2003-01-13 2004-07-15 Ward W. Kenneth Body fluid trap anlyte sensor
US20040171910A1 (en) 2003-02-27 2004-09-02 Moore-Steele Robin B. Sexually stimulating panty insert
EP2052684A1 (en) 2003-03-17 2009-04-29 Arkray Inc. Puncture device
US20040186373A1 (en) 2003-03-21 2004-09-23 Dunfield John Stephen Method and device for targeted epithelial delivery of medicinal and related agents
US20050070819A1 (en) 2003-03-31 2005-03-31 Rosedale Medical, Inc. Body fluid sampling constructions and techniques
US7134999B2 (en) 2003-04-04 2006-11-14 Dexcom, Inc. Optimized sensor geometry for an implantable glucose sensor
EP1614382B1 (en) 2003-04-11 2012-07-11 ARKRAY, Inc. Needle insertion device
US6797877B1 (en) 2003-04-28 2004-09-28 Jonn Maneely Company Electrical metallic tube, coupling, and connector apparatus and method
ATE474611T1 (en) 2003-05-08 2010-08-15 Novo Nordisk As AN INJECTION DEVICE THAT CAN BE APPLIED TO THE SKIN WITH A SEPARABLE ACTUATING PART FOR INSERTING THE NEEDLE
US6926694B2 (en) * 2003-05-09 2005-08-09 Medsolve Technologies, Llc Apparatus and method for delivery of therapeutic and/or diagnostic agents
US7875293B2 (en) 2003-05-21 2011-01-25 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
WO2004103170A1 (en) 2003-05-22 2004-12-02 Novo Nordisk A/S A glucose measuring device
KR100502713B1 (en) 2003-05-29 2005-07-20 주식회사 헬스피아 Battery pack and system for self-diagnosis
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8460243B2 (en) 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
WO2006001797A1 (en) * 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
DE20320207U1 (en) 2003-06-12 2004-10-14 Disetronic Licensing Ag Insertion device for an infusion set comprises a thrust linkage which is constituted so that the forward motion of the set takes place without a sliding contact with the device housing
CA2525549A1 (en) 2003-06-12 2004-12-23 Disetronic Licensing Ag Insertion device for infusion sets
US20040254433A1 (en) 2003-06-12 2004-12-16 Bandis Steven D. Sensor introducer system, apparatus and method
US7604592B2 (en) 2003-06-13 2009-10-20 Pelikan Technologies, Inc. Method and apparatus for a point of care device
JP4041018B2 (en) 2003-06-25 2008-01-30 Tdk株式会社 Temperature sensor
US7510564B2 (en) 2003-06-27 2009-03-31 Abbott Diabetes Care Inc. Lancing device
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
WO2005012873A2 (en) 2003-07-25 2005-02-10 Dexcom, Inc. Electrode systems for electrochemical sensors
US7424318B2 (en) 2003-12-05 2008-09-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US7460898B2 (en) 2003-12-05 2008-12-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7366556B2 (en) 2003-12-05 2008-04-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
EP1648298A4 (en) 2003-07-25 2010-01-13 Dexcom Inc Oxygen enhancing membrane systems for implantable devices
US20050176136A1 (en) 2003-11-19 2005-08-11 Dexcom, Inc. Afinity domain for analyte sensor
US7108778B2 (en) 2003-07-25 2006-09-19 Dexcom, Inc. Electrochemical sensors including electrode systems with increased oxygen generation
US7467003B2 (en) 2003-12-05 2008-12-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US7986986B2 (en) 2003-08-01 2011-07-26 Dexcom, Inc. System and methods for processing analyte sensor data
EP1502613A1 (en) 2003-08-01 2005-02-02 Novo Nordisk A/S Needle device with retraction means
US8060173B2 (en) 2003-08-01 2011-11-15 Dexcom, Inc. System and methods for processing analyte sensor data
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US20100168543A1 (en) 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US7494465B2 (en) 2004-07-13 2009-02-24 Dexcom, Inc. Transcutaneous analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US8626257B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. Analyte sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
DE10336933B4 (en) 2003-08-07 2007-04-26 Roche Diagnostics Gmbh Blood Collection system
US20050038331A1 (en) 2003-08-14 2005-02-17 Grayson Silaski Insertable sensor assembly having a coupled inductor communicative system
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7097637B2 (en) 2003-08-27 2006-08-29 C. R. Bard, Inc. Safety needle with positive flush
US9133024B2 (en) 2003-09-03 2015-09-15 Brigitte Chau Phan Personal diagnostic devices including related methods and systems
JP4356088B2 (en) 2003-09-26 2009-11-04 日本光電工業株式会社 Telemeter system for multi-channel biological signals
USD579541S1 (en) * 2003-10-15 2008-10-28 Unomedical A/S Medical insertion device
US20050090607A1 (en) 2003-10-28 2005-04-28 Dexcom, Inc. Silicone composition for biocompatible membrane
US20050090725A1 (en) 2003-10-28 2005-04-28 Joseph Page Disposable couplings for biometric instruments
US6928380B2 (en) 2003-10-30 2005-08-09 International Business Machines Corporation Thermal measurements of electronic devices during operation
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US7699807B2 (en) * 2003-11-10 2010-04-20 Smiths Medical Asd, Inc. Device and method for insertion of a cannula of an infusion device
WO2005046477A2 (en) 2003-11-12 2005-05-26 Facet Technologies, Llc Lancing device and multi-lancet cartridge
DE602004028649D1 (en) 2003-11-13 2010-09-23 Medtronic Minimed Inc LONG-TERM ARRANGEMENT ANALYTENSENSOR
WO2005051170A2 (en) 2003-11-19 2005-06-09 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US8425417B2 (en) 2003-12-05 2013-04-23 Dexcom, Inc. Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device
US8364230B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8425416B2 (en) 2006-10-04 2013-04-23 Dexcom, Inc. Analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US20080200788A1 (en) 2006-10-04 2008-08-21 Dexcorn, Inc. Analyte sensor
US20100185071A1 (en) 2003-12-05 2010-07-22 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
EP2239567B1 (en) 2003-12-05 2015-09-02 DexCom, Inc. Calibration techniques for a continuous analyte sensor
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US20080197024A1 (en) 2003-12-05 2008-08-21 Dexcom, Inc. Analyte sensor
EP3241490A1 (en) 2003-12-08 2017-11-08 DexCom, Inc. Systems and methods for improving electrochemical analyte sensors
EP2329763B1 (en) 2003-12-09 2017-06-21 DexCom, Inc. Signal processing for continuous analyte sensor
US7763042B2 (en) 2003-12-16 2010-07-27 Panasonic Corporation Lancet for blood collection and puncture needle unit
WO2005058154A1 (en) 2003-12-16 2005-06-30 Medeikon Corporation Method for monitoring of analytes in biological samples using low coherence interferometry
JP4502634B2 (en) * 2003-12-16 2010-07-14 テルモ株式会社 Puncture device
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US7637868B2 (en) 2004-01-12 2009-12-29 Dexcom, Inc. Composite material for implantable device
JP4250169B2 (en) * 2004-01-16 2009-04-08 株式会社トップ Indwelling needle
US8465696B2 (en) 2004-02-03 2013-06-18 Polymer Technology Systems, Inc. Dry test strip with controlled flow and method of manufacturing same
US7699964B2 (en) 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US8165651B2 (en) 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
US7364592B2 (en) 2004-02-12 2008-04-29 Dexcom, Inc. Biointerface membrane with macro-and micro-architecture
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
CN1921803B (en) 2004-02-23 2011-01-26 伊西康公司 Diagnostic swab and biopsy punch systems, and diagnostic caps for use in such systems
WO2005084257A2 (en) 2004-02-26 2005-09-15 Vpn Solutions, Llc Composite thin-film glucose sensor
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
WO2005084557A1 (en) 2004-03-02 2005-09-15 Facet Technologies, Llc Compact multi-use lancing device
US6971274B2 (en) 2004-04-02 2005-12-06 Sierra Instruments, Inc. Immersible thermal mass flow meter
US20050222518A1 (en) 2004-04-06 2005-10-06 Genocell, Llc Biopsy and injection catheters
US20060009727A1 (en) 2004-04-08 2006-01-12 Chf Solutions Inc. Method and apparatus for an extracorporeal control of blood glucose
US8277713B2 (en) 2004-05-03 2012-10-02 Dexcom, Inc. Implantable analyte sensor
US9101302B2 (en) 2004-05-03 2015-08-11 Abbott Diabetes Care Inc. Analyte test device
US20050245799A1 (en) 2004-05-03 2005-11-03 Dexcom, Inc. Implantable analyte sensor
EP1744679A2 (en) 2004-05-03 2007-01-24 AMS Research Corporation Surgical implants and related methods
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US9380975B2 (en) 2004-05-07 2016-07-05 Becton, Dickinson And Company Contact activated lancet device
US7727147B1 (en) 2004-05-14 2010-06-01 Flint Hills Scientific Llc Method and system for implantable glucose monitoring and control of a glycemic state of a subject
US7125382B2 (en) 2004-05-20 2006-10-24 Digital Angel Corporation Embedded bio-sensor system
JP2008501037A (en) 2004-06-01 2008-01-17 マイクロチップス・インコーポレーテッド Devices and methods for measuring and enhancing transport of drugs or analytes to / from medical implants
CA2572455C (en) 2004-06-04 2014-10-28 Therasense, Inc. Diabetes care host-client architecture and data management system
US7299081B2 (en) 2004-06-15 2007-11-20 Abbott Laboratories Analyte test device
US7585287B2 (en) 2004-06-16 2009-09-08 Smiths Medical Md, Inc. Device and method for insertion of a cannula of an infusion device
US7519430B2 (en) 2004-06-17 2009-04-14 Cardiac Pacemakers, Inc. Dynamic telemetry encoding for an implantable medical device
US7457669B2 (en) 2004-06-17 2008-11-25 Cardiac Pacemakers, Inc. On-demand retransmission of data with an implantable medical device
SI1765288T1 (en) 2004-06-18 2013-02-28 Novartis Ag Tobramycin formualtions for treatment of endobronchial infections
US8343074B2 (en) 2004-06-30 2013-01-01 Lifescan Scotland Limited Fluid handling devices
US20060001551A1 (en) 2004-06-30 2006-01-05 Ulrich Kraft Analyte monitoring system with wireless alarm
US20060001538A1 (en) 2004-06-30 2006-01-05 Ulrich Kraft Methods of monitoring the concentration of an analyte
US20060015020A1 (en) 2004-07-06 2006-01-19 Dexcom, Inc. Systems and methods for manufacture of an analyte-measuring device including a membrane system
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
EP3524142B1 (en) * 2004-07-13 2021-04-28 Dexcom, Inc. Transcutaneous analyte sensor
US20080242961A1 (en) 2004-07-13 2008-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US20060270922A1 (en) 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US7310544B2 (en) 2004-07-13 2007-12-18 Dexcom, Inc. Methods and systems for inserting a transcutaneous analyte sensor
US7344500B2 (en) 2004-07-27 2008-03-18 Medtronic Minimed, Inc. Sensing system with auxiliary display
EP1781164A1 (en) 2004-08-10 2007-05-09 Novo Nordisk A/S A method of forming a sterilised sensor package and a sterilised sensor package
JP5032321B2 (en) 2004-08-31 2012-09-26 ライフスキャン・スコットランド・リミテッド Manufacturing method of automatic calibration sensor
EP1788930A1 (en) 2004-09-03 2007-05-30 Novo Nordisk A/S A method of calibrating a system for measuring the concentration of substances in body and an apparatus for exercising the method
DE102004048864A1 (en) 2004-10-07 2006-04-13 Roche Diagnostics Gmbh Analytical test element with wireless data transmission
US20090048499A1 (en) 2004-10-18 2009-02-19 Novo Nordisk A/S Sensor film for transcutaneous insertion and a method for making the sensor film
CN101087625B (en) 2004-11-22 2012-02-22 因特利杰克特有限公司 Devices and systems for medicament delivery
DE102004059491B4 (en) 2004-12-10 2008-11-06 Roche Diagnostics Gmbh Lancet device for creating a puncture wound and lancet drive assembly
US7568619B2 (en) 2004-12-15 2009-08-04 Alcon, Inc. System and method for identifying and controlling ophthalmic surgical devices and components
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US20110060196A1 (en) 2009-08-31 2011-03-10 Abbott Diabetes Care Inc. Flexible Mounting Unit and Cover for a Medical Device
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US20110190603A1 (en) 2009-09-29 2011-08-04 Stafford Gary A Sensor Inserter Having Introducer
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US7731657B2 (en) * 2005-08-30 2010-06-08 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US8333714B2 (en) * 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US20090082693A1 (en) 2004-12-29 2009-03-26 Therasense, Inc. Method and apparatus for providing temperature sensor module in a data communication system
US20090105569A1 (en) 2006-04-28 2009-04-23 Abbott Diabetes Care, Inc. Introducer Assembly and Methods of Use
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US20070027381A1 (en) 2005-07-29 2007-02-01 Therasense, Inc. Inserter and methods of use
US7470237B2 (en) 2005-01-10 2008-12-30 Ethicon Endo-Surgery, Inc. Biopsy instrument with improved needle penetration
EP1848476A1 (en) 2005-01-24 2007-10-31 Novo Nordisk A/S Transcutaneous device assembly
US20060166629A1 (en) 2005-01-24 2006-07-27 Therasense, Inc. Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
US8435289B2 (en) * 2005-02-11 2013-05-07 Abbott Medical Optics Inc. Rapid exchange IOL insertion apparatus and methods of using
KR100638727B1 (en) 2005-02-28 2006-10-30 삼성전기주식회사 Concurrent transceiver for zigbee and bluetooth
EP1698279A1 (en) 2005-03-04 2006-09-06 Disetronic Licensing AG Sequential insertion of main-penetrators
EP1871218B1 (en) 2005-03-09 2012-05-16 Coloplast A/S A three-dimensional adhesive device having a microelectronic system embedded therein
US20090076360A1 (en) 2007-09-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
BRPI0610446B1 (en) * 2005-04-07 2023-05-16 Becton, Dickinson And Company LANCET DEVICE
WO2006110193A2 (en) 2005-04-08 2006-10-19 Dexcom, Inc. Cellulosic-based interference domain for an analyte sensor
EP1877116A1 (en) 2005-04-13 2008-01-16 Novo Nordisk A/S Medical skin mountable device and system
US8060174B2 (en) 2005-04-15 2011-11-15 Dexcom, Inc. Analyte sensing biointerface
DE102005019306B4 (en) 2005-04-26 2011-09-01 Disetronic Licensing Ag Energy-optimized data transmission of a medical device
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7905868B2 (en) 2006-08-23 2011-03-15 Medtronic Minimed, Inc. Infusion medium delivery device and method with drive device for driving plunger in reservoir
US7955305B2 (en) 2005-05-06 2011-06-07 Medtronic Minimed, Inc. Needle inserter and method for infusion device
US20060276771A1 (en) 2005-06-06 2006-12-07 Galley Paul J System and method providing for user intervention in a diabetes control arrangement
WO2006133305A2 (en) 2005-06-08 2006-12-14 Sensors For Medicine And Science, Inc. Insertion device and method
DK2260759T3 (en) 2005-06-17 2015-08-17 Hoffmann La Roche Feel and conditioning device and method for monitoring a connection, in particular glucose, in body tissue
US8298389B2 (en) 2005-09-12 2012-10-30 Abbott Diabetes Care Inc. In vitro analyte sensor, and methods
PL1762259T3 (en) 2005-09-12 2011-03-31 Unomedical As Inserter for an infusion set with a first and second spring units
ATE500860T1 (en) 2005-09-15 2011-03-15 Hoffmann La Roche SYSTEM COMPRISING INSERTION HEAD AND INSERTER
DE502005009907D1 (en) 2005-09-15 2010-08-26 Roche Diagnostics Gmbh Insertion head with handle
US9072476B2 (en) 2005-09-23 2015-07-07 Medtronic Minimed, Inc. Flexible sensor apparatus
US7846311B2 (en) 2005-09-27 2010-12-07 Abbott Diabetes Care Inc. In vitro analyte sensor and methods of use
US7761165B1 (en) 2005-09-29 2010-07-20 Boston Scientific Neuromodulation Corporation Implantable stimulator with integrated plastic housing/metal contacts and manufacture and use
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US7550053B2 (en) 2006-01-26 2009-06-23 Ilh, Llc Catheters with lubricious linings and methods for making and using them
IL178557A0 (en) 2005-10-19 2007-02-11 Animas Corp Safety infusion set
US20070095661A1 (en) 2005-10-31 2007-05-03 Yi Wang Method of making, and, analyte sensor
CN101389366B (en) 2005-11-03 2012-12-26 巴顿医疗设备有限公司 Fluid delivery devices and system
US8182444B2 (en) 2005-11-04 2012-05-22 Medrad, Inc. Delivery of agents such as cells to tissue
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
WO2007056504A1 (en) 2005-11-08 2007-05-18 M2 Medical A/S Infusion pump system
US20070173706A1 (en) 2005-11-11 2007-07-26 Isense Corporation Method and apparatus for insertion of a sensor
US9615851B2 (en) 2005-11-11 2017-04-11 Waveform Technologies, Inc. Method and apparatus for insertion of a sensor
US7918975B2 (en) 2005-11-17 2011-04-05 Abbott Diabetes Care Inc. Analytical sensors for biological fluid
US8815175B2 (en) 2005-11-30 2014-08-26 Abbott Diabetes Care Inc. Integrated meter for analyzing biological samples
US7922971B2 (en) 2005-11-30 2011-04-12 Abbott Diabetes Care Inc. Integrated meter for analyzing biological samples
US20100036281A1 (en) 2005-12-01 2010-02-11 Arkray, Inc. Integrated Sensor and Lancet Device and Method for Collecting Body Fluid Using the Same
US7643798B2 (en) 2005-12-09 2010-01-05 Sony Ericsson Mobile Communications Ab Passive NFC activation of short distance wireless communication
US8515518B2 (en) 2005-12-28 2013-08-20 Abbott Diabetes Care Inc. Analyte monitoring
EP1968432A4 (en) 2005-12-28 2009-10-21 Abbott Diabetes Care Inc Medical device insertion
US8160670B2 (en) 2005-12-28 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US8195267B2 (en) 2006-01-26 2012-06-05 Seymour John P Microelectrode with laterally extending platform for reduction of tissue encapsulation
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
WO2007097754A1 (en) 2006-02-22 2007-08-30 Dexcom, Inc. Analyte sensor
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7811430B2 (en) 2006-02-28 2010-10-12 Abbott Diabetes Care Inc. Biosensors and methods of making
EP1991110B1 (en) 2006-03-09 2018-11-07 DexCom, Inc. Systems and methods for processing analyte sensor data
US7887682B2 (en) 2006-03-29 2011-02-15 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US7618369B2 (en) 2006-10-02 2009-11-17 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US20070233013A1 (en) 2006-03-31 2007-10-04 Schoenberg Stephen J Covers for tissue engaging members
US7559899B2 (en) 2006-04-12 2009-07-14 Salutron, Inc. Power saving techniques for continuous heart rate monitoring
US20070255126A1 (en) 2006-04-28 2007-11-01 Moberg Sheldon B Data communication in networked fluid infusion systems
EP1857129B8 (en) 2006-05-19 2009-09-02 Roche Diagnostics GmbH Adapter device for sticking a medical instrument to the skin surface
US20090054749A1 (en) 2006-05-31 2009-02-26 Abbott Diabetes Care, Inc. Method and System for Providing Data Transmission in a Data Management System
US20080071158A1 (en) 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
EP2023818A2 (en) 2006-06-07 2009-02-18 Unomedical A/S Inserter for transcutaneous sensor
US7909842B2 (en) 2006-06-15 2011-03-22 Abbott Diabetes Care Inc. Lancing devices having depth adjustment assembly
US20080011971A1 (en) 2006-07-11 2008-01-17 Jiffy-Tite Co., Inc. Quick opening drain plug assembly
US8114023B2 (en) 2006-07-28 2012-02-14 Legacy Emanuel Hospital & Health Center Analyte sensing and response system
US7866026B1 (en) 2006-08-01 2011-01-11 Abbott Diabetes Care Inc. Method for making calibration-adjusted sensors
MX2009000876A (en) 2006-08-02 2009-02-04 Unomedical As Insertion device.
US7789857B2 (en) 2006-08-23 2010-09-07 Medtronic Minimed, Inc. Infusion medium delivery system, device and method with needle inserter and needle inserter device and method
WO2008022476A1 (en) 2006-08-24 2008-02-28 F. Hoffmann-La Roche Ag Insertion device for insertion heads, in particular for infusion sets
US8234706B2 (en) 2006-09-08 2012-07-31 Microsoft Corporation Enabling access to aggregated software security information
US8449464B2 (en) 2006-10-04 2013-05-28 Dexcom, Inc. Analyte sensor
US8478377B2 (en) 2006-10-04 2013-07-02 Dexcom, Inc. Analyte sensor
US8275438B2 (en) 2006-10-04 2012-09-25 Dexcom, Inc. Analyte sensor
US8562528B2 (en) 2006-10-04 2013-10-22 Dexcom, Inc. Analyte sensor
US8298142B2 (en) 2006-10-04 2012-10-30 Dexcom, Inc. Analyte sensor
US7831287B2 (en) 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8447376B2 (en) 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
US7822557B2 (en) 2006-10-31 2010-10-26 Abbott Diabetes Care Inc. Analyte sensors and methods
FR2909001B1 (en) * 2006-11-24 2009-12-18 Bernard Perriere MINIATURIZED AND AUTOMATIC INJECTION AND SAMPLING DEVICE FOR MEDICAL USE.
US8696570B2 (en) * 2006-11-28 2014-04-15 Roche Diagnostics Operations Inc. Insertion device and method for inserting a subcutaneously insertable element into body
US20080139903A1 (en) 2006-12-08 2008-06-12 Isense Corporation Method and apparatus for insertion of a sensor using an introducer
US7802467B2 (en) 2006-12-22 2010-09-28 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7946985B2 (en) 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US20080161666A1 (en) 2006-12-29 2008-07-03 Abbott Diabetes Care, Inc. Analyte devices and methods
US8808515B2 (en) 2007-01-31 2014-08-19 Abbott Diabetes Care Inc. Heterocyclic nitrogen containing polymers coated analyte monitoring device and methods of use
WO2008105768A1 (en) 2007-03-01 2008-09-04 Dexcom, Inc. Analyte sensor
DE502007005457D1 (en) 2007-03-14 2010-12-09 Roche Diagnostics Gmbh Insertion head for medical or pharmaceutical applications
WO2008115409A1 (en) 2007-03-19 2008-09-25 Bayer Healthcare Llc Continuous analyte monitoring assembly and method of forming the same
US20080243053A1 (en) 2007-03-30 2008-10-02 Animas Corporation Method for inserting a cannula into an infusion site
JP2010523227A (en) 2007-04-04 2010-07-15 アイセンス コーポレーション Analyte sensing device having one or more sensing electrodes
US20080269673A1 (en) 2007-04-27 2008-10-30 Animas Corporation Cellular-Enabled Medical Monitoring and Infusion System
WO2008134587A1 (en) 2007-04-27 2008-11-06 Abbott Diabetes Care, Inc. Test strip identification using conductive patterns
JP5102350B2 (en) 2007-04-30 2012-12-19 メドトロニック ミニメド インコーポレイテッド Reservoir filling / bubble management / infusion medium delivery system and method using the system
WO2008133702A1 (en) 2007-04-30 2008-11-06 Medtronic Minimed, Inc. Needle inserting and fluid flow connection for infusion medium delivery system
WO2008138006A2 (en) 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
DE102007026083A1 (en) 2007-05-25 2008-11-27 Haselmeier S.A.R.L. injection device
WO2008150917A1 (en) 2007-05-31 2008-12-11 Abbott Diabetes Care, Inc. Insertion devices and methods
EP2152350A4 (en) 2007-06-08 2013-03-27 Dexcom Inc Integrated medicament delivery device for use with continuous analyte sensor
EP2155296B1 (en) 2007-06-20 2019-08-28 Unomedical A/S Cannula insertion device with automatic needle retraction comprising only one spring
EP3533387A3 (en) 2007-06-21 2019-11-13 Abbott Diabetes Care, Inc. Health management devices and methods
CA2690870C (en) 2007-06-21 2017-07-11 Abbott Diabetes Care Inc. Health monitor
US8002752B2 (en) * 2007-06-25 2011-08-23 Medingo, Ltd. Protector apparatus
US20080319327A1 (en) 2007-06-25 2008-12-25 Triage Wireless, Inc. Body-worn sensor featuring a low-power processor and multi-sensor array for measuring blood pressure
US8641618B2 (en) 2007-06-27 2014-02-04 Abbott Diabetes Care Inc. Method and structure for securing a monitoring device element
RU2010104457A (en) 2007-07-10 2011-08-20 Уномедикал А/С (Dk) TWO SPRING INPUT DEVICE
WO2009010399A1 (en) * 2007-07-18 2009-01-22 Unomedical A/S Inserter device with controlled acceleration
RU2010105684A (en) 2007-07-18 2011-08-27 Уномедикал А/С (Dk) TURNING INTRODUCTION DEVICE
CN103349804B (en) * 2007-08-01 2017-04-26 F·霍夫曼-拉罗氏股份公司 Device for facilitating infusion of therapeutic fluids and sensing of bodily analytes
US8926509B2 (en) 2007-08-24 2015-01-06 Hmicro, Inc. Wireless physiological sensor patches and systems
US8303545B2 (en) 2007-09-07 2012-11-06 Stat Medical Devices, Inc. Infusion device and method of using and making the same
CA2699875A1 (en) * 2007-09-17 2009-03-26 Icu Medical, Inc. Insertion devices for infusion devices
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
EP2060284A1 (en) 2007-11-13 2009-05-20 F.Hoffmann-La Roche Ag Medical injection device having data input means and a pivotable display
WO2009068661A1 (en) 2007-11-29 2009-06-04 Universiteit Maastricht Device for thoracostomy
US8078592B2 (en) 2007-12-07 2011-12-13 Roche Diagnostics Operations, Inc. System and method for database integrity checking
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
WO2009097450A1 (en) 2008-01-30 2009-08-06 Dexcom. Inc. Continuous cardiac marker sensor system
US20110046456A1 (en) 2008-02-08 2011-02-24 Hoerdum Elo Lau Assembly Comprising Inserter, Cannula Part and Base Part
EP2452709B1 (en) 2008-02-08 2022-01-19 Unomedical A/S Cannula part
WO2009105337A2 (en) 2008-02-20 2009-08-27 Dexcom, Inc. Continuous medicament sensor system for in vivo use
AU2009216703A1 (en) * 2008-02-20 2009-08-27 Unomedical A/S Insertion device with horizontally moving part
US8229535B2 (en) 2008-02-21 2012-07-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
US8122783B2 (en) 2008-02-22 2012-02-28 Sauer-Danfoss Inc. Joystick and method of manufacturing the same
BRPI0906017A2 (en) 2008-02-27 2015-06-30 Mond4D Ltd System and device for measuring an analyte from a body fluid over a measuring area, device for controlling an analyte measuring device, method for measuring an analyte from a body fluid, system for monitoring an analyte from a body fluid , specialized analyte measuring element and vehicle
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US20090242399A1 (en) 2008-03-25 2009-10-01 Dexcom, Inc. Analyte sensor
US8682408B2 (en) 2008-03-28 2014-03-25 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US20090247856A1 (en) 2008-03-28 2009-10-01 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8583204B2 (en) 2008-03-28 2013-11-12 Dexcom, Inc. Polymer membranes for continuous analyte sensors
WO2009124095A1 (en) 2008-03-31 2009-10-08 Abbott Diabetes Care Inc. Shallow implantable analyte sensor with rapid physiological response
EP3659628A1 (en) 2008-04-10 2020-06-03 Abbott Diabetes Care, Inc. Method and system for sterilizing an analyte sensor
US9924898B2 (en) 2008-04-15 2018-03-27 Becton, Dickinson And Company Flash activated passive shielding needle assembly
USD618337S1 (en) 2008-05-02 2010-06-22 KCI Licensing, Inc, Reduced pressure treatment apparatus
US9295786B2 (en) 2008-05-28 2016-03-29 Medtronic Minimed, Inc. Needle protective device for subcutaneous sensors
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US20090294277A1 (en) 2008-05-30 2009-12-03 Abbott Diabetes Care, Inc. Method and system for producing thin film biosensors
WO2010003886A1 (en) 2008-07-07 2010-01-14 Unomedical A/S Inserter for transcutaneous device
US20100030052A1 (en) 2008-07-31 2010-02-04 Bommakanti Balasubrahmanya S Analyte sensors comprising plasticizers
JP5125876B2 (en) * 2008-08-20 2013-01-23 ニプロ株式会社 Insertion device
US8636884B2 (en) 2008-09-15 2014-01-28 Abbott Diabetes Care Inc. Cationic polymer based wired enzyme formulations for use in analyte sensors
EP4227675A3 (en) 2008-09-19 2023-09-06 DexCom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US8983568B2 (en) 2008-09-30 2015-03-17 Abbott Diabetes Care Inc. Analyte sensors comprising leveling agents
US20100331644A1 (en) 2008-11-07 2010-12-30 Dexcom, Inc. Housing for an intravascular sensor
US20100145377A1 (en) * 2008-12-04 2010-06-10 Venture Corporation Limited Lancing Device For Minimizing Pain
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8560082B2 (en) 2009-01-30 2013-10-15 Abbott Diabetes Care Inc. Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US20100198033A1 (en) 2009-02-05 2010-08-05 Peter Krulevitch Flexible indwelling biosensor, flexible indwelling biosensor insertion device, and related methods
DK3714788T3 (en) 2009-02-26 2023-04-17 Abbott Diabetes Care Inc Method for manufacturing improved analyte sensors
US20100213057A1 (en) 2009-02-26 2010-08-26 Benjamin Feldman Self-Powered Analyte Sensor
WO2010111660A1 (en) 2009-03-27 2010-09-30 Dexcom, Inc. Methods and systems for promoting glucose management
EP2272553A1 (en) 2009-06-29 2011-01-12 Unomedical A/S Inserter Assembly
WO2010127052A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Dynamic analyte sensor calibration based on sensor stability profile
WO2010127169A2 (en) 2009-04-30 2010-11-04 Dexcom, Inc. Performance reports associated with continuous sensor data from multiple analysis time periods
US8595607B2 (en) 2009-06-04 2013-11-26 Abbott Diabetes Care Inc. Method and system for updating a medical device
US8613892B2 (en) 2009-06-30 2013-12-24 Abbott Diabetes Care Inc. Analyte meter with a moveable head and methods of using the same
US20100331643A1 (en) 2009-06-30 2010-12-30 Abbott Diabetes Care Inc. Extruded Analyte Sensors and Methods of Using Same
US10376213B2 (en) 2009-06-30 2019-08-13 Waveform Technologies, Inc. System, method and apparatus for sensor insertion
US8437827B2 (en) 2009-06-30 2013-05-07 Abbott Diabetes Care Inc. Extruded analyte sensors and methods of using same
US9237864B2 (en) 2009-07-02 2016-01-19 Dexcom, Inc. Analyte sensors and methods of manufacturing same
KR20120054598A (en) * 2009-07-30 2012-05-30 우노메디컬 에이/에스 Inserter device with horizontal moving part
CA2766961A1 (en) 2009-08-07 2011-02-10 Unomedical A/S Delivery device with sensor and one or more cannulas
US20110046466A1 (en) 2009-08-19 2011-02-24 Feldman Benjamin J Analyte Sensors Including Nanomaterials and Methods of Using Same
WO2011025999A1 (en) 2009-08-29 2011-03-03 Abbott Diabetes Care Inc. Analyte sensor
WO2011026130A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Inserter device including rotor subassembly
WO2011026149A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Mounting unit having a sensor and associated circuitry
CN102473276B (en) 2009-08-31 2016-04-13 雅培糖尿病护理公司 Medical treatment device and method
US8882710B2 (en) 2009-09-02 2014-11-11 Medtronic Minimed, Inc. Insertion device systems and methods
WO2011041531A1 (en) 2009-09-30 2011-04-07 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
CN102724913A (en) 2009-09-30 2012-10-10 德克斯康公司 Transcutaneous analyte sensor
WO2011044386A1 (en) 2009-10-07 2011-04-14 Abbott Diabetes Care Inc. Sensor inserter assembly having rotatable trigger
CN102869400A (en) 2009-10-30 2013-01-09 梅丁格有限公司 Systems, methods and devices for adjusting insertion depth of cannula associated with portable therapeutic device
EP2335565A1 (en) 2009-12-18 2011-06-22 Roche Diagnostics GmbH Protective container for holding reusable diagnostic components
CN102791186B (en) 2009-12-23 2015-08-05 德尔塔丹麦光电声学公司 For being connected to the monitoring device on the surface of target
US8474335B2 (en) 2010-01-12 2013-07-02 Veltek Associates, Inc. Microbial air sampler
WO2011091336A1 (en) 2010-01-22 2011-07-28 Abbott Diabetes Care Inc. Method and apparatus for providing notification in analyte monitoring systems
US20110184258A1 (en) 2010-01-28 2011-07-28 Abbott Diabetes Care Inc. Balloon Catheter Analyte Measurement Sensors and Methods for Using the Same
USD924406S1 (en) * 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
US9041730B2 (en) 2010-02-12 2015-05-26 Dexcom, Inc. Receivers for analyzing and displaying sensor data
AU2011217067A1 (en) 2010-02-19 2012-09-06 Lightship Medical Limited Subcutaneous glucose sensor
GB201003581D0 (en) 2010-03-04 2010-04-21 Bacon Raymond J Medicament dispenser
US10448872B2 (en) 2010-03-16 2019-10-22 Medtronic Minimed, Inc. Analyte sensor apparatuses having improved electrode configurations and methods for making and using them
WO2011162843A1 (en) * 2010-03-24 2011-12-29 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
BR112012024635A2 (en) 2010-03-30 2017-08-08 Unomedical As medical device
CA2794104A1 (en) 2010-03-31 2011-10-06 Animas Corporation Method and system to display analyte sensor data
US9591971B2 (en) 2010-04-05 2017-03-14 Helen Of Troy Limited Insertion detector for medical probe
US8588284B2 (en) 2010-06-01 2013-11-19 Adeptence, Llc Systems and methods for networked wearable medical sensors
US9336353B2 (en) 2010-06-25 2016-05-10 Dexcom, Inc. Systems and methods for communicating sensor data between communication devices of a glucose monitoring system
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US20110319738A1 (en) 2010-06-29 2011-12-29 Abbott Diabetes Care Inc. Medical Devices and Insertion Systems and Methods
EP2415395A1 (en) 2010-08-04 2012-02-08 Roche Diagnostics GmbH Medical device with receptacle channel for bodily fluids
DK2621339T3 (en) 2010-09-29 2020-02-24 Dexcom Inc ADVANCED SYSTEM FOR CONTINUOUS ANALYTICAL MONITORING
EP3744249A1 (en) 2010-10-27 2020-12-02 Dexcom, Inc. Continuous analyte monitor data recording device operable in a blinded mode
US8784383B2 (en) 2010-11-30 2014-07-22 Becton, Dickinson And Company Insulin pump dermal infusion set having partially integrated mechanized cannula insertion with disposable activation portion
USD668164S1 (en) 2011-02-04 2012-10-02 Crestron Electronics Inc. Battery powered occupancy sensor
WO2012118872A2 (en) 2011-02-28 2012-09-07 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
USD694397S1 (en) 2011-02-28 2013-11-26 Abbott Diabetes Care Inc. Medical device inserter
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
JP2014514032A (en) 2011-03-11 2014-06-19 プロテウス デジタル ヘルス, インコーポレイテッド Wearable personal body-related devices with various physical configurations
EP3536241B1 (en) 2011-04-08 2023-03-29 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
USD691710S1 (en) 2011-05-23 2013-10-15 Abbott Diabetes Care Inc. Medical device inserter
US9402570B2 (en) * 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US8930028B2 (en) 2012-07-27 2015-01-06 Roche Diagnostics Operations, Inc. Handheld medical device functionality without battery
USD711541S1 (en) * 2013-01-15 2014-08-19 4A Medicom Gmbh Body fluid testing device
USD731334S1 (en) 2013-08-20 2015-06-09 Fibar Group sp. z o.o. Flood sensor
CA162350S (en) 2014-11-14 2016-08-29 Farmshed Labs Ltd Sensing device
US10213139B2 (en) * 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
CA2984939A1 (en) 2015-05-14 2016-11-17 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
USD775987S1 (en) 2015-09-08 2017-01-10 Nix Sensor Ltd. Egg cover
CA169912S (en) 2015-09-30 2016-11-01 Misfit Inc Activity monitoring device
USD806254S1 (en) 2015-12-07 2017-12-26 Samsung Electronics Co., Ltd. Apparatus for medical diagnosis
US10765369B2 (en) 2016-04-08 2020-09-08 Medtronic Minimed, Inc. Analyte sensor
US10765348B2 (en) 2016-04-08 2020-09-08 Medtronic Minimed, Inc. Sensor and transmitter product
USD810952S1 (en) 2016-11-25 2018-02-20 Raymond Hsu Transcutaneous electrical nerve stimulation or TENS device
USD824034S1 (en) 2016-12-15 2018-07-24 Sano Intelligence, Inc. Biomonitoring interface device
USD854146S1 (en) * 2017-03-09 2019-07-16 Amgen Inc. Handheld drug delivery device
EP3928688B1 (en) * 2017-06-23 2022-06-01 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and needle hub comprising anti-rotation feature
WO2019195661A1 (en) * 2018-04-06 2019-10-10 Zense-Life Inc. Continuous glucose monitoring device
USD888252S1 (en) * 2018-06-18 2020-06-23 Dexcom, Inc. Transcutaneous analyte sensor applicator
AU2019404908A1 (en) * 2018-12-21 2021-06-10 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte sensor insertion

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100040A1 (en) * 1997-12-05 2003-05-29 Therasense Inc. Blood analyte monitoring through subcutaneous measurement
US20060222866A1 (en) * 2003-02-26 2006-10-05 Tsuyoshi Nakamura Silsesquioxane resin, positive resist composition,layered product including resist and method of forming resist pattern
US20080114280A1 (en) * 2006-10-23 2008-05-15 Gary Ashley Stafford Variable speed sensor insertion devices and methods of use
US20110021889A1 (en) * 2009-07-23 2011-01-27 Abbott Diabetes Care Inc. Continuous Analyte Measurement Systems and Systems and Methods for Implanting Them
WO2011119898A1 (en) * 2010-03-24 2011-09-29 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US20130267811A1 (en) * 2012-04-04 2013-10-10 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973443B2 (en) 2002-11-05 2021-04-13 Abbott Diabetes Care Inc. Sensor inserter assembly
USD914881S1 (en) * 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
USD902408S1 (en) * 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
USD979766S1 (en) 2005-09-30 2023-02-28 Abbott Diabetes Care Inc. Analyte sensor device
USD961778S1 (en) 2006-02-28 2022-08-23 Abbott Diabetes Care Inc. Analyte sensor device
USD957642S1 (en) 2009-02-03 2022-07-12 Abbott Diabetes Care Inc. Analyte sensor inserter
USD957643S1 (en) 2009-02-03 2022-07-12 Abbott Diabetes Care Inc. Analyte sensor device
USD955599S1 (en) 2009-02-03 2022-06-21 Abbott Diabetes Care Inc. Analyte sensor inserter
USD882432S1 (en) 2009-02-03 2020-04-28 Abbott Diabetes Care Inc. Analyte sensor on body unit
USD962446S1 (en) 2009-08-31 2022-08-30 Abbott Diabetes Care, Inc. Analyte sensor device
US20220359074A1 (en) * 2009-08-31 2022-11-10 Abbott Diabetes Care Inc. Medical devices and methods
USD924406S1 (en) * 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
USD987830S1 (en) 2010-03-24 2023-05-30 Abbott Diabetes Care Inc. Analyte sensor inserter
USD997362S1 (en) 2010-03-24 2023-08-29 Abbott Diabetes Care Inc. Analyte sensor inserter
US11304631B2 (en) 2012-04-04 2022-04-19 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US9931065B2 (en) 2012-04-04 2018-04-03 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US9615779B2 (en) 2012-04-04 2017-04-11 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
AU2016260547B2 (en) * 2015-05-14 2020-09-03 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
EP3294134A4 (en) * 2015-05-14 2018-11-07 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
USD980986S1 (en) 2015-05-14 2023-03-14 Abbott Diabetes Care Inc. Analyte sensor inserter
WO2016183493A1 (en) 2015-05-14 2016-11-17 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10278732B2 (en) 2015-10-21 2019-05-07 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US10595900B2 (en) 2015-10-21 2020-03-24 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US9827369B2 (en) * 2016-03-16 2017-11-28 Baxter International Inc. Percutaneous administration device and method for injecting medicinal substances
US20170266369A1 (en) * 2016-03-16 2017-09-21 Baxter International Inc. Percutaneous administration device and method for injecting medicinal substances
US11134896B2 (en) 2017-06-23 2021-10-05 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11311241B2 (en) 2017-06-23 2022-04-26 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11510625B2 (en) 2017-06-23 2022-11-29 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11311240B2 (en) * 2017-06-23 2022-04-26 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US10905377B2 (en) * 2017-06-23 2021-02-02 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11207026B2 (en) 2017-06-23 2021-12-28 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
WO2019005627A1 (en) * 2017-06-23 2019-01-03 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11395631B2 (en) 2017-06-23 2022-07-26 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US20180368772A1 (en) * 2017-06-23 2018-12-27 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11504063B2 (en) 2017-06-23 2022-11-22 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US10863944B2 (en) 2017-06-23 2020-12-15 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11331019B2 (en) 2017-08-07 2022-05-17 The Research Foundation For The State University Of New York Nanoparticle sensor having a nanofibrous membrane scaffold
US11382540B2 (en) 2017-10-24 2022-07-12 Dexcom, Inc. Pre-connected analyte sensors
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11706876B2 (en) 2017-10-24 2023-07-18 Dexcom, Inc. Pre-connected analyte sensors
US11296731B2 (en) 2018-03-07 2022-04-05 Phc Holdings Corporation Communication device
USD926325S1 (en) 2018-06-22 2021-07-27 Dexcom, Inc. Wearable medical monitoring device
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
US20220080678A1 (en) * 2020-09-15 2022-03-17 Abbott Diabetes Care Inc. Systems, devices, and methods for an analyte sensor
USD982762S1 (en) 2020-12-21 2023-04-04 Abbott Diabetes Care Inc. Analyte sensor inserter
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter
USD1006235S1 (en) 2020-12-21 2023-11-28 Abbott Diabetes Care Inc. Analyte sensor inserter

Also Published As

Publication number Publication date
US20120197098A1 (en) 2012-08-02
US8764657B2 (en) 2014-07-01
US9687183B2 (en) 2017-06-27
US10010280B2 (en) 2018-07-03
EP3123934A1 (en) 2017-02-01
US20210204850A1 (en) 2021-07-08
EP4248866A3 (en) 2023-12-20
JP5904500B2 (en) 2016-04-13
CN102573616A (en) 2012-07-11
US11000216B2 (en) 2021-05-11
EP4066731A1 (en) 2022-10-05
US20210000400A1 (en) 2021-01-07
CN102573616B (en) 2016-01-20
EP2549918A4 (en) 2014-05-14
JP2016128031A (en) 2016-07-14
US20240008779A1 (en) 2024-01-11
EP3766408B1 (en) 2022-04-27
EP2552532A1 (en) 2013-02-06
US20210007651A1 (en) 2021-01-14
CA3134869A1 (en) 2011-09-29
US20210113126A1 (en) 2021-04-22
US20120190942A1 (en) 2012-07-26
LT3622883T (en) 2021-08-25
EP2549918B1 (en) 2016-06-29
US10772547B1 (en) 2020-09-15
USD997362S1 (en) 2023-08-29
ES2924054T3 (en) 2022-10-04
WO2011119896A1 (en) 2011-09-29
US9186098B2 (en) 2015-11-17
AU2011230615A1 (en) 2012-01-19
CA3138585C (en) 2023-01-17
EP4248866A2 (en) 2023-09-27
US10881340B2 (en) 2021-01-05
US10945649B2 (en) 2021-03-16
US20200405208A1 (en) 2020-12-31
US10959654B2 (en) 2021-03-30
US20220142533A1 (en) 2022-05-12
IL217129A0 (en) 2012-02-29
EP3622883B1 (en) 2021-06-30
US20210022654A1 (en) 2021-01-28
CA3096110C (en) 2023-11-14
CA2766685A1 (en) 2011-12-29
US20210038137A1 (en) 2021-02-11
US20120190943A1 (en) 2012-07-26
CA3138585A1 (en) 2011-09-29
US11266335B2 (en) 2022-03-08
CA3228738A1 (en) 2011-09-29
US20190076073A1 (en) 2019-03-14
CN102548476A (en) 2012-07-04
EP3622883A1 (en) 2020-03-18
ES2881798T3 (en) 2021-11-30
EP2549918B2 (en) 2023-01-25
EP3123934B1 (en) 2019-07-10
US9265453B2 (en) 2016-02-23
US11246519B2 (en) 2022-02-15
CN105581781B (en) 2019-02-15
DK3622883T3 (en) 2021-07-19
JP2013523217A (en) 2013-06-17
EP3766408A1 (en) 2021-01-20
US20200397358A1 (en) 2020-12-24
US10952657B2 (en) 2021-03-23
US20230125528A1 (en) 2023-04-27
EP2549918A1 (en) 2013-01-30
CA3135001A1 (en) 2011-09-29
US11064922B1 (en) 2021-07-20
US11013440B2 (en) 2021-05-25
AU2011269796A1 (en) 2012-02-16
WO2011162843A1 (en) 2011-12-29
JP2013523216A (en) 2013-06-17
CN102639185B (en) 2015-02-04
IL217082A0 (en) 2012-02-29
DK3766408T3 (en) 2022-05-30
US10881341B1 (en) 2021-01-05
BRPI1105778A2 (en) 2016-05-03
US20220125358A1 (en) 2022-04-28
EP4245220A3 (en) 2023-12-20
LT3766408T (en) 2022-07-11
US20210204849A1 (en) 2021-07-08
US20120010642A1 (en) 2012-01-12
US20210161445A1 (en) 2021-06-03
JP2016187574A (en) 2016-11-04
US20120197222A1 (en) 2012-08-02
US20220087580A1 (en) 2022-03-24
CA3134869C (en) 2024-03-05
CA2766693A1 (en) 2011-09-29
CN102639185A (en) 2012-08-15
US20160030078A1 (en) 2016-02-04
US11058334B1 (en) 2021-07-13
CA2766232C (en) 2021-12-07
AU2011269796A2 (en) 2012-02-16
US20190298240A1 (en) 2019-10-03
BRPI1105769A2 (en) 2016-05-03
CN105581781A (en) 2016-05-18
US20110319729A1 (en) 2011-12-29
US10292632B2 (en) 2019-05-21
US9215992B2 (en) 2015-12-22
US20120190941A1 (en) 2012-07-26
US20120190951A1 (en) 2012-07-26
CA2766232A1 (en) 2011-09-29
US20220218247A1 (en) 2022-07-14
USD948722S1 (en) 2022-04-12
EP4245220A2 (en) 2023-09-20
USD987830S1 (en) 2023-05-30
US20110288574A1 (en) 2011-11-24
IL217081A0 (en) 2012-02-29
US20160128615A1 (en) 2016-05-12
US20210204851A1 (en) 2021-07-08
US20210000399A1 (en) 2021-01-07
CA3096110A1 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
US10945649B2 (en) Medical device inserters and processes of inserting and using medical devices
AU2011230596A1 (en) Medical device inserters and processes of inserting and using medical devices
WO2012118872A2 (en) Medical device inserters and processes of inserting and using medical devices

Legal Events

Date Code Title Description
AS Assignment

Owner name: ABBOTT DIABETES CARE INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LEE, DANIEL H.;LOVE, MICHAEL;PACE, LOUIS G.;AND OTHERS;SIGNING DATES FROM 20110720 TO 20110815;REEL/FRAME:033932/0101

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION